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Abstract 
Introduction: In Canada, people with HIV are legally required to disclose their HIV status to 
their sexual partners prior to having sex that presents a “realistic possibility of HIV 
transmission”. This policy has been criticized for failing to consider the safety and autonomy 
of women with HIV, which can be compromised following disclosure. 
Objectives: To investigate whether experiences of childhood physical or sexual abuse 
(CPSA) affect barriers to HIV disclosure to partners in adulthood, which include: later 
physical or sexual abuse, sexual agency, HIV stigma, and perceived social support.  
Methods: Propensity scores and inverse probability of treatment weights were used to 
estimate the difference in barriers to HIV disclosure attributable to CPSA among n=1307 
women with HIV. Effects were reported for the total sample, and within ethnoracial groups 
(Indigenous, Black African, Black Caribbean, white, and “other”).  
Results: CPSA increased prevalence of both physical and sexual abuse in adulthood in the 
total sample and within ethnoracial groups, while effects for other barriers were subgroup 
specific.  
Conclusion: This study illustrates that the environment in which women are legally expected 
to disclose their HIV status is often characterized by abuse, with high risk of revictimization 
from childhood to adulthood. While further research should investigate mediating pathways 
between CPSA and disclosure barriers across ethnoracial groups, this study provides the first 
targeted evidence suggesting that the causes of HIV disclosure may be more distal and more 
complex than presumed under Canadian non-disclosure policy.   
Keywords 
Women with HIV; child abuse; violence; HIV disclosure; intersectionality; propensity 
scores; generalized boosted modelling  
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Chapter 1  
1 Introduction and Objectives 
This chapter will provide background information to contextualize the study rationale, 
discuss the data source, identify study objectives, and specify my role in the project.  
1.1 Study Rationale 
The Canadian legal system (and in some provinces, the Public Health system) enforces 
regulations requiring the sexual and/or needle-sharing partners of people living with HIV 
to be notified that they may be at risk for HIV.1 The legal precedent set by the Supreme 
Court of Canada in 2012 requires people living with HIV to disclose their HIV status to 
their sexual partners prior to having sex that presents a “realistic possibility of HIV 
transmission”, with potential legal consequences including criminal charges of 
aggravated sexual assault.2 Canada’s position on HIV criminalization has been criticized 
for failing to account for scientific advances in HIV treatment, and for diminishing the 
safety and autonomy of people with HIV.3,4 This precedent-setting case law purports to 
enhance public safety, but does not acknowledge what all people with HIV know: 
disclosure of one’s HIV status can be dangerous, sometimes leading to discrimination, 
loss of resources, and life-threatening violence. For women with HIV, disclosure is often 
inextricably tied to gendered power imbalances which intersect with other social 
positions including race, class, and Indigeneity.5 However, the criminal justice system 
frames HIV disclosure as a fairly simplistic choice, with limited understanding of how 
violence against women and girls influences decision making. Thus, the overarching goal 
of this thesis is to complicate how the system understands “choice” as related to HIV 
non-disclosure. 
Among women in the general population, childhood physical or sexual abuse (CPSA) is a 
salient risk factor for adverse outcomes in adulthood. Women who experience CPSA are 
at greater risk for further violence in the future (“revictimization”)6,7 and may be more 
vulnerable to power-imbalanced sexual relationships than women who did not experience 
CPSA.8–10 Importantly, CPSA is also known to increase HIV risk.11–13 While the 
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pathways between violent victimization and HIV infection have been studied widely, less 
attention has been given to how experiences of violence may produce further 
vulnerability among women with HIV. Of particular interest is whether experiences of 
childhood violence have an impact on factors which enable or disenable women to 
disclose their HIV status to sexual partners in adulthood. These include experiencing 
physical or sexual abuse in adulthood, having low sexual relationship power, 
experiencing high HIV stigma, and perceiving oneself to have low social support. If 
CPSA has a causal effect on these outcomes (as has sometimes been found among the 
general population), the implication is that adverse childhood experiences not only 
increase risk for HIV, but for further vulnerability among women with HIV. In the 
Canadian context of HIV criminalization, this vulnerability to non-disclosure translates 
into socio-legal risk. Thus, the goal of this research is to assess whether women with HIV 
who experienced abuse during childhood experience barriers to partner disclosure 
differently from the larger population of women with HIV. This question will be explored 
using intersectionality theory in an eco-social framework in order to account for aspects 
of CPSA which may be unique to women with HIV at particular intersections of gender, 
HIV, and ethnoracial identity. 
This project is positioned to advocate for women living with HIV by highlighting 
potential inequities that are not addressed by Canadian HIV criminalization. Additionally, 
this research has the potential to reach women with HIV who have experienced child 
abuse and assure them that their experiences with HIV disclosure are valid, shared, and 
not their own fault. 
1.2 Thesis Objectives and Hypotheses 
1. Objective: To adapt a theoretical model which incorporates an eco-social 
intersectionality perspective with the goal of appropriately contextualizing the 
causes and consequences of CPSA among women with HIV in Canada. This 
objective will be addressed as part of the literature review. 
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2. Objective: To assess whether women with HIV who experienced CPSA 
experience greater barriers to disclosing their HIV status to partners [(a) current 
experiences of physical or (b) sexual violence, (c) low sexual relationship power, 
and (d) high levels of HIV stigma, and (e) reduced perceived social support] 
compared to women with HIV who have not experienced child abuse.  
Hypothesis: It is expected that among women with HIV, as for other women not 
in the study, exposure to CPSA will impact later experiences of (a) physical or (b) 
sexual violence, (c) sexual relationship power, and (d) perceived social support, 
but with additional HIV-specific consequences such as (e) heightened feelings of 
HIV stigma. On average, it is expected that women with HIV who have 
experienced child abuse will face greater barriers to partner disclosure during 
adulthood. 
3. Objective: To evaluate the aforementioned causal relationships across strata of 
ethnoracial groups, specifically: Indigenous, Black African, Black Caribbean, and 
white women, as well as a group for other ethnoracial groups limited by sample 
size (e.g. Latin American, South Asian women).  
Hypothesis: It is expected that the causal relationships between child abuse and 
barriers to HIV disclosure will be somewhat distinct across these groups. Lasting 
familial effects of institutionalized abuse within residential schools, as well as 
current experiences of colonialism will impact Indigenous women in causal 
pathways not experienced by non-Indigenous women. At a structural level, 
racialization may also be a determinant of access to treatment and services 
following child abuse and into adulthood. Furthermore, cultural perceptions and 
acceptance of child abuse can be highly heterogeneous, potentially affecting the 
nature and sequelae of child abuse.  
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1.3 Canadian HIV Women’s Sexual and Reproductive 
Health Cohort Study 
The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS) 
is a national prospective study developed in response to a lack of research on women 
with HIV outside of studies on reproductive health.14 The overarching objective of this 
study is to identify the barriers and facilitators to accessing women-centred HIV care 
experienced by HIV positive women in Canada.15 Here, women-centred HIV care is 
briefly defined as “care that supports women living with HIV to achieve the best health 
and wellbeing as defined by them.”15 In order to establish a basis for women-centred HIV 
care in Canada, the CHIWOS team operates under several guiding 
frameworks/principles, including: community based research (CBR), Greater (and 
Meaningful) Involvement of People Living with HIV (GIPA, MIPA), as well as 
intersectionality, critical feminism, and anti-oppression.14 CBR is an increasingly 
common research method which prioritizes community needs and ideas by placing 
decision-making power into the hands of community members working alongside 
researchers.16 The involvement of the community under study not only maximizes the 
relevance of research results, but ensures that results are properly contextualized as well 
as communicated to all relevant stakeholders.16 In CHIWOS, CBR has been 
operationalized by involving women with HIV in identifying study objectives, as well as 
developing and testing the survey.17 Most notably, the CHIWOS team hired and trained a 
national team of 39 women with HIV as Peer Research Associates (PRA) responsible for 
data collection, among other research activities.15 CHIWOS is one among few studies 
which have successfully implemented CBR on a national scale, especially within 
quantitative research. The heavy involvement of women with HIV in study design 
through to knowledge translation and exchange also speaks to the principles of GIPA and 
MIPA.18 Finally, CHIWOS applies several feminist and social justice frameworks such as 
intersectionality and anti-oppression in order to create a study that acknowledges the 
diverse experiences of women with HIV while shedding light on social 
privilege/oppression, and striving for meaningful change.  
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In addition to peer research associates, the CHIWOS research team consists of a national, 
multi-disciplinary team of principal investigators, led by nominated principal investigator 
Mona Loutfy (MD, FRCPC, MPH) at the University of Toronto. Each province where 
CHIWOS collects data has a research coordinator, as well as a Community Advisory 
Board. Along with the Community Advisory Boards, the study is led by the National 
Steering Committee. Women with HIV are active decision makers at all levels of the 
CHIWOS team. The study is also supported by an extended team of co-investigators, 
collaborators, and students. As of June 2018, knowledge and data from CHIWOS has 
supported the publication of 25 papers along with multiple webinars and conference 
presentations.   
1.3.1 My Role in the Project 
Under its Project and Data Request Policy, CHIWOS allows researchers (including 
principal investigators, co-investigators, students, and collaborators) access to CHIWOS 
data under several conditions. Students, in particular, must be under the supervision of a 
CHIWOS-affiliated researcher, and anyone who accesses data must be added to the 
regional ethics board statement and submit a Data Request Form for acceptance by the 
National Management Team. My thesis supervisor, Dr. Greta Bauer, is a CHIWOS co-
investigator who participated in survey development and provides ongoing support to the 
study team, especially concerning studies of transgender health. The idea for the current 
study was formulated by Dr. Bauer and myself, born from my interest in the effects of 
trauma from a life course perspective, a mutual interest in quantitative intersectionality, 
and Dr. Bauer’s knowledge of community perspectives of HIV non-disclosure policy in 
Canada.  
Under Dr. Bauer’s supervision and with the support of two CHIWOS peer research 
associates (Shazia Islam, Mary Ndung’u), my thesis supervisory committee (Dr. Greta 
Bauer, Dr. Igor Karp), other CHIWOS students (Mostafa Shokoohi, Ashley Lacombe-
Duncan), research objectives and methodology were developed and submitted to the 
National Management Team for review. The form involved identifying a manuscript 
preparation team, a plan for meaningful involvement of people with HIV, study rationale 
and objectives, and detailed statistical methods. While the form was being refined for 
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submission, a novel theoretical model to support the research question was adapted by 
myself along with Dr. Bauer, Shazia Islam, and Mary Ndung’u. The form was accepted 
with minor revisions in December 2017, with data cleaning and analysis conducted by 
myself (supported by Dr. Greta Bauer, Dr. Igor Karp, Dr. Guangyong Zou, and Dr. Dan 
Lizotte) over the next several months. Results were interpreted with the use of personal 
and community knowledge along with quantitative expertise by my CHIWOS study team 
(myself, Dr. Bauer, Shazia Islam and Mary Ndung’u). During the preparation of this 
thesis, a corresponding manuscript for submission to a scientific journal was developed. 
While the entirety of this thesis was written by myself, the journal manuscript will be co-
authored by myself, Dr. Bauer, Shazia Islam, Mary Ndung’u, Angela Kaida, Alexandra 
de Pokomandy, and Mona Loutfy on behalf of the CHIWOS Research Team. Prior to 
publication, the journal manuscript (though not the body of this thesis) will be reviewed 
for acceptance by the CHIWOS National Management Team.  
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Chapter 2  
2 Literature Review 
This chapter introduces the medical and social history of HIV, and describes the 
population of women with HIV in Canada, contextualizing their experience using 
intersectionality theory. Canada’s current legal policy of criminalizing HIV non-
disclosure to sexual partners is discussed, alongside scientific and ethical objections to 
this practice. Literature on selected barriers to partner disclosure among women with HIV 
is presented, with barriers chosen being those identified from previous research, and 
which are also available in the CHIWOS dataset. Child abuse is defined and its causes are 
discussed using eco-social theory and intersectionality. Finally, a novel theoretical model 
integrating the aforementioned theories is presented, with the objective of outlining the 
causes of child abuse, as well as how child abuse may cause barriers to HIV disclosure 
later in life.  
2.1 HIV in Canada 
Human immunodeficiency virus (HIV) is a viral infection affecting an estimated 63,400 
to 87,600 Canadians as of 2014.19 Symptomatology of HIV was first documented in 1981 
among patients with late stage HIV infection which would come to be known as acquired 
immune deficiency syndrome (AIDS).20 From the beginning, AIDS was a disease steeped 
in stigma and exceptionalism, stemming from prejudicial fear of the populations affected 
by the virus, and fear of the death sentence that it carried.21,22 In particular, AIDS was 
first documented among American gay men and intravenous drug users.21 The symptoms 
included skin lesions, enlargement of the lymph nodes, pneumonia, and apparent 
immunosuppression leading to opportunistic infection.20 By 1984, it was established that 
AIDS was likely a sexually transmitted disease also transmitted by exposure to blood 
products,23 the retrovirus implicated as the cause of AIDS was isolated,24 and the 
biological mechanisms driving the shift from HIV infection (“pre-AIDS”) to 
symptomatic AIDS were under investigation.25 It is now known that HIV can be 
transmitted by exchange of specific body fluids from an infected person via contact with 
the blood, a mucous membrane, or damaged tissue.26 Furthermore, untreated HIV 
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infection begins with a latent period of an estimated 4.2 to 15 years27 characterized by a 
progressive decline in CD4 lymphocytes28 and increase in plasma viral load.29 The latent 
period is followed by onset of symptoms (wasting, fatigue, pain, pyrexia, and coughing)30 
often attributable to immunosuppression by way of CD4 lymphocyte deficiency.31 
Without treatment, the current estimated survival time after a diagnosis with AIDS is two 
years, but this estimate can vary greatly based on age at diagnosis and comorbid 
conditions.32,33  
Elucidation of the HIV mechanism has led to the development of anti-retroviral therapy 
(ART).34,35 Where such treatment is accessible, HIV can be treated as a communicable 
chronic condition rather than a deadly infectious disease.36 ART, established as the 
standard of care for HIV in 1996,37 refers to a given combination of antiretroviral 
medications which can render plasma viral load undetectable, increase CD4 cell count, 
and increase lifespan to match that of those without HIV.34,35,38 Consequently, more 
people than ever are living with HIV.39 Since the uptake of ART in the 1990s, cases of 
AIDS in Canada have dropped 90% to 188 reported cases in 2014,19 an indicator of 
people with HIV living longer on treatment. Additionally, because ART can reduce 
plasma viral load, transmission rates among couples where one partner is HIV-positive 
have been estimated at 0 events per 100 couple-years, with some variability based on 
sexual behaviour.40 As of 2016, Health Canada has also approved the use of pre-exposure 
prophylaxis (PrEP), an antiretroviral medication aimed at reducing transmission risk by 
treating those at risk for HIV.41  
While medical advances since 1981 have succeeded in allowing people with HIV who 
have access to treatment to live long and healthy lives, the social stigma surrounding HIV 
infection remains pervasive in Canadian society. Since the onset of the epidemic, 
widespread homophobia and misinformation about HIV led many members of the public 
to hold prejudicial beliefs about HIV and the people affected by it, so much so that HIV 
has been theorized to occupy a dual status as both an infectious disease and social 
phenomenon.42 Today, public and institutionalized HIV stigma is less overt but remains 
an issue affecting people with HIV every day. As of 2012, 29% of Canadians still held 
medium or high levels of stigmatizing beliefs about those with HIV (e.g. fear, belief that 
9 
 
people with HIV are to blame for their HIV status) and 34% held medium or high levels 
discriminatory beliefs (e.g. the rights to employment, sexual activity, and privacy of 
people with HIV should be restricted).43 The discrimination experienced by those with 
HIV and the internalized stigma that results from it can have widespread and devastating 
effects including lack of access to healthcare44 as well as loss of income or housing.45 
HIV stigma is also known to affect a person’s ability to disclose their HIV status to 
family, friends, and sexual partners.44 While many campaigns and programs have been 
implemented in Canada with the goal of reducing HIV related discrimination, it remains a 
pervasive determinant of health and wellness for people with HIV.  
2.2 Women Living with HIV 
An estimated 15,219 women in Canada are have been diagnosed with HIV since the 
onset of the epidemic, with adult women accounting for 23.3% of incident cases 
nationally in 2016.46 This proportion has remained stable since 2004.46 While the 
incidence of HIV is lower among women compared to men (3.0 per 100,000 and 9.8 per 
100,000, respectively),47 women with HIV face unique challenges that make them a key 
population in the study of HIV. Until very recently women in Canada tended to be, on 
average, diagnosed with HIV and AIDS at younger ages than men, though it was unclear 
whether this difference was attributable to differences in age of infection or diagnosis 
itself.19 As of 2016 these age differences are negligible, with the majority of HIV 
diagnoses for both men and women (27.7% and 31.8%, respectively) occurring between 
ages 30 to 39.46 The majority of women with HIV in Canada, since the start of the 
epidemic, have been diagnosed in the most populous provinces: Ontario (ON), Quebec 
(QC), and British Columbia (BC) (Table 1). However, the 2016 HIV diagnosis rate per 
100,000 population indicates that incidence of HIV among women is highest in 
Saskatchewan, Yukon, and Manitoba. CHIWOS data reports that 81.7% of women with 
HIV in Canada (ON, QC, and BC) live in a large city as opposed to a small or medium 
city, a factor which likely impacts access to HIV care.48 According to the same study, 
3.7% of Canadian women with HIV have not engaged in HIV care in the past year while 
2.8% have never accessed HIV care.48  
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Table 1: All-ages Canadian HIV cases by sex and province/territory, 1985-2016 
 
Total number of reported 
cases, 1985-2016 
Diagnosis rate per 100,000 
population, 2016 
Province/territory Females Males Females Males 
British Columbia 2,270 12,913 1.7 9.0 
Yukon 19 44 10.8 0.0 
Alberta 1,617 5,362 4.0 9.1 
Northwest Territories 12 45 DS DS 
Nunavut 0 4 DS DS 
Saskatchewan 921 1,410 13.6 16.5 
Manitoba 690 1,660 6.0 13.0 
Ontario 5,690 29,590 2.5 10.1 
Quebec 3,745 14,155 2.8 11.5 
New Brunswick 70 374 1.3 0.5 
Nova Scotia 114 729 0.6 2.4 
Prince Edward Island 9 32 DS DS 
Newfoundland and Labrador 62 250 0.4 1.9 
TOTAL 15,219 66,568 3.0 9.8 
Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 
Data on sex were submitted for 99.6% of reported HIV cases in 2016. DS: indicates cases where data 
has been suppressed per the request of the province or territory. Reporting of HIV cases for individuals 
younger than two years of age varies among provinces and territories. For Quebec, the number of HIV 
cases is based on the minimum number of HIV-positive individuals. 
HIV exposure patterns are also distinct among women compared to men; while men who 
have sex with men (MSM) remains the predominant HIV exposure category among men, 
three times as many cases among women are attributable to heterosexual contact (63.5% 
versus 21.6%) and approximately twice the proportion of cases are attributable to 
injection drug use (IDU) (27.3% versus 10.9% IDU and 5.1% MSM/IDU) (Table 2).46 
Other exposure categories commonly applied in public health surveillance are perinatal 
transmission, receipt of blood or blood products, no identified risk (NIR), and other, 
which may include less common exposures such as receipt of semen from an HIV-
positive donor.19 Furthermore, the heterosexual contact category is broken down into 
exposure from heterosexual contact with a person at risk (Het-risk, i.e. heterosexual 
contact with someone who has HIV, who injects drugs, is a bisexual male, or is a person 
from an HIV-endemic country), heterosexual contact with no identified risk factors (Het-
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NIR), and origin from an HIV-endemic country (Het-endemic).19 HIV-endemic countries 
are those with an HIV prevalence greater than 1% and either (a) 50% or more HIV cases 
attributable to heterosexual transmission, (b) a male to female ratio of 2:1 or less, or (c) 
HIV prevalence greater than or equal to 2% among women receiving prenatal care.19 
While cases originating from HIV-endemic countries may not necessarily have acquired 
HIV in the HIV-endemic country or be attributable to heterosexual contact, they are 
presumed to be so based on the above conditions. In 2016, origin from an HIV-endemic 
country was the most common heterosexual exposure for incident HIV cases among 
women, followed by heterosexual contact with no identified risk and heterosexual contact 
with a person at risk (Table 2). Data on exposures from HIV-endemic countries may be 
more complete than domestic exposures as Citizenship and Immigration Canada has 
conducted mandatory HIV screening for permanent resident applicants over the age of 15 
(or under the age of 15 with given risk factors) since 2002.19,49  
Table 2: Number and percentage distribution of Canadian HIV diagnoses among adults 
(≥ 15 years old) by sex and exposure category, 2016 
 Females Males 
Exposure category n % n % 
MSM - - 633 59.0 
MSM/IDU - - 55 5.1 
IDU 99 27.3 117 10.9 
Blood/blood products 
Recipient of blood/clotting factor 0 0.0 1 0.1 
Recipient of blood 0 0.0 1 0.1 
Recipient of clotting factor 0 0.0 0 0.0 
Heterosexual contact 
Origin from HIV-endemic country 85 23.5 66 6.2 
Sexual contact with person at risk 67 18.5 60 5.6 
No identified risk, heterosexual 78 21.5 106 9.9 
Other* 33 9.1 33 3.1 
Subtotal 362 100.0 1,072 100.0 
No identified risk 18 N/A 69 N/A 
Not reported 160 N/A 640 N/A 
TOTAL** 540 N/A 1,781 N/A 
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Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data 
on exposure category were submitted for 61.6% of reported HIV cases in 2016. Exposure categories are 
mutually exclusive and are meant to identify an individual’s most likely transmission route. Where multiple 
potential transmission routes are reported, a hierarchy is used to assign the case to a single category (see 
Appendix 1). 
*For Alberta, cases identified as Citizenship and Immigration Canada/Out of Country (CIC/OOC) were 
classified in the exposure category of “Other” 
**Excludes 2,612 cases where sex was not reported or reported as transsexual or transgender.  
Due to inter-provincial and territorial heterogeneity in case reporting practices, some 
surveillance data may not completely represent the current state of the HIV epidemic. In 
particular, surveillance data on race/ethnicity and exposure category is often incomplete 
or is not submitted by some provinces.46 At the national level, only 48.6% of reported 
cases among adults included information on race/ethnicity and 61.6% specified an 
exposure category in 2016.46 With the understanding that this limitation severely impacts 
the interpretability of this data, existing data indicates that there may be greater racial 
diversity among women compared to men with HIV in Canada.46 Black women made up 
36.5% of incident diagnoses among women in 2016, followed by Indigenous First 
Nations women (32.7%) and white women (21.0%) (Table 3).46 Comparatively, half 
(47.8%) of 2016 male cases were among white men, followed by Indigenous men and 
Black men.46 While greater sex-stratified proportions of new cases are among Black and 
Indigenous women than Black and Indigenous men, the proportion of new cases among 
white, South Asian/West Asian, Arab, Asian, and Latin American women is lower than 
that of males of the same racial/ethnic group.46  
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Table 3: Number and percentage distribution of all-ages Canadian HIV cases by sex and 
race/ethnicity, 2014, 1998-2014 
 Females Males 
 2016 Total (1998-2016) 2016 Total (1998-2016) 
Race/ethnicity n % n % n % n % 
Indigenous 
First Nations 103 32.7 1,082 30.2 113 13.7 1,149 13.0 
Métis 7 2.2 117 3.3 11 1.3 166 1.9 
Inuit 1 0.3 5 0.1 2 0.2 13 0.1 
Indigenous, 
unspecified 
3 1.0 256 7.2 1 0.1 287 3.2 
South Asian/West 
Asian/Arab 
7 2.2 38 1.1 37 4.5 249 2.8 
Asian 4 1.3 69 1.9 62 7.5 458 5.2 
Black 115 36.5 1220 34.1 135 16.4 1,226 13.8 
Latin American 3 1.0 36 1.0 52 6.3 386 4.4 
White 66 21.0 730 20.4 394 47.8 4,792 54.1 
Other 6 1.9 27 0.8 17 2.1 136 1.5 
Subtotal 315 100 3580 100 824 100 8,862 100 
Race/ethnicity not 
reported 
232 N/A 7083 N/A 964 N/A 23,782 N/A 
TOTAL* 547 N/A 10,663 N/A 1,788 N/A 32,644 N/A 
Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data 
on race were submitted for 48.6% of reported HIV cases in 2016. For all provinces and territories, 
race/ethnicity information is not available before 1998. Race/ethnicity information is not submitted by 
Quebec or British Columbia, and is not available for Ontario before 2009. Reporting of HIV cases for 
individuals younger than two years of age varies among provinces and territories. *Excludes 291 cases 
where sex was not reported or reported as transsexual or transgender.   
Presumably due to the aforementioned reporting limitations, Public Health Agency of 
Canada surveillance reports do not provide sex-segregated rates of exposure by category 
and race/ethnicity simultaneously. However, based on cross-classification of exposures 
by category and race/ethnicity for males and females combined (Figure 1) as well as 
some regional sex-stratified data,50 there is reason to believe that exposure category 
varies by race and sex. Where race and exposure category were reported, IDU was the 
primary exposure category among Indigenous populations in 2016.46 53.2% of people 
with HIV who are Black were classified as Het-Endemic, though, as previously noted, 
this does not necessarily mean that exposure was actually heterosexual, or took place in 
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the HIV-endemic country.46 Among people with HIV who are South Asian, West Asian, 
or Arab, as well as white, Asian, Latin American, or another ethnicity, exposures were 
primarily MSM followed by heterosexual contact.46 Some provinces provide a more 
nuanced breakdown of incident HIV cases by sex, race, and exposure category. Looking 
to Saskatchewan, where the 2016 HIV diagnosis rate for women was the highest in 
Canada,46 88% of newly diagnosed women were Indigenous and 58% of newly 
diagnosed Indigenous women reported IDU while 38% reported heterosexual activity as 
their primary HIV risk factor.50 This speaks to a larger trend elucidated by Roy and 
colleagues, whereby IDU in general is becoming less common, however, specific drugs 
and/or drug use practices may contribute to increased risk of blood-borne infection.51 Roy 
specifically points to the growing opioid epidemic, and a recent study of people who 
inject drugs in Montreal which found that people who injected opioids exhibited more 
behaviours related to transmission risk (syringe sharing, injecting more frequently and in 
public places), and greater Hepatitis C risk than people who inject drugs other than 
opioids.51,52 In this way, increased injection of opioids may drive HIV incidence, even in 
the context of reduced IDU in the general population. This illustrative example points to 
the need for further research on HIV transmission patterns in Canada, while reporting 
quality of surveillance data indicates the need for such data at the intersection of race and 
sex. 
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Figure 1: Percentage distribution of all-ages Canadian HIV cases by race/ethnicity and 
exposure category, 2016 [n=2,344] 
Data source: Canadian Community Disease Reports, HIV in Canada – Supplementary tables, 2016.47 Data 
on race were submitted for 48.6% of reported HIV cases, while data on exposure category were submitted 
for 61.6% cases in 2016. Reporting of HIV cases for individuals younger than two years of age varies 
across provinces and territories. Abbreviations: MSM=Men who have sex with men, MSM/IDU= men who 
have sex with men and use injection drugs, IDU=injection drug use, Blood= receipt of blood or blood 
products, Het-risk= heterosexual contact with risk factor, Het-NIR= heterosexual contact with no identified 
risk factors, Het-Endemic= origin from HIV-endemic country, NIR= no identified risk.  
The social position occupied by women with HIV can be articulated within the 
framework of intersectionality, a term coined by Black feminist legal scholar Kimberlé 
Crenshaw.53 Intersectional perspectives posit that embodied social positions and identities 
interact in the context of structural power inequities, resulting in inequities across 
population groups.53–55 In this context, intersectionality theory suggests that population 
characteristics of women with HIV are determined by the systematic factors such as 
sexism, racism, colonialism, transphobia, and homophobia which interact with gender 
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(and one another) to make women vulnerable to HIV. The result of intersecting power 
inequities such as racism and transphobia impacting vulnerability to HIV is that the 
population of women with HIV tends to be multiply-marginalized, further affecting 
health and access to care, as well as other aspects of life such as stigma and 
discrimination. Furthermore, the HIV care women receive is often not population-
specific, but rather tailored to men with HIV, posing a systematic obstacle to women 
achieving optimal health and wellness.14 Systematic intersectional disadvantages for 
women with HIV are also visible in fields outside of health, one notable example being 
that the majority of women convicted in HIV non-disclosure cases occupy 
intersectionally marginalized positions which likely influence their ability to disclose.56 
Indigenous women are particularly over-represented, accounting for an estimated 42% of 
women charged.57 An intersectional framework will be used to contextualize the 
experiences of women with HIV throughout this thesis.   
2.3 Criminalization of HIV Non-Disclosure in Canada 
Under Canadian case law (R v Mabior), criminal charges may be laid against people with 
HIV who do not disclose their HIV status to sexual partners prior to having sex that poses 
a “realistic possibility of HIV transmission”.2 Charges can be laid regardless of whether 
transmission actually occurred, and can range from common nuisance to murder, with the 
most common charge being aggravated sexual assault.1 However, the precedent set in the 
2012 R. v. Mabior case does not specify which sexual acts under which circumstances 
constitute a realistic possibility of transmission. Guidelines created by the Canadian 
HIV/AIDS Legal Network interpret the R. v. Mabior ruling such that people with HIV 
have a legal obligation to disclose prior to engaging in vaginal sex with a condom if their 
plasma viral load is not “low,” or prior to condomless vaginal sex regardless of viral 
load.1 Based on risk of transmission, the guidelines estimate that disclosure requirements 
for anal sex would be at least as strict, and requirements for oral sex may be more 
lenient.1 Notably, in 2017, the Ontario Attorney General and Ontario Minister of Health 
and Long Term Care announced that cases of HIV non-disclosure in Ontario would not 
be prosecuted where the person with HIV has had a suppressed viral load for six 
months.58 However, this decision is limited to Ontario and (similarly to the Supreme 
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Court decision) does not specifically address other situational factors which may make 
HIV transmission risk negligible. As of 2016, at least 184 individuals in Canada have 
been charged in cases of HIV non-disclosure, 101 have been convicted, and 93% of those 
convicted have received a prison sentence.57 As of 2014, Canada was second to only the 
United States, a population ten times its size, in the number of arrests and prosecutions in 
cases of HIV non-disclosure.1,59  
Another consequence of criminalization is that it renders the empirical study of HIV 
disclosure to sexual partners unethical. Because information exchanged between 
researchers and participants may be subject to subpoena in a court of law investigating 
claims of non-disclosure, researchers often deliberately avoid asking participants whether 
they have disclosed their HIV status to their sexual partners. One way to circumvent this 
obstacle is to study barriers to HIV disclosure rather than disclosure itself.   
2.3.1 Evidence-Based Objections to HIV Criminalization 
While HIV status disclosure prior to sex represents a “best-case scenario” in some 
circumstances, research does not support the use of criminal law to encourage this 
behaviour. Canada’s legal enforcement of HIV disclosure in particular has been criticized 
for failing to take into account scientific evidence regarding transmission risk; the 
Supreme Court of Canada’s vague definition (“realistic possibility of HIV transmission”) 
has allowed for charges to be laid where evidence shows the risk of transmission to be 
insignificant.60 To reiterate the evidence supporting use of ART, risk of HIV transmission 
when viral load is suppressed is estimated to be near zero for all sex acts, even without 
the use of condoms.40 If prosecution was consistently carried out with attention to such 
evidence, condomless sex with suppressed viral load would no longer be considered to 
pose realistic possibility of HIV transmission.  
From a policy perspective, public health professionals have criticized the Canadian legal 
system for undermining HIV prevention strategies.60 In particular, criminalization may 
serve as a disincentive for HIV testing: it is theorized that those who suspect that they 
have HIV may knowingly avoid HIV testing in order to claim inculpability should they 
expose someone else.61 This concern is significant, as an estimated 21% of people with 
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HIV in Canada do not know their HIV status,19 and this population is more likely to 
engage in condomless sex than their HIV status-aware counterparts.62 In addition to the 
potential for unintended consequences due to HIV criminalization, there remains 
uncertainty regarding whether the law actually prevents HIV transmission in the 
population. Canadian policy research accounting for the coverage and efficacy of HIV 
criminalization as an intervention concluded that non-disclosure law is likely a poor tool 
to promote population change.63 Because HIV criminalization only targets those who are 
aware of their serostatus (and who transmit HIV at rates far lower than those who are 
unaware), the intervention does not apply to the population with the highest potential for 
impact.63 In fact, if criminalization does serve as a disincentive for HIV testing, the 
intervention may actually increase the rate of HIV transmission among people with HIV 
who do not know their serostatus.63 The inconsistent use of scientific evidence in 
convictions related to HIV non-disclosure, and the potentially dysfunctional mechanism 
of HIV criminalization call to question the practical value of this approach. 
2.3.2 Ethical Objections to HIV Criminalization 
From an ethical perspective, the use of criminal law to enforce HIV disclosure has been a 
highly contested topic in Canada and around the world. Beyond the efficacy of such laws, 
many have argued that HIV non-disclosure should be criminalized based on two main 
legal philosophies: the harm principle and legal moralism. The harm principle, proposed 
by John Stuart Mill,64 argues that an action should only be criminalized if it causes harm 
to another person, regardless of whether the action was moral or was done for the good of 
the person committing it. However, Mill states that if the harm is consented to by the 
person being harmed, or if a person harms themselves, there should be no legal 
consequences.64 By his definition, “harm” is inclusive of not only intentional harms but 
also negligent harm such as failure to meet an obligation;64 the majority of HIV non-
disclosure cases would meet this definition. However, when applied to cases of HIV non-
disclosure the harm principle raises several issues, primarily, what constitutes harm? 
Some scholars argue that only transmission of HIV without disclosure constitutes harm,65 
while others argue that exposure to HIV without disclosure can also potentially represent 
harm, analogous to endangerment.66 Non-disclosure itself, regardless of whether 
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transmission occurs, has also been deemed by some to be a moral wrong.65,67 Moral 
wrongs are actions which violate some ethical standard, and under the principle of legal 
moralism may be punished by criminal law.68 Criminalization of moral wrongs functions 
to hold society to a given moral standard and disincentivize behaviour that the society 
decides is immoral, including acts that do not harm others. This principle has been 
applied to HIV criminalization, arguing that failing to disclose information that might 
otherwise cause someone to withdraw consent to sex invalidates that consent.67 However, 
simply because an act causes harm or is judged to be morally wrong does not mean that 
this act has sufficient cause to be criminalized. Both the harm principle and legal 
moralism warn that if criminalization causes more harm than it prevents, application of 
criminal law is not justified.69  
In order to judge whether HIV non-disclosure should be criminalized, attention must be 
given to practical factors including the efficacy (or inefficacy) of the current law, 
definitions of harm in the context of improved HIV treatment, potential disclosure-related 
harm to people with HIV, and criminalization as it relates to HIV stigma. Without 
minimizing the gravity of an HIV diagnosis, it is important to note that since the Supreme 
Court of Canada first addressed HIV non-disclosure in 1998,70 significant advances in 
HIV research have rendered HIV a largely treatable chronic condition for those with 
access to care.36 Considered alongside the dearth of cases prosecuting instances of non-
disclosure for other treatable but serious communicable diseases (herpes, hepatitis B and 
C),1 one must ask whether harms resulting from HIV exposure today are truly significant 
or the result of longstanding HIV stigma and exceptionalism. The drastic and exceptional 
treatment of HIV underpins other aspects of HIV criminalization as well; criminalization 
purports to protect the general population (especially heterosexual women) from 
contracting HIV5 but fails to consider that legal obligations to disclose place people with 
HIV (especially women) in vulnerable situations. In fact, it is not uncommon for ethical 
analyses of HIV disclosure to explore exclusively the potential harms to HIV negative 
partners without so much as mentioning the harms that disclosure can inflict on people 
living with HIV.65,66 For some, disclosure of one’s HIV status can result in financial 
instability, loss of relationships, loss of social support, social defamation, and physical, 
sexual, or emotional abuse.71 In the context of financial dependence or intimate partner 
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violence, non-disclosure can be an act of survival. Non-disclosure law in Canada does not 
adequately address any of these factors,5 and in-fact allows for estranged or abusive 
partners of people with HIV to file or threaten to file a non-disclosure lawsuit. In this 
way, the law not only holds people with HIV accountable for disclosing but gives the 
people who make disclosure impossible the power to enforce that accountability.  
At the societal level, criminalization has been criticized for contributing to the HIV 
stigma and exceptionalism that drives the epidemic.1 Attribution of social stigma to a 
behaviour deemed to be immoral is at the heart of legal moralism’s mechanism, and 
existing stigma is reinforced when legitimized by Canadian law.61 The fact that the legal 
system most often treats cases of non-disclosure as aggravated sexual assault further 
problematizes this issue. Sexual assault charges imply that, as with sexual assault, 
responsibility for the act lies only with the actor.1 However, the responsibility for 
engaging in safer sex lies with both partners and cannot be wholly attributed to people 
with HIV.1 Non-disclosure law tells the public otherwise, generating additional stigma, 
the effects of which are not insignificant. The UN Secretary-General has famously stated 
that “[stigma] helps make AIDS the silent killer, because people fear the social disgrace 
of speaking about it, or taking easily available precautions. Stigma is a chief reason why 
the AIDS epidemic continues to devastate societies around the world.”72 Reflecting on 
the justification of applying the harm principle and legal moralism in cases of HIV non-
disclosure given the surrounding context, it is difficult to argue that criminalization 
prevents more harm than it incites. This position has been upheld by expert groups 
including the Joint United Nations Programme on HIV/AIDS and an international team 
of twenty HIV scientists who strongly condemn non-disclosure laws for reasons related 
to lack of evidence based justification and respect for the autonomy and safety of people 
with HIV.3,4 
2.4 Barriers to Partner Disclosure 
A woman’s decision to disclose (or not to disclose) her HIV status to a sexual partner is 
known to be informed by several factors related to herself, her relationships, and her 
support system. These factors may serve as barriers to, or facilitators of partner 
disclosure. Despite differing cultural perceptions of HIV, studies across the world report 
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that fear of rejection and abandonment serves as a major barrier to partner disclosure 
among women with HIV.73–75 Fear of rejection in an intimate relationship is tied to the 
relationship’s power dynamics, including whether the relationship is abusive. The threat 
of violence, whether physical, sexual, or emotional, can make partner disclosure 
dangerous.73,75–77 Factors outside of the relationship may also have bearing on disclosure; 
at the level of the individual, people who feel internalized stigma about their own HIV 
status are known to struggle with disclosure.78 Furthermore, those without adequate 
social support may be hesitant to disclose due to the possibility of rejection or 
abandonment, especially in the presence of societal HIV stigma.78  
The following paragraphs on the barriers to partner disclosure are cognizant of the 
varying theoretical models and corresponding measures of disclosure, which have 
changed over the years. A common practice has been to consider disclosure a 
unidimensional process whereby an individual progressively informs their social network 
of their HIV status one-by-one, with the same barriers and facilitators informing each 
decision. The most common measure that maps onto this approach enquires about the 
members of an individual’s social network, and which of those members are aware of the 
individual’s HIV status. Using this information, the proportion of social network 
disclosed to is calculated (e.g. 79,80). The creation of unidimensional disclosure indices 
(e.g. 81,82) is a similar method in that neither allows the researcher to examine whether 
disclosure practices vary based on the target of disclosure. Such measures may be a threat 
to research validity, as research has demonstrated that disclosure rates80,83 as well as 
reasons for disclosing80 vary by target. A recent study of 158 people with HIV (70% 
women) in Tanzania investigated the dimensionality of voluntary disclosure to a 
comprehensive list of 21 potential targets, finding that disclosure to children, close 
family, larger community, and partners represented four independent factors.84 Moreover, 
disclosure to targets across these categories was differentially associated with two of the 
main determinants of disclosure: stigma and social support.84 These results indicate that 
traditional conceptions of disclosure as a unidimensional process may be insufficient to 
capture the true determinants of disclosure. Accordingly, while the following barriers to 
partner disclosure may also apply to other disclosure targets, studies specific to partner 
disclosure have been prioritized in order to maximize construct validity. 
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2.4.1 Physical and Sexual Abuse 
Physical abuse refers to acts of physical violence against another person, while sexual 
abuse refers to sexual acts which are forced or coerced.85 Often these types of abuse are 
grouped together under the term intimate partner violence (IPV), which refers more 
broadly to the perpetration of controlling behaviours, as well as physical, sexual, or 
emotional abuse against an intimate partner.85 However, physical and sexual abuse do not 
only occur within the context of intimate relationships, and IPV is not the only type of 
abuse relevant to HIV disclosure. Physical and sexual abuse in any context may 
undermine the personal agency of those who experience it and thus affect the perceived 
costs of partner disclosure.86 Furthermore, physical and sexual abuse may be perpetrated 
by and experienced by people of any gender.87,88 However, the majority of abuse against 
women is perpetrated by men,87 a factor reflected in the literature and thus the following 
paragraphs.   
Women who experience physical or sexual violence, or who expect that their partner may 
become abusive, cite fear of such abuse as a barrier to disclosing their HIV status to 
sexual partners.73,75–77 This barrier is significant given that women with HIV experience a 
high rate of violence, and that experiencing violence following disclosure of one’s HIV 
status is not uncommon.89,90 The same survey of American medical and mental health 
care providers that identified fear of abandonment as a prevalent concern for women with 
HIV also found that 29% of their female patients feared physical abuse, and 56% feared 
emotional abuse upon disclosing their HIV status to their partners.73  A qualitative study 
of 50 mostly African-American women found similar results; 12% feared that people 
would react violently to them disclosing their HIV status, and two women described 
consciously choosing not to disclose because they feared that their partner would react 
violently.76 Notably, one of these women described that her partner had not been 
physically violent towards her in the past, but that the anger he had displayed in other 
situations made her question whether communicating with him about safer sex was 
worthwhile.76 This experience was echoed by women from a different American 
disclosure study; one woman who experienced life-threatening IPV from a previous 
partner would not disclose her HIV status to her current partner, stating that “… 
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sometimes the sweetest men on earth will just turn on you … You just can’t tell”.77 Thus, 
fear of violence even without current experiences of IPV, may be a barrier to disclosure.  
HIV disclosure may also incite violence against women with HIV, even among those 
who did not experience violence prior to disclosure. In a clinic sample of 310 HIV+ 
women, 4% reported physical abuse as a direct result of disclosing their HIV status to 
somebody (i.e. not partner-specific).90 However, upon examining the prevalence of 
physical and sexual abuse experienced before and after their HIV diagnosis (and 
presumably some degree of disclosure), a larger gap was discovered: 45% of women had 
experienced abuse after diagnosis, with 13% of that abuse being new, i.e. occurring only 
after diagnosis.90 Among those who experience abuse prior to disclosure, disclosure may 
also affect the frequency and severity of abuse as articulated by one participant from this 
study: “He was abusive before I told him I was HIV-positive, and afterwards, well, the 
beatings got worse and more . . . they happened more regularly.”90 Indeed, the majority of 
abuse experienced after diagnosis is among those who also experienced abuse prior to 
diagnosis.90 Because current abuse provokes fear of further abuse upon disclosure, and 
this fear is shown to be valid, abuse represents a significant barrier to partner disclosure. 
2.4.2 Sexual Relationship Power 
According to Social Exchange Theory and feminist literature, power is defined as the 
potential one has to influence the actions of another (“power to”)91,92 as well as one’s 
ability to do something against another’s wishes (“power over)”.92 Sexual relationship 
power (SRP) can be defined as the balance or imbalance of interpersonal power across 
partners in an intimate relationship.93 Just as intersectional power differentials cause 
health inequities at the societal level,94 an imbalance of interpersonal power can affect the 
health of those within a sexual relationship.93 SRP dynamics often come to light in the 
context of partnered decision making; a more dominant partner may take control of joint 
decisions, a tendency that is especially relevant to HIV research in the context of sexual 
communication and decision making.93 In fact, reduced sexual relationship power has 
been repeatedly implicated as a risk factor for sexually transmitted infections (STIs) 
including HIV,95 under the theory that gendered power imbalances disenable 
heterosexual women from negotiating safer sex practices with their male partners.96 Since 
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the advent of this theory in the 1990s, scholars have hypothesized that such power 
imbalances are not only gendered but intersectional, mutually constructed by gender, 
race, class, and sexual orientation.97 Furthermore, it is hypothesized that in addition to 
being a barrier to safer sex practices, reduced SRP may be a barrier to HIV status 
disclosure.  
However, the construct of SRP is more often applied explicitly in research on HIV risk 
than HIV disclosure, where SRP is evident in discussions of fear of abandonment,73–75 
loss of economic support,74 rejection,75 abuse,73,75–77 and accusations of infidelity.75 Each 
of these fears is indicative of reduced power under Social Exchange Theory, which 
argues that power is based on the balance/imbalance of resources (e.g. emotional, 
economic) across partners and any resulting interpersonal dependence.98,99 Fear of 
abandonment, an indicator that the partner with this fear is in some way dependent on the 
other partner, was reported by women with HIV in the Africa and North America. A 
qualitative study of recently tested people with HIV in Tanzania found that fear of their 
partner’s reaction was the most influential barrier to HIV disclosure, and among women, 
abandonment was the most-feared reaction.100 This result was replicated in the partnered 
quantitative study, where among a sample of 245 women who underwent HIV testing, 
52% of those who had not disclosed their HIV status to their sexual partner after three 
months cited fear of their partner’s reaction as their reason for non-disclosure.74 In 
addition to fearing abandonment, these women feared loss of economic support,74 another 
indicator of reduced SRP.75 North American studies also demonstrate women with HIV 
fearing abandonment as a result of disclosure; Moneyham et al. conducted a series of 
focus groups on disclosure with women in the southeastern United States, where 
participants feared that disclosure would put an end to romantic relationships, resulting in 
a loss of social support.101 Similarly, an American survey of 136 medical and mental 
health care providers with experience treating women with HIV found that an estimated 
35% of their female HIV patients had expressed fear of abandonment (defined as 
withdrawal of resources) as a result of disclosure.73 While “abandonment” can refer to 
withdrawal of both tangible resources and emotional support, “rejection” encompasses 
the emotional aspects of abandonment. Fear of rejection was similarly reported by 
women.75 Anticipated abuse and loss of social support as a result of disclosure, whether 
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actualized or not, also represent aspects of SRP which may disenable women from 
communicating with their partners about HIV. 
2.4.3 HIV Stigma 
HIV stigmatization has been conceptualized as a dynamic social process that marks 
differences between groups of people, especially those experiencing social inequalities 
pertaining to class, race, gender, and sexuality.102 Stigma is produced by these 
inequalities, and reproduces them,102 affecting health outcomes for those who are 
stigmatized.103 Furthermore, HIV stigma has been theorized to operate at multiple levels: 
interpersonal, in the form of enacted stigma or discrimination, as well as intrapersonal in 
the form of felt-normative or perceived stigma (the subjective awareness of societal 
stigma) and internalized stigma (the degree to which individuals accept stigmatized 
beliefs to be true).104 These types of stigma have the potential to enact different outcomes 
for people with HIV, including in the context of partner disclosure.105  
A 2016 systematic review gathered studies on the partner disclosure-specific effects of 
enacted (n=1), felt-normative (n=6), and internalized stigma (n=7), as well as studies 
where the type of stigma measured was multidimensional or not specified (n=14).105 This 
review found that enacted stigma was often presented as a barrier to partner disclosure in 
qualitative research, with two studies documenting abuse perpetrated by the partners of 
seropositive individuals following disclosure,106,107 findings which have been mirrored in 
other studies where enacted stigma is framed as acts of discrimination.90,108 Felt-
normative stigma had a variable effect on disclosure to sexual partners, with three studies 
reporting higher levels of perceived stigma to be associated with reduced partner 
disclosure109–111  and two studies reporting no association between the two.84,112 These 
studies come exclusively from Africa and the United States, with sample composition 
ranging from 27% to 100% women. The largest sample (n=1552, 59% women) comes 
from a longitudinal study of ever-married women and their husbands in Malawi.111 This 
study provided HIV testing and counselling to each spouse in private, and two years later 
investigated the factors associated with partner non-disclosure. Among women only, 
higher levels of felt-normative HIV stigma were associated with non-disclosure to their 
spouse (OR=1.22 [95% CI 1.05, 1.42]). While data on disclosure to extra-marital sex 
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partners was also collected, the role of perceived stigma in this context was not reported 
and thus this inference is limited to married heterosexual couples. An American study of 
341 people with HIV (34% heterosexual women, 26% heterosexual men, 40% MSM) 
investigated the role of relationship type further, finding that increased perceived HIV 
stigma was associated with decreased odds of disclosing to all sex partners (OR=0.89 
[95% CI 0.81, 0.93]), and that this relationship was not moderated by sexual behaviour 
subgroup, the nature of sexual relationships (primary partner, casual partner(s), both) or 
the HIV serostatus of sexual partners.109 However, perceived stigma in this study was 
measured using an HIV stigma subscale specific to disclosure concerns (see Berger and 
colleagues113), which may not be synonymous with felt-normative stigma, and 
theoretically should be associated with disclosure. A similar study in South Africa 
(n=630, 67% women) found the same association between perceived stigma and 
disclosure, however, the effect was found to be significant only among those in steady 
relationships as opposed to casual partners.110 Other studies reported no relationship 
between perceived stigma and disclosure: the Dima study that investigated the 
multidimensionality of disclosure among people with HIV in Tanzania (detailed in 2.4) 
found that perceived stigma was unrelated to both cumulative disclosure and partner 
specific disclosure, but was positively associated with level of disclosure to the larger 
community.84 An American study found similar results; perceived stigma was unrelated 
to partner disclosure, but negatively associated with disclosure to parents.112 Taken 
together, these results indicate that felt-normative stigma may be a barrier to HIV 
disclosure, however, further analyses should be mindful of gender differences and the 
potential effect of partner relationship type.  
While the effects of enacted and felt-normative stigma have not fully been established, 
there is compelling evidence pointing towards internalized stigma as a barrier to partner 
disclosure among women. However, the only identified North American study on this 
topic is specific to middle-aged homeless and unstably housed people with HIV, the 
majority (70.7%) of whom were male.114 This cross-sectional study found that higher 
levels of internal HIV stigma were associated with 1.47 greater odds of non-disclosure to 
at least one recent sex partner prior to their first sexual encounter, adjusted for variables 
associated with general HIV stigma (including gender). While women reported higher 
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levels of internalized stigma than men, the effect of gender on this relationship was not 
reported. Similarly, in a sample of 862 people with HIV (56.3% women) in Ethiopia, 
Mozambique, and Africa, Geary and colleagues found that women reported higher 
internalized stigma compared to men, and that disclosure to one’s sexual partner was 
significantly associated with lower levels of internalized stigma in bivariate analysis.115 
Again, the effect of gender on the relationship between stigma and partner disclosure was 
not reported, however gender was found to moderate associations between internalized 
stigma and perceived wellbeing, indicating the potential importance of addressing 
gendered aspects of internalized stigma. Partially filling this gap, a longitudinal study of 
293 pregnant women recently diagnosed with HIV in South Africa measured internalized 
HIV stigma during and post-pregnancy, finding that while stigma had no effect on partner 
disclosure during pregnancy, higher internalized stigma predicted continuing partner non-
disclosure at 3 months post-pregnancy among those who had not yet disclosed at 
baseline.116 This result indicates that internalized stigma may develop over time, or be a 
characteristic of women who chronically struggle with partner disclosure. Further 
longitudinal research from Uganda (n=259, 67% women) found similar results; 
internalized stigma measured at baseline was negatively associated with subsequent 
partner disclosure in both univariable and multivariable models (ARR=0.94 [95% CI 
0.90, 0.99]).117 Expressed as an average marginal risk, each additional point on the 
study’s internalized stigma scale was associated with a 4.0% [95% CI 1.0%, 7.0%] lower 
probability of disclosure to a primary sexual partner over the median 1.8 years of 
observation. Interestingly, the magnitude of the relationship between internalized stigma 
and disclosure increased with social distance from the participant, such that stigma was a 
greater barrier to disclosure to neighbours and religious leaders, and the general public 
than it was to sexual partners. Other studies have found no relationship between 
internalized stigma and partner disclosure; a mixed-methods analysis found no 
association between internalized stigma and partner disclosure in univariate or 
multivariable models.118 However, a two-item measure was used to capture internalized 
stigma, which may be insufficient compared to the psychometrically evaluated measures 
applied in the other studies in question. Furthermore, outcome data on disclosure to 
sexual partners was missing for 17.8% of respondents who knew their HIV status and 
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were married/cohabitating with a partner, calling to question the validity of these results. 
Interestingly, the methodologically sound Dima study of 158 people with HIV (70% 
women) detailed prior found that internalized stigma was associated with cumulative 
disclosure, as well as disclosure to close family, children, and the larger community, but 
not sexual partners.84 The results of this analysis appear to support the social distance 
hypothesis posited in the Tsai study. Taken together, current evidence does not discount 
the presence of a relationship between internalized stigma and partner disclosure, though 
this relationship may be more important to disclosure targets at greater social distance. 
2.4.4 Social Support 
Social support, or the security that we gain from positive interpersonal relationships, is a 
known facilitator of positive health outcomes.119 Such support may come in the form of 
tangible support (for example, someone who will take care of you when you’re sick), 
emotional support, affection, and social companionship.119 In the context of HIV 
disclosure, social support has been cited as both a reason for disclosing (i.e. desire for 
support) and not disclosing (i.e. fear of losing social support). A meta-analysis (n=2253) 
of the relationship between social support and HIV disclosure (inclusive of all targets) 
revealed a weak positive correlation between the two (r=0.159), though the confidence 
interval included zero.78 Furthermore, the analysis does not specify the temporal 
relationship between the two variables, making it impossible to draw conclusions about 
social support as a facilitator or barrier to HIV disclosure. Some quantitative studies 
support the hypothesis that social support is associated with higher cumulative83 and 
target-specific120,121 rates of disclosure, while others found no association between 
cumulative disclosure and social support.79,121 Within these studies, it is important to 
identify which types of social support are being measured. Social support measures often 
tap into several dimensions (tangible support, emotional support, affection, and social 
companionship,119 from any of the following perspectives: received support,83 perceived 
support,79,84,120 reciprocated support,122 need for support,83 or satisfaction with 
support.83,121 Additionally, measures may be HIV-specific83,84 or target-specific.79,120 
Some domains and perspectives appear to be more salient to disclosure than others; both 
Simoni83 and Petrak121 found no association between satisfaction with support and 
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cumulative disclosure. Conversely, perceived social support has been associated with 
cumulative disclosure,84 and target-specific disclosure,120 including disclosure to intimate 
partners.84 Among a sample of 158 people with HIV (70% women) in Tanzania, 
perceived instrumental support (specific to HIV) was positively correlated with voluntary 
disclosure to intimate partners (r=0.14, p<0.05).84 Interestingly, neither HIV-specific 
emotional/informational support nor adherence support were related to partner disclosure 
in this study, indicating that the dimensionality of social support in addition to disclosure 
target is of importance.    
However, quantitative studies of disclosure and social support specific to intimate 
relationships have been largely cross-sectional, raising the question of whether given 
levels of social support preclude disclosure, or result from it. Qualitative research can aid 
in nuancing this relationship; while some women report fear of losing social support from 
their partners as a result of disclosing,101 others disclose because they desire additional 
social support from their partners.100,101,123 It seems that social support can function as a 
facilitator to disclosure, if it is perceived to be present already. One woman from Sowell 
et al.’s study of American women with HIV spoke to this dynamic: “I tell people who I 
know will be there for me no matter what. The people I have chosen has been there for 
me with other problems”.124 This relationship has also been documented in the context of 
HIV testing; one of the strongest predictors of partner disclosure is the degree of 
awareness and involvement the partner has in the HIV testing experience.74,100 
Additionally, women who chose not to involve their partners in the testing procedure 
were more likely to experience abuse as a result of disclosure,100 indicating that their 
partner’s negative reaction was likely anticipated. It appears that social support may drive 
disclosure similarly to involvement with HIV testing such that women who experience 
low social support anticipate low social support as a result of disclosure, and vice versa. 
Further quantitative longitudinal studies of perceived social support and partner 
disclosure would aid in substantiating this hypothesis. 
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2.5 Childhood Physical and Sexual Abuse 
2.5.1 Definition 
Child abuse or maltreatment, as defined by the WHO, refers to “all forms of physical 
and/or emotional ill-treatment, sexual abuse, neglect or negligent treatment or 
commercial or other exploitation, resulting in actual or potential harm to the child’s 
health, survival, or development of dignity in the context of a relationship of 
responsibility, trust, or power”.125 This definition frames abuse based on the impact of 
abusive behaviour on the child rather than the intention of the abuser, as the child is the 
subject of interest for this study. Furthermore, this definition captures the main forms of 
child abuse covered under the Criminal Code of Canada, including physical abuse, sexual 
abuse, exposure to family violence, and neglect.126 According to retrospective self-report 
from the 2001 wave of the Ontario Child Health Study, before the age of 16, 28.2% of 
females had experienced physical abuse and 22.1% experienced had sexual abuse.127 The 
combined proportion of females who experienced childhood physical and/or sexual abuse 
was 38.8%.127 While these figures come from a representative population-based study, 
the prevalence of child abuse tends to be elevated among community samples of women 
with HIV.128  
2.5.2 Child Abuse and HIV-Related Outcomes 
The frequent co-occurrence of HIV and histories of CPSA among women has been the 
subject of a great deal of research. Multiple meta-analyses have indicated significant, 
positive relationships between both childhood physical11 and sexual abuse12,13 and HIV 
vulnerability in adulthood. Factors increasing HIV vulnerability in these studies include 
engaging in condomless sex, sex work, early first sexual experience, having multiple sex 
partners, and experiencing sexual abuse in adulthood.11–13 Many theoretical models exist 
to explain the relationship between CPSA and HIV, tending to focus on 
intrapersonal/psychological factors such as learned sexual scripts.129 However, any such 
model must be contextualized by accounting for social power hierarchies, particularly 
with respect to gender. Gendered power imbalances have been articulated in several 
models of HIV risk, 86,130,131 however, Rosenthal and Levy explicitly extend the definition 
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of gender-based violence to include violence against young girls.86 Acts such as rape and 
abuse (termed “force”) are said to undermine the personal agency of women and girls, 
contributing to HIV vulnerability via reduced sexual relationship power.86 Recalling that 
reduced sexual relationship power is also a barrier to HIV disclosure, CPSA is revealed 
to not only be a risk factor for HIV, but may also impact a woman’s ability to disclose 
her HIV status once diagnosed. In this way CPSA acts as a sort of “double jeopardy,” 
increasing risk for HIV as well as for further vulnerability among those who are affected.  
The relationship between CPSA and reduced sexual relationship power has been 
investigated implicitly via factors contributing to relationship power including low self-
esteem,9,10 distrust,10 lack of meaningful communication with partners,8 having a partner 
who is controlling and/or uncaring8,10 and relationship dissatisfaction.8,10 However, 
sexual relationship power is not the only HIV-related outcome of CPSA. Studies among 
women in the general population have shown CPSA to be a risk factor for physical/sexual 
abuse in adulthood (i.e. revictimization),10,132 as well as reduced perceptions of social 
support.133,134 If these relationships hold among women with HIV, CPSA will be further 
implicated as a cause of barriers to HIV status disclosure among women. There is also the 
potential for experiences of CPSA to impact barriers to HIV disclosure that are not 
investigable among the general population, such as HIV stigma. While theoretical bases 
for these relationships have not been formally articulated in the literature, the effects of 
CPSA are diverse and can reach far into adulthood. Women in the general population 
who have experienced CPSA have reported stigma related to the abuse as well as distrust 
and perceived powerlessness in adulthood.135 These outcomes, while not specific to HIV, 
document connections between CPSA and later stigma, as well as relationships between 
CPSA and factors known to contribute to HIV disclosure concerns. Whether the HIV-
specific analogues of these outcomes are related to CPSA among women with HIV 
should be the subject of further inquiry, including the current study.   
2.5.3 Eco-Social Theory 
Given that CPSA has been implicated as a cause of both HIV vulnerability and barriers to 
HIV disclosure, it is of interest, from a causal modelling perspective, to understand the 
causes of CPSA (i.e. the “causes of the cause”). While many theoretical models exist to 
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explain the etiology of child maltreatment, the currently favoured model is Belsky’s 
ecological or eco-social model.136 This model posits that CPSA is caused by social-
psychological forces acting and interacting across multiple domains: the developmental 
experiences of the caregiver (termed “ontogenic environment”), the family 
(“microsystem”), the community (“exosystem”) and the larger social culture 
(“macrosystem”). Belsky identified several risk factors and potential mechanisms at each 
level. Notably, risk factors stemming from colonization of Indigenous land are not 
addressed in this theory, and are thus further discussed in section 2.6. Belsky’s analysis 
of the ontogenic environment suggests that the child-caregiver relationship is likely 
influenced by the caregiver’s childhood relationship with their own caregivers. 
Intergenerational transmission of abuse is a widespread theory, though the relationship 
between experience of abuse and perpetration of abuse is complex, depending on parental 
and contextual factors.137–139 The family microsystem risk factors include characteristics 
of the child that, in interacting with caregiver characteristics, may make the child more 
vulnerable to abuse. These include low birthweight or premature birth, as well as 
temperamental characteristics such as hyperactivity, lethargy, or disobedience. 
Furthermore, family attributes such as having many family members and small living 
spaces have been theorized to cause stress on the family, and may interact with caregiver 
factors to increase the risk of CPSA. While caregiver factors are important, it must be 
stated that parents/caregivers are not the only potential perpetrators of child maltreatment. 
However, the Belsky model focuses on CPSA within families, stating that “the parent-
child system is the crucible of child maltreatment” 136 
In this eco-social model the family is nested within larger social units within the 
community, or the exosystem.136 At this level, social isolation of the family may play a 
role in potentiating abuse; families without support may lack friends or extended family 
to aid with child care, and lack of close connections may lead to fewer “outsiders” in the 
home observing or monitoring caregiving practices. The workplace represents another 
major connection to the outside world, and workplace factors such as unemployment or 
lack of job satisfaction are theorized to have bearing on a caregiver’s propensity to 
maltreat children under their care. At the macrosystem, or societal level, national or even 
global events can influence factors at other levels; an example is given of a global 
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financial crisis causing mass unemployment, an exosystem factor relevant to CPSA. Also 
existing at this level are cultural attitudes towards violence and child rearing; Belsky 
presents cross-cultural descriptive evidence suggesting that societies where corporal 
punishment is not accepted have lower rates of child maltreatment.136 It is important to 
consider that such societal attitudes can shift dramatically over time. At the time that 
Belsky’s theory was published in 1980 most forms of corporal punishment were legal in 
North America, while as of 2004 corporal punishment was significantly sanctioned under 
Canadian law,140 and mass social campaigns exist with the intent of criminalizing all 
forms of corporal punishment.141 Furthermore, while Belsky’s ecological model 
represents a significant advancement in the history of CPSA research, the theories 
presented in this model should be further substantiated with more contemporary research.  
Since the publication of Belsky’s theory, the four ecological levels have been re-
conceptualized and additional risk factors have been identified. In 2002 the World Health 
Organization published the World Report on Violence and Health, undertaking a review 
of the literature on the causes and consequences of child maltreatment that have been 
implicated repeatedly in studies across the world.142 Rather than the first level focusing 
on the child-caregiver relationship, or ontogenic environment, this model focuses on 
factors increasing a child’s vulnerability as the initial level nested within the other three. 
Risk factors identified at this level include the child’s age (cases of physical abuse occur 
more commonly among pre-pubescent children while rates of sexual abuse generally 
increase after puberty),142 the child’s sex (female children are at greater risk for most 
forms of abuse other than harsh physical punishment)142–144, and special characteristics of 
the child. Special characteristics increasing children’s vulnerability to abuse, like low 
birth weight or disobedience as identified in Belsky’s theory, have been expanded to 
include children who are twins,142,145–147 and children who have a disability or 
illness.142,148,149 When considering such risk factors, it is important to reiterate Belsky’s 
condition stating that a child cannot sufficiently cause their own abuse; it is only through 
interaction with risk factors at other levels that these child-level risk factors may have an 
effect.136 These may include attributes of the child’s caregiver and family, as well as 
others. In particular, the type of abuse perpetrated may be related to the sex of an abusive 
caregiver. For example, while physical discipline is more common among female 
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caregivers,142,150–153 sexual abuse142,154,155 and severe physical abuse142,156,157 are 
committed largely by male caregivers. As in Belsky’s original theory, the WHO model 
notes the potential importance of the caregiver’s history of abuse,137,156,158 family and 
household size,158,159 social isolation of the family,158 and stress.142,156,160 Furthering these 
theories, recent research has conceptualized family risk factors as resources, or lack 
thereof, that the family may draw on to care for the child and the family as a whole. 
These include caregiver education/income,158,160 age,158 employment status,158 and the 
number of caregivers in a household.142,151,156,158 Additionally, a lack of stability in the 
household (i.e. the environment changes often or people come and go frequently) is 
known to be related to CPSA.142,161 This risk factor speaks to the fact that CPSA is not 
exclusive to parents or caregivers, but may be perpetrated by others present in a child’s 
household and life more broadly. Finally, children have been found to be at increased risk 
of experiencing CPSA in households where a caregiver perpetrates intimate partner 
violence.142,156,162 Taken together, many of these caregiver and family characteristics are 
indicative of the reserves a family draws upon to raise and protect children, and the ways 
that these resources may become depleted.  
In both Belsky’s theory and the updated WHO model, the child and family are nested 
within their community. While Belsky placed the family’s access to social support and 
workplace satisfaction at this level, the WHO model focuses more explicitly on poverty 
and social capital.142 Communities where many people are living in poverty, and 
experiencing unemployment, overcrowding, and population instability are known to be 
high-risk sites for CPSA.163–165 Social capital was not directly addressed in Belsky’s 
theory but refers to the interpersonal connectivity drawn on by a community in order to 
live and work together.166 Research has shown that social capital, as measured by 
neighbourhood instability (e.g. high turnover, vacancy) has been predictive of 
neighbourhood-level maltreatment rates.167 Norms, a component of a network’s social 
capital may also be determinants of CPSA. According to both the Belsky and WHO 
models, societal norms regarding violence as well as value of children can affect child 
maltreatment rates by positioning violence and abuse as more or less socially 
acceptable.136,142 While risk factors at this level have not been adequately investigated, 
the WHO identifies several potential social forces and resulting norms that may influence 
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rates of child maltreatment, including: gendered income inequality, gender roles, public 
policy related to children and families, the role of preventative health care and social 
services in identifying and preventing cases of CPSA, and social or political conflicts 
including war.142  
2.5.4 Intersectionality Theory 
Expanding further upon the eco-social model of CPSA, Nadan et al. provided insight on 
how intersectionality can be incorporated into this framework.168 Applied to the 
ecological model, intersectionality emphasizes that while children and families are nested 
in communities and culture, they also exist at the intersection of multiple social positions 
such as gender, race, ethnicity, and socioeconomic status. While children and to some 
extent families occupy intersectional positions, at a higher level interlocking social and 
structural forces affect these children and families at all eco-social levels. These forces 
are not limited to sexism and ageism as identified in the WHO model, but can include 
racism, ableism, colonialism, and others. Race has sometimes been erroneously treated as 
a potential risk factor in the child maltreatment literature, incorporated at the child/family 
levels often without addressing the mechanisms by which race may impact experiences of 
CPSA. Intersectionality asks researchers to consider the higher-level social and structural 
impacts of racism and other axes of oppression given that society systematically 
advantages people who are white and disadvantages those who are not. For example, 
while cases of CPSA involving Indigenous children are disproportionately reported to 
and substantiated by child protection services,169 this effect has been attributed to the 
poverty, family disruption, and lack of access to government services often experienced 
by Indigenous families.170,171 While the systematic and ongoing disenfranchisement of 
Indigenous peoples in Canada and other countries has not been addressed specifically in 
the Belsky or WHO models, multilevel intersectional thinking allows for the 
incorporation of these and other factors. 
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2.6 Theoretical Model: Eco-Social Intersectionality for 
Women with HIV 
Building on the foundational models of eco-social theory and intersectionality, a new 
theoretical model is proposed to contextualize the relationship between childhood 
maltreatment and HIV disclosure among women with HIV in Canada. The adaptation of 
this model, as follows, fulfils Objective 1 of this thesis. Belsky and WHO provide us with 
the nested levels at which risk and protective factors for CPSA exist: child/individual, 
family, community, and society.136,142 Nadan has tied eco-social theory of child 
maltreatment to feminist intersectionality by locating these four levels within 
intersectionality’s “matrices of domination”.54,168 In order to adapt these existing theories 
to the context of the study at hand it is of interest to (1) clarify the role of culture as 
related to CPSA; (2) understand how intersectionality and axes of oppression operate at 
the four eco-social levels; and (3) address colonialism as an axis of oppression affecting 
Indigenous women in Canada. Finally, this model will be used as a roadmap to 
understand the objectives and study design for the current project.  
In the past, race and cultural factors have been wrongfully treated and studied as potential 
risk factors for CPSA. In more recent years, efforts have been made to unpack race and 
culture to gain a more nuanced understanding of how not only race and culture, but 
systematic racism affect health and social outcomes for people of colour. It has been 
shown that use of broad phenotypic racial categories is the most superficial means of 
studying race, as race and culture as constructs are undoubtedly multidimensional.172 In 
order to understand the dimensions of race and ethnicity that are relevant to studies of 
CPSA, these constructs must be unpacked. Unpacking culture refers to examining 
specific traits associated with given cultures which have the potential to impact child 
maltreatment, rather than bluntly assuming that the culture itself is the cause.172 Examples 
of such traits include familism (a value elevating the importance of family bonds, often 
attributed to Latinx families)173 ‘ohana (a similar construct in Hawaiian American 
families),174 and machismo (valuing male pride and dominance, also an aspect of Latinx 
culture).175 These values have been found to predict CPSA such that familism173 and 
‘ohana174 are protective factors, while machismo represents a risk factor.175 When 
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unpacking culture into values, it is imperative to remember that no culture is monolithic 
and that culture, values, and race are not synonymous. Another important attribute of 
cultural values is their potential to be protective against CPSA. Furthermore, culture does 
not exist in a vacuum; as posited by intersectionality, individuals exist within larger 
interlocking axes of oppression.54 Racism, colonialism, and xenophobia intersect with 
other axes including sexism/patriarchy and ableism to affect our lives, social structures, 
policies, and institutions. Paired with eco-social theory, these interlocking axes can be 
visualized as reaching over all levels of analysis, while individuals and to some extent 
families occupy intersectional social positions which exist within the larger social 
hierarchy (Figure 2). To illustrate, hypothetical examples of given intersections and their 
potential impact at each eco-social level are provided in Table 4. 
Table 4: Mapping intersectionality onto eco-social theory levels with examples 
Eco-Social 
Theory 
Level  
Level applied to 
contextualize 
child abuse  
Intersectionality at this 
level168 
Hypothetical example 
intersection and outcome 
Macro-
system 
Societal level Societal factors are 
impacted by larger 
intersecting power 
differentials in the 
context of that society  
Sexism (male dominance) and 
ageism (the value a society 
places on children) intersect to 
produce societal norms, such 
as the normativity of physical 
punishment of children 
Exo-system Community 
level 
Community level factors 
are impacted by larger 
intersecting power 
differentials in the 
context of that 
community 
Racism and classism intersect 
resulting in discriminatory 
practices within local child 
welfare agencies, such as a 
system that removes racialized 
children without class 
privilege from the home, 
where while children lacking 
class privilege would not be 
removed 
Meso-system Family level As a unit, families 
occupy intersectional 
positions within a larger 
system of intersectional 
social inequality 
Discrimination based on 
immigration status and racism 
intersect resulting in a family 
being socially isolated and 
without access to childcare  
Micro-system Individual 
(child) level 
Individuals occupy 
embodied intersectional 
positions existing within 
Sexism and ableism intersect 
resulting in increased 
vulnerability to sexual abuse 
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a larger system of 
intersectional social 
inequality 
for a female child with a 
disability 
The number of social positions and their intersections at which an individual exists is 
virtually unknowable, as the matrices of oppression that govern our society are vast, 
varying, and dynamic. Furthermore, some intersectional positions are present/relevant in 
given contexts but non-existent in others. In a Canadian context (as well as American, 
Australian, and others) theories of child maltreatment are incomplete without 
consideration of the intersecting axes of colonialism and sexism resulting in the historic 
and ongoing systematic oppression of Indigenous peoples, and Indigenous women. 
Colonialism here refers to “Indigenous peoples’ forced disconnection from land, culture 
and community by another group.”176 When European settlers colonized Indigenous land 
and imposed both patriarchal gender roles and racist cultural assimilation efforts upon 
Indigenous communities, the position of Indigenous women was transformed.177 While 
First Nations varied in structure, Indigenous women had traditionally occupied positions 
of power and leadership in their communities, such as that of the Clan Mother, working 
in non-hierarchical balance with men in the community.177 After colonization, Indigenous 
women were harshly punished for not conforming to patriarchal European expectations 
of womanhood: domesticity, perceived sexual virtue, and monogamy.177 Formal policy 
was used not only to punish those who did not conform to European standards, but to 
indoctrinate Indigenous children with such values, alienating them from their own 
culture. One of the largest efforts to eliminate Indigenous family structures and values 
was the government-funded residential school system, operating from 1870-1996.178 
Attendance at off-reserve residential schools was mandatory for Indigenous children aged 
7-16, and parents were forced to rescind legal custody of their children to the principals 
of these schools.178 The abuse perpetrated by employees of residential schools unto 
children under their care took many forms, including forced abandonment of Indigenous 
language and beliefs, unsafe/unsanitary living conditions, as well as physical, sexual, 
emotional, and medical abuse.178 If/when children returned home outside of the school 
terms, the cultural fabric that bonded families together was tarnished: parents and 
children spoke different languages and were taught different values.178 Forced cultural 
and familial disruption, including trauma inflicted by the residential school system, is 
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widely regarded as the root cause of health and social inequities among Indigenous 
people today.176 Furthermore, colonial practices continue to impact the lives of 
Indigenous women and children, one example being the “sixties scoop” (1960s-1980s) 
during which Canadian authorities forcibly placed thousands of Indigenous children into 
the foster care system, again disrupting families and placing Indigenous children at 
risk.179 To this day,  48% of children in the foster care system are Indigenous and 54% of 
Indigenous children in foster care live in homes without an Indigenous foster parent.180  
The causes of CPSA among Indigenous people are qualitatively different from 
determinants for people without a history of systematic colonialism and sexism. The 
proposed theoretical model acknowledges that causes of CPSA within Indigenous 
populations stem from this ongoing history of institutionalized child maltreatment and 
family disruption. The mechanisms by which European colonization have affected (and 
continue to affect) Indigenous people living in Canada are clearly traceable, and the 
effects of these actions are visible today. Survivors of this legacy of cultural disruption 
are remarkably resilient, but carry with them the burden of intergenerational trauma. 
Multiple generations of familial disruption can result in cyclical generations of parents 
who were raised in the absence of a healthy parenting model and thus are disadvantaged 
when attempting to provide such a model for their own children.181 In particular, this 
cycle can include intergenerational transmission of abuse. Illustrating the overarching 
impact of colonization on this outcome, it is worth noting that physical discipline of 
children was reportedly an uncommon practice prior to implementation of the residential 
school system.181 However, as of 2008, the Canadian Incidence Study of Reported Child 
Abuse and Neglect reports that the rate of substantiated maltreatment investigations 
among Indigenous children was 5.1 times that among non-Indigenous children (noting, of 
course, the potential for substantiation judgements to differ for Indigenous vs. non-
Indigenous children). The lasting effects of this familial disruption, institutionalized 
abuse and systematic disenfranchisement of Indigenous women are expected to impact 
Indigenous women in causal pathways not experienced by non-Indigenous women. Thus, 
the proposed theoretical model will include risk factors from multiple eco-social levels 
that acknowledge the intersectional position and experiences of Indigenous women in 
Canada. 
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Figure 2: Intersectional/eco-social model of determinants of childhood physical or sexual 
abuse 
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2.7 Current Study  
A final objective of the proposed theoretical model is to use intersectionality and eco-
social frameworks to understand the relationship between CPSA and HIV. Briefly, CPSA 
has repeatedly been implicated as a risk factor for HIV.11–13 Additionally, child 
maltreatment is known to affect other outcomes in adulthood (e.g. sexual relationship 
power, experiences of abuse, perceived social support, etc.). Among women with HIV, 
these outcomes hold particular significance, as they may be barriers or facilitators of HIV 
disclosure to sexual partners. If CPSA is a cause of HIV, as well as a cause of barriers to 
partner disclosure among women with HIV, abuse during childhood may represent a 
“double jeopardy” of sorts. By acting as a risk factor for HIV and disenabling those 
women who acquire HIV from disclosing their HIV status, child abuse may substantially 
affect both the quality of life and the socio-legal vulnerability of women with HIV in 
Canada. Portions of this causal chain are already well described in the literature. These 
include the relationship between CPSA and HIV risk,11–13 CPSA and outcomes such as 
experiences of abuse/disempowerment in adulthood among the general population,8–10,132 
and the relationship between HIV disclosure and legal risk.1 The causal relationship that 
has yet to be examined is that between CPSA and barriers to disclosure among a 
population of women with HIV (Figure 3).   
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The eco-social intersectionality framework will be incorporated in investigating this 
causal question. In particular, the eco-social framework will be used to identify CHIWOS 
variables at the level of the individual, family, community, and society which may affect 
risk for CPSA. In contrast to past models, variables acknowledging the effects of colonial 
practices such as family attendance at residential school will be incorporated. Using 
advanced statistical methods, the eco-social risk factors will be balanced across the group 
of participants with and without histories of CPSA as a method of confounding control. 
Furthermore, an intersectional framework will be incorporated in calculating measures of 
effect for the given hypothesis. This involves allowing effects to vary across population 
groups defined by intersecting social positions/identities that exist within larger systems 
of power and oppression: here, defined by gender, HIV status, and ethnoracial group. 
Among women with HIV, it is expected that experiences of CPSA as well as its 
consequences will be qualitatively different based on ethnoracial group. Thus, measures 
of effect for CPSA on barriers for HIV disclosure will be reported separately for 
Indigenous, Black African, Black Caribbean, white, and other women.  
The need for this study arises from not only the documented barriers to disclosure faced 
by women with HIV, but also from the Canadian legal precedents which fail to protect 
them. Investigating the causes of disclosure barriers can create space for future 
interventions, shed light on the disclosure experiences of women with HIV, and highlight 
the lack of understanding of these experiences implicit in Canadian HIV non-disclosure 
policies.    
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Chapter 3  
3 Methodology 
This chapter will describe the methodology used in the study, including: study design, 
recruitment procedures, statistical methods, variable selection rationale, 
measurement/coding, and approaches to missing data.  
3.1 Canadian HIV Women’s Sexual and Reproductive 
Health Cohort Study 
3.1.1 Ethics and Funding 
Ethics approval for CHIWOS was provided by the research ethics boards for Women’s 
College Hospital, McGill University Health Centre, University of British 
Columbia/Providence Health, Simon Fraser University, and recruitment sites with 
independent REBs. CHIWOS is funded by the Canadian Institutes of Health Research 
(CIHR) and the Ontario HIV Treatment Network, with support from the CIHR Canadian 
HIV Trials Network. In addition to institutions already mentioned, CHIWOS is supported 
by Women’s College Research Institute, Women’s Health in Women’s Hands 
Community Health Centre, and the British Columbia Centre for Excellence in 
HIV/AIDS.  
3.1.2 Recruitment and Sampling 
CHIWOS is a multi-province prospective study, collecting data at three time-points: 
baseline (Wave 1), 18-months (Wave 2), and 36 months (Wave 3).14 Originally, three 
provinces were selected to participate based on the relatively high estimated prevalence 
of women with HIV in each area: ON, QC, and BC.14,19 Wave 1 data collection for these 
provinces occurred from August 2013 through May 2015,14 while Wave 2 data were 
collected from June 2015 to January 2017.14 Wave 3 data for ON, QC, and BC started in 
February 2017 and is scheduled to finish in August 2018.14 Data from Waves 1 and 2 are 
included in the present analysis. Since data collection began for these provinces, a 
decision was made to also collect data in Saskatchewan (SK) and Manitoba (MB), based 
on the relatively high HIV incidence in these regions.19 Alternative research methods 
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including arts-based data collection has been used to draw inference from these 
provinces, and thus these data were not included in the present analysis.14 Within the 
selected provinces, a non-random quota sampling method was applied, starting with 
overall provincial quotas of n=700 for ON, n=350 for BC, and n=350 for QC. The 
decision to use sampling quotas was informed by the objectives to compare outcomes 
across health service delivery areas, and to collect data on key subgroups of women with 
HIV who may not be captured by traditional sampling methods.14 Provinces identified 
“health regions” based on existing data on HIV prevalence among women in order to set 
regional sampling quotas; in ON, the Ontario HIV Epidemiologic Monitoring Unit health 
regions were used,182 collapsing some regions with low HIV prevalence. BC based their 
sampling frame on Drug Treatment Program data across Regional Health Authorities. In 
QC, surveillance data from Institut National de Santé Publique du Québec characterized 
the distribution of HIV cases among women across geographic regions. Based on 
community and clinician expertise, as well as data availability by province, sampling 
quotas were also created for priority populations within provinces and sometimes within 
health regions. In Ontario, sampling quotas of n=70 per strata were set for priority 
populations including: younger women, older women, trans people, lesbian, gay, 
bisexual, queer, questioning, and Two-Spirit women, Indigenous women, African and 
Caribbean Black women, other women of colour, those not accessing care, women with a 
history of IDU, and women with a history of sex work. BC and QC set similar quotas for 
recruiting women diverse in terms of age, ethnoracial group, language, and HIV exposure 
category.  
Recruitment procedures for CHIWOS were driven by the PRAs alongside the research 
team.15 Potential participants were identified through the personal networks of PRAs, 
community advisory board members, and other women in the community, as well as 
AIDS service organizations, HIV clinics, social media promotion, and posters circulated 
in non-HIV specific organizations such as women’s shelters.14 Screening of potential 
participants was done by PRAs or provincial research coordinators either in person or by 
phone when required, and those who met the inclusion criteria and provided informed 
consent were enrolled. In order to be included in CHIWOS at baseline, participants were 
required to (1) identify as women (inclusive of cisgender, transgender, intersex, Two-
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Spirit, and gender queer or questioning women); (2) be at or over the age of 16; (3) have 
been diagnosed with HIV; and (4) reside in one of the included provinces.14 In some 
cases, women who met these criteria were not enrolled in the study in order to comply 
with the quota sampling targets.14 Inclusion was not restricted by language, as surveys 
were administered in either English or French, or with the assistance of a translator for 
other languages.14 PRAs administered the survey in person or by phone/Skype183 using 
White Label FluidSurveys™,184 a web-based platform allowing for automatic skip-
patterns.14 Median time to complete the survey was 120 minutes for Wave 1, while the 
mean time to completion at Wave 2 was 111 minutes. Participants were compensated $50 
cash after completing an interview, while PRAs were compensated $75 for every 
interview they conducted. Follow-up contact from one wave to the next was made by the 
same PRA who conducted the previous interview, by means of contact indicated by the 
participant.14 PRAs attempted contact three times, and if all were unsuccessful attempted 
contact through community organizations or clinics associated with the participant.14 
Where follow-up interviews could not be conducted and reasons for loss-to-follow-up 
were known, these reasons were recorded in the dataset.  
The Wave 1 CHIWOS questionnaire, developed with CBR methods, contained 436 items 
and spanned nine general content areas (Table 5).14 Participants had the option to skip 
items (response options: “don’t know” or “prefer not to answer”) or subsections (e.g. 
questions on residential school) as they deemed appropriate. The sections on violence and 
abuse and women’s sexual health contained sensitive content with the potential to invite 
response bias in the presence of a survey administrator, thus, these sections could 
optionally be self-administered rather than administered by a PRA.14 The Wave 2 survey 
included a subset of sections/items from Wave 1, with the addition of some new 
sections/items. Most relevant to the present study, Wave 2 collected supplementary 
information on immigration experiences.  
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Table 5: CHIWOS Survey content areas by wave 
Section Wave 1 Section Topic Wave 2 Section Topic 
1. Demographics and Socio-economic 
Status 
Demographics and Social 
Determinants of Health 
2. Medical and HIV Disease 
Information 
Medical and HIV Disease 
Information 
3. Health Care and Support Service 
Utilization 
Health Care and Support Service 
Utilization 
4. Women’s Reproductive Health Emotional Wellbeing, Resiliency, 
and Health Related Quality of Life 
5. Stigma and Discrimination Women’s Reproductive Health 
6. Substance Use Stigma and Discrimination 
7. Violence and Abuse Substance Use 
8. Women’s Sexual Health Violence and Abuse 
9. Emotional Wellbeing, Resiliency, 
and Health Related Quality of Life 
Women’s Sexual Health 
10. N/A Resilience 
3.2 Summary of Statistical Methods 
Section 3.2 introduces theory, rationale, and statistical specifications for the analytic 
methods applied in this study. Counterfactual theory and the corresponding potential 
outcomes framework are outlined as the chosen approach for addressing confounding. 
Following this, propensity score methodology is described, along with the chosen 
propensity score estimation method (generalized boosted modelling), application method 
(inverse probability of treatment weighting by weighted regression), and counterfactual 
estimand (average treatment effect among the treated). Rationale based on causal 
modelling and counterfactual theory is provided for variable selection, and corresponding 
measurement/coding information is provided.  
For the present study, the exposure variable was a measure of ever experiencing 
childhood physical or sexual abuse (CPSA), while the outcomes were barriers to HIV 
disclosure to sexual partners. These included ever experiencing physical abuse in 
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adulthood, ever experiencing sexual abuse in adulthood, sexual relationship power, HIV 
stigma, and perceived social support. The causes of the exposure to be balanced across 
groups, referred to hereinafter as propensity score covariates, were participant age, sexual 
orientation, gender identity, immigration to Canada before age 16, indicator for stress-
related circumstances surrounding that immigration, being a survivor of the residential 
school system, and having one or more family members who attended residential school. 
For the sensitivity analyses, child physical abuse (CPA) and childhood sexual abuse 
(CSA) became the exposure variables. 
3.2.1 Counterfactual Theory & Potential Outcomes Framework 
Counterfactual theory, born in philosophy, conceptualizes causation using multiple 
realities: one where a potential causal factor exists, and another reality identical but for 
the potential cause and its subsequent effects.185,186 If a given outcome occurs in the first 
reality where the causal factor is present, but not in the second, the factor is indeed 
causal. When translating this philosophical concept into empirical research we are 
presented with several issues, most significantly the existence of a single reality. Aiding 
in the explanation of empirical counterfactual thinking is Rubin’s potential outcomes 
framework for binary exposures.187 Within this framework, an exposure and its 
counterfactual opposite (i.e. lack of exposure) are denoted T=1 and T=0, respectively 
(Table 6).187 Each study subject has the potential to be exposed or unexposed, as well as a 
potential outcome under each exposure [Yi(1) denoting the outcome of an exposed 
individual, and Yi(0) denoting the outcome of that same individual under the unexposed 
condition]. Clearly, only one of these situations (exposed vs. unexposed) represents an 
observable reality, while its opposite represents a counterfactual reality.188 At a 
population level, Y(1) refers to the average outcome of a group of exposed individuals, 
while Y(0) refers to the average outcome of the same group were they unexposed.  
  
49 
 
Table 6: Rubin’s potential outcomes framework for binary exposures 
 Individual level Group level 
Exposure Ti =1 for exposed individual,  
Ti=0 for unexposed individual 
T=1 for a group where all individuals were 
exposed,  
T=0 for a group where all individuals were 
unexposed 
Outcome Yi = the outcome level (i.e. mean, 
proportion) for an individual 
Y= the outcome level (i.e. mean, 
proportion) for a group of individuals 
Outcome 
at given 
exposure 
level 
Yi(1) = outcome level for individual i if this 
individual were exposed, Yi(0) = outcome 
level for individual i if this individual were 
unexposed 
Y(1) = mean outcome level for a given 
group, if everyone in the group were 
exposed.  
Y(0) = mean outcome level for a given 
group, if everyone in the group were 
unexposed. 
Sources: Rubin 1974 and Hirano & Imbens 2001187,189  
If we could observe the same group of people in each reality, we could calculate the 
difference in average outcomes between the two conditions, and thus the causal effect. 
Because this is impossible, the next best solution is to observe the outcomes of two 
groups that are exchangeable, i.e. under the same exposure conditions, group A would 
experience the same outcome as group B. This exchangeability of groups can be achieved 
by randomization, which is why randomized control trials (RCTs) represent the gold 
standard for causal effect estimation. Causal effects that can be estimated directly from 
RCTs include the Average Treatment Effect (ATE=E [Y(1) - Y(0)]) or the effect 
attributable to the exposure among the population, and the Average Treatment Effect 
among the Treated (ATT=E[Y(1) – Y(0)|T=1]) or the effect attributable to the exposure 
among those actually exposed. Estimation of causal effects in observational research 
presents another issue: other factors (potential confounders) may select subjects non-
randomly into the exposed and unexposed groups, rendering them un-exchangeable. 
Because these groups differ based on factors other than the exposure itself, the ATE and 
ATT cannot be estimated directly.  
In different research settings, one of the ATE or the ATT may be more meaningful than 
the other. Austin gives the example of providing people who smoke with a brochure, or 
some other intervention easily applied to the total implicated population.190 In this 
situation where treatment of the total population is realistic, it is most useful to base 
inference on the total population sampled by calculating the ATE. Conversely, if the 
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intervention is an intensive cessation program, it may be unrealistic to provide the 
treatment to all people who smoke, and thus the effect of the program on those who 
actually received it (ATT) is more valuable.190 Likewise, in a non-experimental context, 
it is often of interest to estimate the effect of a factor that (1) can only be studied 
observationally and (2) does not warrant inference for the total population based on its 
lack of desirability. CPSA falls into this category, where inference based on the ATT 
allows us to estimate the effect of counterfactually eliminating CPSA experiences among 
the women who actually experienced them. Because the undesirable nature of CPSA also 
means it should not be called a “treatment”, the ATT will hereinafter be referred to as the 
AEE, or average effect of the exposure among the exposed.     
3.2.2 Propensity Scores 
Propensity scoring is a statistical method for controlling multiple confounders in 
observational studies, allowing them to mimic the exchangeability of an RCT (with the 
understanding that residual confounding is ubiquitous in observational research).191 First 
proposed by Rosenbaum and Rubin in 1983, a propensity score (PS) represents the 
probability that an individual experiences a given exposure, conditional on a set of 
covariates preceeding that exposure (Formula 1).191 In the case of this study, a PS will be 
the probability from 0-1 (exclusive) that an individual experienced CPSA, as predicted by 
the potential causes of child abuse. PSs can be used to control for confounding in several 
ways, most generally: matching on the PS,191 creating PS strata,191 regression adjusted for 
the PS,191 and PS weighting192 (also called model-based direct adjustment, or inverse 
probability of treatment weighting). Inverse probability of treatment weighting (IPTW) 
was selected for the present study on the basis of its superior ability to achieve covariate 
balance (i.e. bias reduction), 193–196 greater interpretability (as compared to stratification 
or adjustment for the PS), and minimization of data loss (as compared to certain types of 
matching).197  
IPTW, when implemented to calculate the AEE, creates a population that is 
representative of the exposed group in terms of distribution of potential 
confounders.198,199 As demonstrated in Table 7 and Formula 2, exposed individuals 
receive a weight of 1, while unexposed individuals receive a weight equal to their odds of 
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exposure. Thus, unexposed individuals with greater odds of exposure (i.e. greater 
similarity to the exposure group) are weighted heavier than those unexposed with reduced 
odds of exposure. In the weighted sample, membership in the exposed or unexposed 
group is independent of the measured causes of such membership, thereby mimicking the 
exchangeability generated by randomization.190 Another way of stating this is that the 
causes of the exposure (confounders) are balanced across the exposed and unexposed 
groups, blocking all measured non-causal pathways between the exposure and the 
outcome. Thus, such weighting allows for estimation of the AEE, controlled for 
measured confounders. The AEE, which represents the average effect of the exposure 
among those actually exposed (and thus, the level of outcome that can be reduced by 
eliminating the exposure) is calculated using Formula 3.  
Table 7: AEE weighting notation 
xi Represents a given model of the propensity score covariates for individual i 
PSi Actual (theoretical) propensity score for individual i 
ê(xi) Propensity score for individual i, estimated by model of propensity score covariates 
wi Inverse probability of treatment weight for individual i 
τt Average treatment effect among the treated (AEE) 
τt,w Average treatment effect among the treated (AEE) calculated using IPTW 
Nt Number of individuals in the exposed group 
i∈T The ith observation in the exposed group 
i∈C The ith observation in the unexposed group 
Sources: Hirano & Imbens 2001, Hirano, Imbens, & Ridder 2003, McCaffrey, Ridgeway, & Morral, 
2004189,198,199 
𝑃𝑆𝑖 = ?̂?(𝑥𝑖) = 𝑃(𝑇𝑖 = 1|𝑥𝑖 = 𝑥) =
𝑒𝑥𝑝⁡(𝑥𝑖)
1 + 𝑒𝑥𝑝⁡(𝑥𝑖)
 
Formula 1: Propensity score for individual i 
𝑤𝑖 =⁡𝑇𝑖 + (1 − 𝑇𝑖)
?̂?(𝑥𝑖)
1 − ?̂?(𝑥𝑖)
 
Formula 2: Inverse probability of treatment weight for the AEE, individual i 
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𝜏𝑡,𝑤 = ∑
𝑦𝑖
𝑁𝑡
𝑖∈𝑇
−
∑ 𝑤𝑖 ∗ 𝑦𝑖𝑖∈𝐶
∑ 𝑤𝑖𝑖∈𝐶
 
Formula 3: AEE calculated using IPTW 
Estimates of treatment effects based on IPTW will be essentially unbiased upon meeting 
several assumptions: (1) each participant has the potential to experience either exposure; 
(2) the stable unit treatment value assumption holds; and (3) the outcome is independent 
of the exposure after accounting for differences in the pre-exposure PS variables (i.e. 
exchangeability is achieved).191,199 Assumption 1 is satisfied in that no child is exempt 
from vulnerability to maltreatment. With regard to item 2, we make the assumption that 
any given participant’s outcome is not influenced by another participant’s history of 
CPSA. This assumption seems reasonable, except in the situation that multiple 
participants were raised in the same household and/or are part of the same family. Given 
that CHIWOS does not collect household or family-level data, the actual risk of peer 
effects is not estimable, however is presumed to be negligible. Assumption 3, which 
maps onto counterfactual theory/exchangeability, can be addressed with extension to 
causal modelling. Briefly, conditioning the exposure on all of its potential causes blocks 
all non-causal paths which may lead to exposure-outcome confounding.200 It is this 
capability which makes PS analyses particularly well-suited to studies with a single 
exposure and multiple outcomes. While theoretically the causes of the exposure create a 
sufficient set, in practice, the ability to measure and operationalize a sufficient set of all 
causes becomes less realistic and the selection of variables which cause not only the 
exposure but also the outcome becomes more important. Inclusion of these “true 
confounders” has been shown to result in improved PS overlap and reduced mean 
squared error when compared to conditioning the PS only on variables related to 
treatment allocation.201 For this reason, PS variable selection was implemented by 
identifying the ecological causes of CPSA, and within these causes identifying variables 
available from the CHIWOS dataset with an eye towards non-mediating causes of study 
outcomes (see 3.3.3 Propensity Score Covariates). 
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3.2.3 Generalized Boosted Modelling for Propensity Score 
Estimation 
Traditionally, PSs are estimated using a logistic regression model with the exposure as 
the dependent variable, and its causes as the independent variables.202 In creating the 
scores, researchers are encouraged to iteratively re-specify the model (adding interaction 
terms and/or higher order functions) until an optimal covariate balance is reached.202 
Ideally, weighting participants using the given scores would result in the exposed and 
unexposed groups having effectively the same distribution of the covariates, thereby 
controlling their effects. However, considering that PS modelling is equipped and even 
intended to accommodate a large number of covariates, the re-specification process can 
be tedious. The traditional logistic regression method for PS estimation also specifies a 
linear relationship between covariates and the logit of the PS, an assumption which may 
or may not be satisfied. Furthermore, PS estimates based on logistic regression models 
can be unstable, generating extreme weights and imprecision.203  
Several PS modelling techniques have been developed in response to these issues, 
including Generalized Boosted Modelling (GBM), proposed in the context of PSs by 
McCaffrey, Ridgeway, and Morral in 2004.199 GBM is a nonparametric, machine-
learning method that fits many multivariate models of a dependent variable which are 
combined to produce a probability estimate, such as a PS.204–206 The method proposed by 
McCaffrey and colleagues uses regression trees which algorithmically partition the 
dataset based on covariate splits which minimize prediction error for the PS.199 
“Boosting” generally refers to an algorithm which adaptively combines weakly predictive 
models to produce a final model that is more predictive than those that it is derived 
from.204 GBM for PS modelling works by modelling the log-odds of treatment 
assignment (i.e. log-odds of actually experiencing CPSA) denoted g(x), then searching 
for an adjustment to the model, h(x), that improves model fit.199 H(x) is a regression tree 
where the residual error of current model fit is the dependent variable and independent 
variables that cause the exposure variable are the covariates.199 In the case that the 
regression tree improves model fit (i.e. that particular covariate split minimizes 
residuals), the model for the log-odds of treatment assignment becomes g(x) + h(x).199 
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This process of selecting and incorporating sub-models that improve model fit happens 
iteratively, however, because the overall model changes with the addition of each sub-
model [g(x) + h(x) + … h(x)], the dependent variable for each new sub-model (i.e. the 
residuals of the new overall model) is also different. In plain language, this means that 
with each iteration, the sub-model selection criteria adapt to improve overall model fit.199 
The data-adaptive nature of this method means it is a sequential ensemble method that 
learns with each iteration, standing in contrast to parallel ensemble methods such as 
bootstrap-aggregating (“bagging”) which fit many sub-models at once to generate an 
overall average model.  
GBM has been demonstrated to outperform traditional logistic regression models, as well 
as other ensemble specification methods,207 especially when estimating the AEE by 
IPTW.208 In a comparative study by Harder et al., GBM with IPTW was the only method 
of nine competitors (logistic regression, logistic regression with iterative inclusion of 
covariate interactions, and GBM each applied using 1:1 matching, full matching, and 
IPTW) which achieved adequate covariate balance for estimation of the AEE.208 GBM 
has also outperformed other ensemble methods such as bagged classification and 
regression trees as well as random forests in terms of covariate balance, confidence 
interval coverage, and tendency to produce extreme weights.207 For these reasons, GBM 
was selected as the method of PS estimation. In the present analysis, GBM was 
operationalized using RAND Corporation’s toolkit for weighting and analysis of non-
equivalent groups (“TWANG”) macro for SAS,209 carried out in SAS 9.4.210 Use of this 
macro required installation and background use of R software version 3.4.3.211 CPSA was 
specified as the binary exposure variable across which PS covariates would be balanced 
(Section 3.4.3). Per the recommendations of Ridgeway et al., the maximum number of 
iterations (i.e. classification trees) was specified as n=5000 in order to allow ample space 
for model optimization.209,212 Also per recommendations, up to 3-way interactions were 
allowed within models. In order to avoid overfitting, the shrinkage parameter was 
specified at 0.01, striking a balance between an overly smooth model with many 
iterations (i.e. over-fit) and a more “jagged” model which does not adequately fit the 
data. Two types of balance criteria were applied to evaluate the optimal iteration; these 
are also called “stopping rules”. The iterations which minimized the absolute 
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standardized mean difference (or effect size, ES), and the mean Kolmogorov-Smirnov 
(KS) statistic for PS variables, respectively were identified. The standardized ES 
identifies differences in covariate balance across the CPSA+ and CPSA- groups while the 
KS test identifies differences in covariate distribution.209,213 Because the KS stopping 
point minimized the mean and maximum ES and KS statistics equally or in some cases 
better than the alternative stopping point, the KS mean stopping point was selected.  
3.2.4 Propensity Score Overlap and Balance Diagnostics 
In order for inferences based on PS weighting to be valid, the PS distributions for the 
exposed and unexposed groups must overlap,214,215 and the weighting must demonstrably 
balance measured covariates across these groups.191,216 In order to avoid potential off-
support inference, PS distributions were evaluated by comparing box plots for the 
CPSA+ and CPSA- groups. Balance diagnostics, which show whether weighting 
successfully balanced covariates across exposure groups, were evaluated as suggested in 
Austin and Stuart’s best practice guidelines.216 Specifically, Wald Chi Square tests, t-tests 
and KS tests (where applicable) of the PS covariates across exposure groups were 
compared before and after weighting. These tests were conducted for the distribution of 
covariates across CPSA for the total analytic sample as well as within each ethnoracial 
group in order to identify potential stratum-specific confounding.209 The TWANG macro 
also creates indicator variables for the level of missingness on each PS covariate, 
allowing users to achieve and evaluate balance on covariate missingness. Balance of 
covariate missingness was evaluated in the same way as covariate balance.  
3.2.5 Outcome Analysis 
Several approaches exist for outcome analysis using IPTW with AEE weights, including 
direct estimation using weighted means, and regression modelling. There are also several 
different approaches for calculating the standard error and confidence intervals for these 
estimates. Ideally, calculation of outcome variance should account for variability in the 
original propensity score model.199 However, for GBM, as for other propensity score 
estimation methods, such a method has not been proposed. Solutions to account for this 
excess variance include estimating bootstrap or jackknife confidence intervals,199 or using 
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robust standard errors.217 Additionally, because outcome estimates are weighted, 
precision calculations must account for the potential increase in variance due to 
weighting.218 Joffe and colleagues suggest that regression models that accommodate 
weighting, along with robust variance estimators can accomplish this.218 This direction 
combined with the desire to estimate prevalence ratios rather than odds ratios for binary 
outcomes led to the decision to use modified Poisson regression with robust variance 
estimators, weighted for the AEE, implemented using PROC GENMOD as per Sato and 
Matsuyama.219 For continuous outcomes, PROC GENMOD with robust variance 
estimation and AEE weights was also implemented, but specifying a normal distribution. 
SAS code is available in Appendix 2. 
In order to account for potential moderating effects differentiating key populations of 
women with HIV, the AEE for all outcomes was calculated for the total population 
(Objective 2), as well as within 5 ethnoracial strata: Indigenous, Black African, Black 
Caribbean, white, and “other” women. Then, interaction terms between CPSA and 
ethnoracial group were used to compare effects across subgroups, with white women as 
the reference group (Objective 3). When comparing effects across subgroups, confidence 
intervals that did not cross the null value were interpreted as evidence of effect 
modification. This subgroup analysis applied the propensity scores and corresponding 
weights calculated using the total sample, rather than generating unique propensity scores 
for each subgroup. Scores derived from this approach are termed cohort propensity 
scores, in contrast to subgroup propensity scores. This decision is justified based on prior 
studies which found that using cohort propensity scores for subgroup analysis resulted in 
effect estimates not significantly different from those obtained with subgroup-specific 
propensity scores, with some variation where subgroups were small.220,221 Cohort scores 
have also performed similarly to subgroup scores across multiple conditions when 
evaluated on covariate balance, bias, and precision.221 There is still debate as to the 
validity of cohort scores as compared to subgroup scores; however, the literature does not 
provide sufficient evidence to recommend one approach over the other.222 In order to 
ensure that the cohort propensity score weights balanced covariates across exposure 
groups in the overall sample and within ethnoracial groups, traditional balance 
diagnostics were supplemented by stratum-specific balance diagnostics.  
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3.2.6 Sensitivity Analysis 
In order to test the assumption that CPA and CSA have sufficiently similar effects to use 
the composite outcome of CPSA, two alternative sets of propensity scores were generated 
for sensitivity analysis: one predicting CPA, and the other predicting CSA. The methods 
for generating and applying these scores were identical to the methods described for 
CPSA, however, scores for CPA included CSA as a covariate and vice-versa. Controlling 
the effect of each variable on the other allowed for the identification of CPSA effects that 
were potentially driven by CPA or CSA only. 
3.2.7 Temporality 
While the CHIWOS project has collected two waves of cohort data, it is important to note 
that the present analysis represented a cross-sectional approach with an aspect of nested 
temporality. Because women were asked retrospectively about their experiences of CPA 
and CSA including an age cut-off of 16, any reported abuse could be attributed to the 
time period prior to outcome measurement. Additionally, variables selected as PS 
covariates were those known to occur or be potentially identifiable prior to that same age 
cut-off. Thus, while it is known that covariates precede outcome measurement, it is 
possible that some covariates measured factors occurring after the exposure. Efforts to 
address this limitation are addressed in 3.3.3. While the present analysis applies a causal 
framework and epidemiological method, the inherent limitations of cross-sectional data 
should be considered when interpreting the results.  
3.3 Study Variables 
3.3.1 Outcomes 
Outcomes were identified using a literature review of qualitative and quantitative 
research documenting determinants of partner HIV status disclosure among women. 
Briefly, these barriers included factors related to current or past relationships (trust, 
dependence, security, abuse), internal factors (HIV stigma) as well as expectations of the 
effects of partner disclosure (perceived social support, expected discrimination, abuse). 
These factors were then mapped onto similar variables available in the CHIWOS dataset: 
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sexual relationship power, history of physical abuse in adulthood, history of sexual abuse 
in adulthood, perceived HIV stigma, and perceived social support. Because sexual 
relationship power was only measured among those women who indicated they had been 
sexually active in the past month (Wave 1) or the past 6 months (Wave 2), the 
relationship between CPSA and sexual inactivity was examined. This outcome was 
intended to add to the interpretability of sexual relationship power, rather than to 
represent a barrier to HIV status disclosure. 
3.3.2 Exposure Variable 
The decision to examine the effect of childhood physical or sexual abuse rather than the 
independent effects of each was based on theoretical and practical considerations. Prior 
research suggests that psychological outcomes among adults with a history of abuse 
during childhood do not vary greatly by the nature of the abuse.9,223 Furthermore, 
physical and sexual abuse during childhood (CPA, CSA) often co-occur,224 making 
effects statistically difficult to tease apart. However, in the interest of testing this 
assumption to the best of our abilities, effects were reported for PS models predicting 
CPSA (main analysis), as well as models predicting CPA and CSA (sensitivity analyses). 
3.3.3 Propensity Score Covariates 
As specified by the statistical analysis plan, the PS estimation variables for this study 
were causes of CPSA, especially causes of CPSA which may also be causes of the 
outcomes. Furthermore, PS estimation variables should not be mediators along the causal 
pathway. A literature review of causal theories for CPSA was conducted, leading to the 
integration of eco-social and intersectional theoretical models for the context of Canadian 
women with HIV (2.6). Using this model, causes of CPSA at the level of society, 
community, family/caregiver, and child were identified. Within these domains, causes of 
vulnerability available from the CHIWOS dataset that could identifiably have an effect 
during childhood were identified. These variables included: age as an indicator for 
society’s shifting acceptability of child abuse over time, sexual orientation, gender 
identity, immigration to Canada at or before the age of 16, stress-related immigration 
circumstances among those who immigrated to Canada in childhood, unstable or refugee 
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housing prior to immigration in childhood, being adopted, spending time in foster care or 
a group home, being a survivor of residential school, and having family members who 
attended residential school. These factors span all eco-social domains identified in the 
theoretical model. Within this set of variables, it was necessary to remove any variable 
which could be caused by CPSA (i.e. potential mediators). Because foster care, group 
home residence, and adoption are so often consequences of CPSA, a decision was made 
to not include these variables in the PS model. Furthermore, the variable related to living 
in unstable or refugee housing prior to immigration in childhood was excluded based on 
low prevalence (0.15%) and thus low potential impact. 
Based on the condition that all variables in a PS model should precede the exposure of 
interest, some may question the inclusion of sexual orientation and gender identity in this 
study. Arguments on the etiology of sexual orientation and gender identity aside, this 
decision was made based on evidence demonstrating that adults who identify as a sexual 
orientation other than heterosexual and/or a gender that doesn’t align with the sex 
assigned to them at birth retrospectively report elevated rates of CPSA compared to their 
heterosexual/cisgender peers.225–227 While opinions on the cause of this relationship vary, 
it is theorized that whether or not an individual is aware of their sexual orientation/gender 
identity during childhood, perceived atypicality with respect to gender/sexual norms 
during childhood can result in increased targetability for abuse.226 In fact, signs of gender 
atypical behaviour during childhood have been associated with onset of verbal and 
physical abuse from both parents and peers.226 This ties into the eco-social framework 
which identifies individual-level markers that may increase likelihood of maltreatment, 
though only in the presence of risk factors at other levels (i.e. children are not responsible 
for their own abuse).136,142 
3.4 Measures 
3.4.1 Outcomes 
All outcomes were measured at both Wave 1 and Wave 2, with the exception of social 
support which was measured at Wave 1 only. Because the measures for physical and 
sexual abuse in adulthood allowed for collapsibility across waves, single “ever-
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experienced” variables are used for these outcomes. Where measures were available from 
both waves but not collapsible as with physical and sexual abuse, the Wave 1 measures 
were used on the basis of larger sample size. An exception to this rule was the sexual 
relationship power variable, which was only asked of women who indicated that they had 
been sexually active in the past month at Wave 1. An unexpectedly high prevalence of 
sexual inactivity at Wave 1 prompted the decision to push the referent time frame for 
sexual activity to the past 6 months in the Wave 2 questionnaire. In addition to potentially 
better validity (this measure can be answered hypothetically for those who are not 
currently sexually active) this decision resulted in a greater number of non-missing 
responses at Wave 2 rather than Wave 1 (n=486 and n=440, respectively). For these 
reasons the sexual relationship power measure (and the corresponding measure of sexual 
inactivity, for interpretability) were based on Wave 2 outcome data.  
Physical Abuse During Adulthood (Ever) 
Experience of physical abuse during adulthood was measured using two yes/no items: 
“As an adult, has someone ever physically hurt you?” (Wave 1) and “Since your last 
CHIWOS interview, has someone physically hurt you?” (Wave 2). Participants who 
reported abuse in either interview were coded “yes” while participants who reported no 
abuse in both interviews were coded “no”. Where Wave 1 was missing and no physical 
abuse was reported in Wave 2 (n=1), the participant was coded as missing as the Wave 2 
item does not capture “ever” abuse, which is the construct of interest. Conversely, where 
Wave 1 was missing but physical abuse was reported in Wave 2 (n=1), the participant 
was coded “yes” since any abuse is “ever” abuse. When Wave 2 responses were missing, 
Wave 1 responses were coded, and if both waves were missing, the final variable was 
also missing. The amount of missing information for this variable in the analytic sample 
was 0.08%. 
Sexual Abuse During Adulthood (Ever) 
Experience of sexual abuse during adulthood was measured using two yes/no items: “As 
an adult, has someone ever sexually forced themselves on you, or forced you to have 
sex?” (Wave 1) and “Since your last CHIWOS interview, has someone sexually forced 
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themselves on you, or forced you to have sex?” (Wave 2). Participants who reported 
abuse in either interview were coded “yes” while participants who reported no abuse in 
both interviews were coded “no”. If Wave 1 was missing but no sexual abuse was 
reported in Wave 2 (n=11), the participants were coded as missing as the Wave 2 item 
does not capture “ever” abuse, which is the construct of interest. No participants who 
were missing Wave 1 reported experiencing sexual abuse at Wave 2. When Wave 2 
responses were missing, Wave 1 responses were coded, and if both waves were missing, 
the final variable was also missing. The amount of missing information for this variable 
in the analytic sample was 0.92%. 
Sexual Relationship Power 
The Sexual Relationship Power Scale (SRPS) was developed by Pulerwitz, Gortmaker, 
and DeJong in 2000 in order to test the hypothesized relationship between low sexual 
relationship power and condom efficacy among women.93 The SRPS consists of two sub-
scales: relationship control (Cronbach’s alpha=0.86) and decision-making dominance 
(Cronbach’s alpha=0.62), using metrics from the original validation study.93 The 
regularly weaker internal consistency as well as questionable construct validity of the 
decision-making dominance subscale has led some researchers (including the CHIWOS 
team) to use only the relationship control subscale.228 The relationship control subscale 
has 15 items, focusing on sexual violence and risk as well as other aspects of power 
including the amount of control a sexual partner has over the participant’s day-to-day 
life.93 In CHIWOS, the SRPS was preceded by the statement: “The following questions 
ask about your relationship with your partner. If you currently have more than one sexual 
partner, please think about the person you consider your primary sexual partner”. 
Furthermore, the partner pronouns from the original scale were changed to “s/he” in order 
to account for non-heterosexual relationships. A four-point Likert scale including 
“strongly agree,” “agree,” “disagree,” and “strongly agree” are the response options, with 
agreement to statements corresponding to lower scores and thus lower sexual relationship 
power in the summed score. Summed scores were divided by the number of non-missing 
items, with participants missing ≥ 20% of items (≥ 3/15) marked as missing (867/1307 
missing at Wave 1, 821/1307 missing at Wave 2). While traditionally the SRPS has been 
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recoded into a categorical variable with three tertiles indicating low, medium, and high 
sexual relationship power,93 these are not validated cutpoints and thus may not represent 
meaningful differences. For this reason, the SRPS was treated as a continuous scale, with 
scores ranging from 1 to 4.  
Sexual Inactivity 
As previously discussed, sexual inactivity as a screening question for the SRPS was 
measured with different referent time frames from Wave 1 to Wave 2. At both waves, 
participants who indicated they would complete the Women’s Sexual Health section were 
asked “Have you had consensual sex in the past 6 months?  This includes any type of 
sexual intercourse you willingly engaged in, including getting or giving oral sex, vaginal 
sex, and/or anal sex with people of any gender” with response options: yes, no, and prefer 
not to answer. In the Wave 1 questionnaire only, participants were also prompted 
with “[t]hese next questions are in regards to your sexual activity in the past month. Have 
you been sexually active during the past month?” and the same response options. 
Participants deemed sexually active using the first item answered the SRPS at Wave 2, 
and participants deemed sexually active using the second item answered the SRPS at 
Wave 1, yielding the smaller sample and leading us to focus on the Wave 2 data. Thus, 
those who answered no to item 1 in Wave 2 were coded as “sexually inactive”, with this 
binary item being used to enhance the interpretability of the SRPS at Wave 2. The 
amount of missing information for this variable in the analytic sample was 6.2%. 
HIV Stigma 
HIV stigma was measured using Wright’s ten-item version of the forty-item HIV Stigma 
Scale,229 which was originally developed by Berger and colleagues.113 Both the original 
and abbreviated scales contain four subscales: personalized stigma (fear of rejection), 
disclosure concerns, negative self-image, and concerns related to public attitudes about 
people with HIV. Similarly, both versions of the scale demonstrated good internal 
consistency and construct validity for subscales as well as the total scale.113,229 Response 
options are on a five-point Likert scale (strongly agree, agree, neither, disagree, strongly 
disagree) with stronger agreement corresponding to higher scores. Items were summed 
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resulting in final scores ranging from 0 to 40. As with other continuous variables, 
participants missing  ≥ 20% of items (i.e. ≥2/10 items) were excluded from analysis of 
this outcome (missingness rate of 1.15%).  
Perceived Social Support 
Perceived social support was captured using a shortened four-item version of the Medical 
Outcomes Study Social Support Scale (MOS-SSS).119,230 The abbreviated MOS-SSS has 
been shown to have comparable internal consistency, test-retest reliability, and construct 
validity to the original 18-item scale.230 Each of the four items taps a different domain of 
social support as identified in factor analysis of the original scale: emotional-
informational support, tangible support, affectionate support, and positive social 
interaction.119,230 In CHIWOS, the abbreviated MOS-SSS items are preceded by the 
statement: “People sometimes look to others for companionship, assistance, or other 
types of support. How often is each of the following kinds of support available to you if 
you need it?” and followed by a five-point Likert scale: all, most, some, a little, or none 
of the time. Greater frequency of support corresponds to higher scores, which are 
summed to create the final score which ranges from 4 to 20. As with other continuous 
measures, participants missing ≥ 20% of items (i.e. ≥1/4 items) were excluded from 
analysis of this outcome (missingness rate of 3.29%). The abbreviated MOS-SSS was 
only asked in the Wave 1 questionnaire.  
3.4.2 Explanatory Variables 
Childhood Physical or Sexual Abuse 
Experience of physical or sexual abuse during childhood was assessed using two yes/no 
items broadly defining each type of abuse: “During your childhood, did an adult ever 
physically hurt you?” and “During your childhood, did someone ever sexually force 
themselves on you, or forced you to have sex?”. Prior to asking these questions PRAs 
informed participants that here “child” is defined as less than 16 years old. PRAs could 
also further define physical abuse, stating “in some cultures, physical discipline of 
children is common; for our purposes, we are including such physical discipline” as well 
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as sexual abuse, stating “this can include the fondling of your private parts, oral sex, 
vaginal sex, and anal intercourse. It can be either forced or with your consent because 
you feared the consequences of resisting the person”. These items were only asked in 
Wave 1. A single variable was created using these two items: participants who answered 
yes to either question were coded as having experienced CPSA, while participants who 
no to both were coded as not experiencing CPSA. Those missing one item (n=19) were 
coded according to their response on the other, while those missing both items were 
excluded from the analysis, yielding an analytic sample size of n=1307/1422.  
Childhood Physical Abuse (for sensitivity analysis) 
CPA was coded as a binary variable using only the physical abuse item from the CPSA 
measure. The analytic sample for the CPA sensitivity analysis included the n=1311/1422 
participants for which the CPA variable was non-missing.  
Childhood Sexual Abuse (for sensitivity analysis) 
CSA was coded as a binary variable using only the sexual abuse item from the CPSA 
measure. The analytic sample for the CSA sensitivity analysis included the n=1291/1422 
participants for which the CSA variable was non-missing.  
Ethnoracial Group 
Participants self-identified their racial and/or ethnic background on an extensive “check 
all that apply” list including: Aboriginal person living in Canada, Indigenous Person from 
a country outside of Canada, Black African, Black Caribbean, Black Other, 
Caucasian/White, Chinese of Taiwanese, Filipino, Japanese, Korean, Latin American, 
South Asian, Southeast Asian, Arab, West Asian, Central Asian, Multiple races / 
Multiracial / “Mixed”, or “Other, specify”. Any participant who reported identifying as 
an Indigenous person in Canada was classified as Indigenous (n=289), while participants 
who identified as Black African only or Black African and Black Other were classified as 
Black African (n=302). Similarly, those who identified as Black Caribbean only or Black 
Caribbean and Black Other were classified as Black Caribbean (n=64). Participants who 
selected only Caucasian/white were classified as white (n=549). The “other” category 
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(n=103) included participants who did not fall into the parameters above, including 
multiracial individuals, those who selected single ethnoracial groups for which the sub-
sample was not large enough to constitute its own strata, and 6 participants who selected 
“Black, Other” with no additional Black ethnoracial group. This coding resulted in no 
participants missing data on race. 
Because of within-group heterogeneity, results pertaining to the “other” group were not 
interpretable in any way other than to serve as a call for further research. To emphasize 
this necessity and remain accountable to the women from under-represented ethnoracial 
groups who participated in CHIWOS, results for the “other” group were reported 
alongside those for the four main ethnoracial groups, and of course included in effect 
estimates for the total sample. In order to provide some insight into the individuals who 
constituted the “other” group, Table 8 provides a breakdown of their ethnoracial 
identities.  
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Table 8: Ethnoracial groups identified by the women classified in the "other' ethnoracial 
group (n=103) 
Ethnoracial group Percentage (n) 
Indigenous person living in Canada (e.g., First Nations, Métis, Inuit) 0 
Indigenous person from a country outside of Canada 0 
Black African (e.g., Nigerian, Somali) 5.83% (6) 
Black Caribbean (e.g., Haitian) 1.94% (2) 
Black Other (e.g., Black Canadian) 5.83% (6) 
Caucasian/White 13.6% (14) 
Chinese or Taiwanese 3.88% (4) 
Filipino 2.91% (3) 
Japanese 5.83% (6) 
Korean 3.88% (4) 
Latin American (e.g., Chilean, Costa Rican, Mexican) 20.4% (21) 
South Asian (e.g., Indian, Bangladeshi, Pakistani, Punjabi, and Sri Lankan) 13.6% (14) 
Southeast Asian (e.g.,Cambodian, Laotian, Malaysian, Vietnamese) 5.83% (6) 
Arab (e.g., Egyptian, Kuwaiti, and Libyan) 5.83% (6) 
West Asian (e.g. Iraqi, Isreali, Lebanese, Afghani, Iranian) 2.91% (3) 
Central Asian (e.g., Kazakhstan, Krgyzstan, Tajikistan, Turkmenistan) 0 
Multiple races / Multiracial / “Mixed” 34.0% (35) 
 Participants could select all ethnoracial groups that applied and thus percentages do not sum to 100%. 
3.4.3 Propensity Score Covariates 
Age 
Age was measured continuously in years, subtracting the participant’s date of birth from 
the baseline interview date. No participants in the analytic sample were missing data on 
age. 
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Sexual Minority 
Sexual orientation was measured by self-identification, using the item “With respect to 
your sexual orientation, how do you currently identify?” and a check-all-that-apply list 
including Heterosexual/Straight, Lesbian, Gay, Queer, Bisexual, Two-Spirited, 
Questioning, and Other, specify. Participants who only selected heterosexual/straight 
were coded as the reference category, while participants who selected any other identity 
alone or in combination with each other or heterosexual were coded as sexual minorities. 
Write-in responses without accompanying checkbox responses were coded into these two 
categories, with two participants identifying other sexual orientations coded as sexual 
minorities. Five participants endorsed “don’t know” or “prefer not to answer” for this 
item, and were marked missing. The amount of missing information for this variable in 
the analytic sample was 0.38%. 
Gender Minority 
Gender identity was measured by self-identification using the items related to current 
gender identity: “With respect to your gender, how do you currently identify?” and sex 
assigned at birth: “What was your biological sex at birth?”. Response options for gender 
identity included Woman, Trans Man (Female to Male), Trans Woman (Male to Female), 
Two-spirited, Intersex, Gender Queer, and Other, specify. Response options for sex at 
birth included “Male, Female, Intersex, Undetermined, and Other, specify. Respondents 
who identified as trans men in the gender identity item were not included in the study as 
per the inclusion criteria. Participants who were assigned female at birth and identified as 
women were coded as cisgender (reference group), while participants who selected any 
other combination of biological sex and gender identity were classified as gender 
minorities. There was no missing data for this variable in the analytic sample. 
Immigrating to Canada at or before age 16 
Immigration to Canada at or before age 16 was measured using items on year and country 
of birth, and year of immigration to Canada. Among participants born outside Canada, 
age at immigration was calculated by subtracting year of birth from year of immigration, 
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with those who immigrated after age 16 being classified as the reference group. Non-
immigrants were also placed in this reference group, creating a binary indicator variable 
for those who came to Canada at or before age 16. Participants who immigrated but were 
missing information on year of immigration were marked as missing. The amount of 
missing information for this variable in the analytic sample was 0.69%. 
Stress-related immigration circumstances among those who immigrated to Canada at or 
before age 16 
Among those who immigrated to Canada at or before age 16, stress-related immigration 
circumstances were coded using the item “What were your reason(s)/your family’s 
reasons for immigrating to Canada?”. If participants selected 1 or more stress-related 
reason (Living conditions, Escape socio-political conditions in home country: political 
persecution, Persecution as a member of a sexual minority group or because of sexual 
orientation, Religious persecution, Conditions of war, slavery, or forced labour, or 
Domestic violence/intimate partner violence) and immigrated at or before 16 they were 
coded as 1, while others, non-immigrants, and those who immigrated after made up the 
reference group. The amount of missing information for this variable in the analytic 
sample was 4.44%. 
Survivor of the residential school system 
Participants who indicated that they were Indigenous and who agreed to answer questions 
about residential school were asked whether they ever attended one of these institutions. 
Participants who answered yes were coded as one, while those who did not attend or were 
not Indigenous constituted the reference group. Indigenous participants who declined to 
answer this section (n=123) or item (n=42) were marked missing. The total amount of 
missing information for this variable in the analytic sample was 12.6%. 
Family member(s) who attended residential school 
Similarly, Indigenous participants living in Canada who agreed to answer questions about 
residential school were asked whether their mother, father, maternal grandmother, 
maternal grandfather, paternal grandmother, paternal grandfather, or any siblings had 
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ever attended residential school. Those who had at one or more family member attend 
were classified accordingly, while those with no family members who attended or were 
not Indigenous were the reference group. Participants who declined to answer this section 
(n=123) or item (n=17) were marked missing. The total amount of missing information 
for this variable in the analytic sample was 10.7%. 
3.5 Missing Data 
3.5.1 Outcomes 
In the analytic sample, outcome missingness ranged from 0.08% to 3.29%, with the 
exception of the SRPS which was considerably higher (62.8% at Wave 2). Because 
missing data for outcomes other than the SRPS was low and missing data for the SRPS 
was derived almost entirely from a known survey design feature for which further 
interpretation is provided (i.e. effect of CPSA on sexual inactivity), analyses were 
conducted on the available data for each outcome.  
3.5.2 Explanatory Variables 
The analysis was restricted to the 1307/1422 cases where the exposure variable (CPSA) 
was non-missing, as calculation of the propensity score depends on valid exposure data. 
3.5.3 Propensity Score Covariates 
Missingness for propensity score covariates ranged from 0% to 12.6% in the analytic 
sample. As addressed in 3.2.4, the generalized boosted modelling algorithm creates 
missingness indicators for each propensity score covariate, and balances missing data 
across exposure groups as it does for non-missing data.  
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Chapter 4  
4 Results 
This chapter will provide the results of IPTW using GBM in the form of propensity score 
overlap and balance diagnostics. It will then describe the unadjusted differences in 
analytic variables observed across ethnoracial strata. With respect to the analytic results, 
the propensity score analysis will provide AEE estimates (prevalence ratios, regression 
coefficients, and robust 95% confidence intervals) in tables and figures for the effect of 
CPSA on barriers to HIV disclosure among women who experienced CPSA. AEE 
estimates will be compared across ethnoracial groups. Finally, the results of the 
sensitivity analysis testing the effect of CPA and CSA on disclosure variables will be 
provided.  
4.1 IPTW using GBM 
The GBM algorithm with a KS mean stopping point successfully balanced all propensity 
score covariates and their missing values at 784 iterations for the main CPSA analysis 
(see Appendix 3 for the optimization plot). The propensity scores generated by the 
algorithm, while higher among women who experienced CPSA (as expected), did overlap 
(see Appendix 4 for side-by-side box plots of propensity scores for CPSA+ and CPSA- 
groups). This indicated that the weights derived from these scores would produce 
minimal off-support inference, and could be applied in analysis. The same was true for 
both the CPA and CSA sensitivity analyses, which achieved covariate balance at 1767 
and 1889 iterations, respectively.  
4.2 Balance Diagnostics 
Covariate balance in the total analytic sample: 
As displayed in Table 9, there were several significant differences between women with 
and without a history of CPSA prior to weighting. These differences rendered the 
unweighted groups incomparable with respect to measured confounders. As expected, 
women who experienced CPSA were more likely to report a minority sexual orientation 
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(P<0.0001) or a minority gender identity (P=0.003). While the proportion of women who 
were survivors of residential school did not reach statistical significance, the proportion 
of women who declined to answer items on self-attendance at residential school was 
greater among women who experienced CPSA (P=0.001). Women who experienced 
CPSA also were significantly more likely to have one or more family members who 
attended residential school (P<.0001) and to decline to answer items on family 
attendance at residential school (P=0.005). While no statistically significant difference 
was observed in the mean age of women in both groups, a Kolmogorov-Smirnov test (for 
continuous variables) did detect a marginally significant difference in the distribution of 
age across the two groups (P=0.062). Other imbalances approached statistical 
significance, such as the difference across exposure groups in proportions of women 
reporting that they immigrated at or before age 16 (P=0.101), or experienced stress-
related circumstances surrounding that immigration (P=0.106). In both cases, the 
outcome was more common among women who experienced CPSA. 
As displayed in Table 10, no statistically significant differences remained across the 
weighted exposure groups. Thus, weighting rendered the groups comparable with respect 
to measured confounders. In addition to all variables and their missingness indicators 
rising above the significance cut-off of α = 0.05, the majority of these variables (even 
those that were not significant before weighting) had P-values much higher than those 
prior to weighting. For example, experiencing stress related to immigration was 
approaching significance at P=0.106 prior to weighting, but any differences could be 
definitively ruled out after weighting (P=0.993).  
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Table 9: Covariate balance, unweighted 
Variable Measure CPSA- 
N=488 
CPSA+ 
N=819 
Standardized 
effect size 
difference 
P-value * 
 
P-value  
(KS-test) 
Age 
x̅ (SE) 
42.9 
(0.53) 
42.7 
(0.35) 
-0.025 0.689 0.062 
Sexual minority 
% (SE) 
6.78 
(1.14) 
16.8 
(1.31) 
0.267 <.0001 N/A 
Missing 
% (SE) 
0.20 
(0.20) 
0.49 
(0.24) 
0.041 0.373 N/A 
Gender minority 
% (SE) 
2.46 
(0.70) 
5.62 
(0.81) 
0.137 0.003 N/A 
Immigrated at or 
before age 16 
% (SE) 
3.92 
(0.88) 
5.90 
(0.83) 
0.084 0.101 N/A 
Missing 
% (SE) 
0.61 
(0.35) 
0.73 
(0.30) 
0.014 0.799 N/A 
Immigration 
related-stress at or 
before age 16 
% (SE) 
0.86 
(0.43) 
1.91 
(0.49) 
0.075 0.106 N/A 
Missing 
% (SE) 
4.71 
(0.96) 
4.27 
(0.71) 
-0.022 0.712 N/A 
Survivor of 
residential school 
% (SE) 
0.45 
(0.32) 
1.15 
(0.40) 
0.058 0.176 N/A 
Missing 
% (SE) 
9.02 
(1.30) 
14.8 
(1.24) 
0.162 0.001 N/A 
Family member(s) 
attended residential 
school 
% (SE) 
3.33 
(0.85) 
11.3 
(1.18) 
0.228 <.0001 N/A 
Missing 
% (SE) 
7.79 
(1.21) 
12.5 
(1.15) 
0.141 0.005 N/A 
SE denotes standard error. 
* P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while 
P-values for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ). 
Kolmogorov-Smirnov tests are only intended for continuous variables and thus were only reported for age.  
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Table 10: Covariate balance, AEE weighted 
Variable Measure CPSA- 
N=744 
CPSA+ 
N=819 
Standardized 
effect size 
difference 
P-value*  
 
P-value  
(KS-test) 
Age 
x̅ (SE) 
42.8 
(0.47) 
42.7 
(0.35) 
-0.01 0.873 0.77 
Sexual minority 
% (SE) 
14.2 
(2.55) 
16.8 
(1.31) 
0.068 0.362 N/A 
Missing 
% (SE) 
0.17 
(0.17) 
0.49 
(0.24) 
0.046 0.281 N/A 
Gender minority 
% (SE) 
5.49 
(1.92) 
5.62 
(0.81) 
0.006 0.949 N/A 
Immigrated at or 
before age 16 
% (SE) 
5.82 
(1.41) 
5.90 
(0.83) 
0.004 0.959 N/A 
Missing 
% (SE) 
0.95 
(0.61) 
0.73 
(0.30) 
-0.026 0.747 N/A 
Immigration 
related-stress at or 
before age 16 
% (SE) 
1.92 
(1.02) 
1.91 
(0.49) 
0.000 0.993 N/A 
Missing 
% (SE) 
4.74 
(1.08) 
4.27 
(0.71) 
-0.023 0.716 N/A 
Survivor of 
residential school 
% (SE) 
0.97 
(0.70) 
1.15 
(0.40) 
0.013 0.831 N/A 
Missing 
% (SE) 
12.4 
(1.97) 
14.8 
(1.24) 
0.068 0.296 N/A 
Family member 
attended residential 
school 
% (SE) 
9.15 
(2.33) 
11.3 
(1.18) 
0.059 0.409 N/A 
Missing 
% (SE) 
11.2 
(1.92) 
12.5 
(1.15) 
0.038 0.573 N/A 
SE denotes standard error. 
* P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while 
P-values for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ). 
Kolmogorov-Smirnov tests are only intended for continuous variables and thus were only reported for age. 
CPSA- sample size differs post-weighting because weights are calculated based on similarity to the CPSA+ 
group; CPSA- women with higher odds of exposure are weighted heavier, resulting in a greater post-
weighting sample size. 
Covariate balance within ethnoracial strata: 
In order to ensure that the use of cohort PSs as opposed to stratum-specific PSs balanced 
measured confounders across exposure groups within each ethnoracial group, weighted 
and unweighted balance diagnostics were calculated for each stratum (see Appendix 6). 
As for the total sample, the unweighted prevalence of sexual minorities was higher 
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among the CPSA+ groups for Black African and white women (P=0.018, P<0.0001). 
Similarly, the prevalence of gender minorities was significantly higher among “other” 
women who experienced CPSA compared to those who did not (P=0.025). Other 
imbalances in the unweighted data were related to CPSA+ women being younger among 
Black African women (P=0.003) and CPSA+ women being more likely to immigrate in 
childhood among Black Caribbean women (P=0.019). Gender identity, however, did not 
allow for calculation of balance diagnostics for any Black women, as no CPSA+ Black 
African women and no CPSA- Black Caribbean women were gender minorities. 
Similarly, no CPSA- Black Caribbean women had immigration-related stress in 
childhood. Because there was no heterogeneity across CPSA groups here prior to 
weighting, GBM could not balance said heterogeneity with weighting, and thus these 
stratum-specific instances of data insufficiency remained. Apart from these stratum-
specific instances of homogeneity in the data, weighting successfully remedied all of the 
measured imbalances in the unweighted data apart from that with respect to the age 
distribution among Black African women. Specifically, CPSA+ Black African women 
had a mean age of 39.8 while CPSA- Black African women had a mean age of 43.4. 
Concerns related to absolute standard effect size difference 
 While the AEE weights successfully balanced all measured exposure group differences 
in the total sample, and the majority of stratum-specific differences, one concern with the 
given weights was the limited effect sizes of the propensity score covariates on CPSA in 
the unweighted sample, as represented by the absolute standardized effect size difference 
(Table 9). McCaffrey and colleagues have loosely defined any standardized effect size 
difference greater than 0.20 to be a potentially problematic imbalance.213 The 
standardized effect size differences observed in the unweighted sample were low relative 
to this metric, with only the effects of sexual minority identity and family member 
attendance at residential school exceeding 0.20. The limited observed differences in the 
unweighted sample lead to limited potential for adjustment and thus affected the 
interpretation of AEE estimates as detailed in section 4.4.1 
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4.3 Descriptive Statistics 
Exposure variables: 
The burden of CPSA (and CPA/CSA respectively) in the sample was very high, with the 
majority of women (62.7%) having some experience of physical or sexual abuse in 
childhood (Table 11). Physical abuse was more prevalent than sexual abuse in the total 
sample and within each ethnoracial group. Proportionally, CPSA experiences were 
highest among Indigenous women (76.8%) and lowest among Black Caribbean women 
(46.9%). This trend held for experiences of physical abuse and sexual abuse, respectively. 
More than half (56.7%) of the sample experienced CPA, while 39.6% of the sample 
experienced CSA. Notably, for all ethnoracial groups, CPA and CSA co-occurred more 
frequently than they occurred independently, with overall an prevalence of co-occurrence 
equal to 34.1%. When measuring mutually exclusive CPA and CSA, experiencing only 
physical abuse was consistently more common than experiencing only sexual abuse. The 
prevalence of co-occurrence and independent occurrence is important when considering 
the validity of the sensitivity analyses, which attempt to disentangle the effects of CPA 
and CSA (see 3.2.6 Sensitivity Analysis).   
Outcome variables: 
Similar to childhood experiences of trauma, the burden of physical and sexual abuse in 
adulthood in the sample was very high. More than half of women (63.6%) had ever 
experienced physical abuse in adulthood (Table 12). This proportion was higher among 
women who experienced CPSA compared to those who did not (79.0% and 37.7%, 
respectively). Just under half of women (45.8%) had ever experienced sexual abuse in 
adulthood. Similarly, adult sexual abuse was more prevalent in the CPSA+ group than the 
CPSA- group (56.7% and 28.6%, respectively). The level of sexual inactivity in the 
sample was also high. In the total sample, and across exposure groups, approximately 
half of women had not engaged in consensual sex in the past six months. Furthermore, 
among women who had engaged in consensual sex, levels of perceived sexual 
relationship power were relatively high overall (x̅ = 3.30 on a 1-4 scale) and high across 
the CPSA- and CPSA+ groups. These results cannot be taken as representative of the 
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level of sexual relationship power among the sexually inactive women in the sample. The 
sample mean score on the HIV stigma scale (which ranges from 0-40) was 22.8, with 
higher scores indicating higher HIV stigma. This measure indicated mid-level HIV 
stigma for the group as a whole. Exposure group means did not appear to differ 
meaningfully from the overall mean. The same was true for perceived social support. The 
sample mean score on the social support scale was 14.2 on a scale from 4-20, which may 
denote mid-to-high levels of perceived social support. 
Table 11: Unweighted prevalence of childhood physical or sexual abuse and associated 
variables by ethnoracial group 
SE denotes standard error. CPSA= childhood physical or sexual abuse, CPA= childhood physical abuse, 
CSA= childhood sexual abuse, CPA & CSA = co-occurrence of childhood physical and sexual abuse, CPA 
only= occurrence of childhood physical abuse without sexual abuse, CSA only= occurrence of childhood 
sexual abuse without physical abuse. 
Table 12: Unweighted distribution of outcomes by exposure status 
 
Total 
N=1307 
CPSA- 
N=488 
CPSA+ 
N=819 
Outcome 
Physical abuse in adulthood % (SE) 63.6 (1.33) 37.7 (2.20) 79.0 (1.43) 
Sexual abuse in adulthood % (SE) 46.2 (1.39) 28.6 (2.05) 56.7 (1.74) 
Sexual inactivity % (SE) 54.4 (1.51) 54.7 (2.43) 54.1 (1.93) 
Sexual relationship power (scale 1-4) x̅ (SE) 3.30 (0.03) 3.39 (0.04) 3.25 (0.03) 
HIV Stigma (scale 0-40) x̅ (SE) 22.9 (0.23) 22.3 (0.36) 23.2 (0.29) 
Social support (scale 4-20) x̅ (SE) 14.2 (0.13) 14.5 (0.20) 14.0 (0.16) 
SE denotes standard error. Sample sizes for Sexual Relationship Power are reduced due to survey design.  
 
  
Total 
 
Indigenous 
Black 
African 
Black 
Caribbean 
 
White 
 
Other 
Exposure 
% (SE) 
 
N=1307 
 
N=289 
 
N=302 
 
N=64 
 
N=549 
 
N=103 
CPSA 62.7 (1.34) 76.8 (2.49) 50.0 (2.88) 46.9 (6.29) 62.3 (2.07) 71.8 (4.45) 
CPA 56.7 (1.37) 70.8 (2.68) 47.0 (2.88) 45.3 (6.27) 54.8 (2.13) 63.1 (4.78) 
CSA 40.1 (1.37) 60.9 (2.92) 17.8 (2.22) 14.1 (4.38) 43.9 (2.13) 44.6 (4.97) 
CPA & CSA 34.1 (1.32) 54.6 (2.98) 14.8 (2.06) 12.5 (4.17) 36.3 (2.06) 35.6 (4.79) 
CPA only 22.0 (1.16) 15.4 (2.16) 31.5 (2.70) 32.8 (5.92) 18.2 (1.65) 26.7 (4.43) 
CSA only 5.98 (0.66) 6.07 (1.43) 3.02 (0.99) 1.56 (1.56) 7.52 (1.13) 8.91 (2.85) 
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4.4 Effect of CPSA on Disclosure Barriers 
4.4.1 Interpretation of AEE 
The AEE weighting scheme of the present analysis was meant to allow measures of effect 
to be interpreted from a counterfactual perspective. For binary outcomes, prevalence 
ratios and their robust 95% confidence intervals were calculated. An AEE weighted 
prevalence ratio (PR) can be interpreted as the effect of an exposure on a given outcome 
among those who actually experienced the exposure. For instance, “women who 
experienced CPSA had 1.96 (95% CI 1.72, 2.25) times greater risk of physical abuse in 
adulthood than they would have, had CPSA never occurred”. Similarly, for continuous 
outcomes, effects were estimated using regression coefficients representing the adjusted 
difference in mean outcome level for the CPSA+ group as compared to the CPSA- group. 
For instance, “women who experienced CPSA had scores on the 40-point HIV stigma 
scale that were 1.34 (95% CI 0.35, 2.40) points higher than they would have been, had 
CPSA never occurred”. For the current analyses, AEE estimates were intended to 
represent causal processes. However, the limited effects of propensity score covariates 
and resulting limited potential for adjustment resulted in fewer than expected differences 
between unweighted and weighted effect estimates. For this reason, among other 
limitations such as the potential for unmeasured confounding, it is cautioned that AEE 
estimates should be interpreted as adjusted risk estimates with CPSA+ women as the 
referent group, rather than causal effects. This limitation is discussed further in Chapter 
5.2.  
4.4.2 Analytic Results 
Objectives 1 through 3 are addressed by outcome within these analytic results. Objective 
1 is addressed by presenting the effect of CPSA on outcomes for the group as a whole. 
Objective 2 to compare the above effect across ethnoracial groups is then addressed by 
presenting effect estimates stratified by ethnoracial group, then further effect estimates 
comparing the groups with white women as the referent group. Finally, a sensitivity 
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analysis is undertaken by repeating steps taken in Objectives 1 and 2 with different 
exposure variables: CPA and CSA.  
Physical abuse in adulthood 
For the total sample as per Objective 1, CPSA had a positive effect on physical abuse in 
adulthood, with women who experienced CPSA having 1.97 (95% CI 1.72, 2.25) times 
greater risk of physical abuse attributable to their CPSA history after weighting for 
measured confounders. Per Objective 2, the effect of CPSA on physical abuse persisted 
within each ethnoracial group, both before and after weighting (Table 13). As reflected in 
Figure 4 (a), the robust 95% confidence intervals for Black Caribbean women, as well as 
for “other” women were relatively imprecise compared to other groups. Black Caribbean 
women made up the smallest ethnoracial group under consideration (n=64), and thus 
estimates for this group were relatively imprecise for all outcomes. Similarly, the mixed 
ethnoracial group was the second smallest group under consideration (n=104) and thus 
some imprecision was expected, however, the wide confidence intervals for this group 
were likely also impacted by within-group ethnoracial heterogeneity. Interestingly, 
despite the relative imprecision for the effect of CPSA on physical abuse among Black 
Caribbean women, comparisons of prevalence ratios across ethnoracial groups revealed 
that the effect was stronger among Black Caribbean women as compared to white women 
(PR=1.12 95% CI 1.12, 4.60).  
The sensitivity analyses for this outcome revealed some heterogeneity of effect; it 
appeared that the effects of CPSA on physical abuse were more broadly attributable to 
CPA than CSA in the weighted analysis. Both CPA and CSA had overall and stratum-
specific effects on adult physical abuse in the unweighted sample, however, after 
weighting, the effect of CSA on physical abuse was restricted to white women (Appendix 
7). Conversely, the weighted effect of CPA on physical abuse persisted within each 
ethnoracial group, and even appeared to differ significantly across ethnoracial groups. As 
for CPSA, the effect of CPA on physical abuse was considerably stronger for Black 
Caribbean women when compared to white women (PR=3.61 95% CI 1.58, 8.24). 
However, in this case, the same was true for Black African women (PR=1.65 95% CI 
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1.11, 2.46). Thus, for physical abuse in adulthood, CPA appeared to drive the observed 
effect of CPSA, and when examined independently the CPA analysis revealed additional 
nuance across ethnoracial groups.  
Sexual abuse in adulthood 
Similar to physical abuse in adulthood, CPSA increased risk for sexual abuse in 
adulthood among CPSA+ women (weighted PR=1.80 95% CI 1.51, 2.13). Furthermore, 
CPSA was found to increase risk of sexual abuse among all CPSA+ women outside of 
Black Caribbean women (Table 13). Tests for effect modification across ethnoracial 
groups did not find differences in the effect of CPSA on sexual abuse for any group when 
compared to white women. It is possible that no effect was detected among Black 
Caribbean women based on the small sample size for this group, allowing less power to 
detect an effect if one was truly present. As expected, the confidence interval for this 
estimate was wider relative to other ethnoracial groups (Figure 4 b).  
As with the sensitivity analyses for adult physical abuse, it was found that the effect of 
CPSA on adult sexual abuse may have been driven more by CSA than CPA. Both CSA 
and CPA had an effect on adult sexual abuse prior to weighting, however, after 
weighting, the effect of CPA on adult physical abuse was much lower in magnitude than 
the weighted CPSA effect. The CPA confidence interval, while small, approached the 
null (PR=1.20, 95% CI 1.02, 1.43). Conversely, the effect of CSA on adult sexual abuse 
was more similar to the CPSA effect both overall (CSA PR=1.63, 95% CI 1.38, 1.93) and 
within ethnoracial groups (Appendix 7). Furthermore, like CPSA, neither CPA or CSA 
analyses revealed any effect modification across ethnoracial groups for adult sexual 
abuse.   
Sexual inactivity and sexual relationship power 
In order to understand the effect of CPSA on sexual relationship power (SRP), it was first 
necessary to examine its effect on sexual inactivity given that SRP was only asked of 
sexually active women. CPSA did not appear to have an effect on sexual inactivity for the 
overall sample (PR=1.02, 95% CI 0.90, 1.16) or within ethnoracial groups (Table 13). 
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Knowing that the sexually active women who answered the SRP items had comparable 
histories of CPSA to those not asked the SRP items, it was possible to proceed in 
interpreting the effect of CPSA on SRP. Overall, women who experienced CPSA had 
lower scores on the SRP scale than they would have had CPSA never occurred, after 
adjusting for confounding. The estimated difference in scores attributable to CPSA was -
0.13 (95% CI -0.23, -0.02). On the SRP scale, which ranged from 1-4, this meant that 
women who experienced CPSA had an estimated score of 3.25 (95% CI 3.19, 3.31); 
according to the scale’s original unvalidated cut-points, this would still be considered as 
having high sexual relationship power. It is important to note that, because of the survey 
design which restricted the SRPS to sexually active women, sample sizes for this 
outcome were reduced overall, but especially within ethnoracial groups. When 
differences in SRPS scores attributable to CPSA were estimated within ethnoracial 
groups, confidence intervals were fairly wide and only indicated a significant CPSA 
effect among white women (Figure 5, Table 13). However, when compared to other 
ethnoracial groups no differences were observed.  
The sensitivity analyses for this outcome revealed some further nuance, particularly with 
respect to the effect of CSA on SRP among white women. Neither CPA nor CSA had an 
overall effect on SRP after weighting (CPA β=-0.03 95% CI -0.14, 0.09; CSA β =-0.07 
95% CI -0.26, 0.11). However, the weighted effect of CSA among CSA+ white women 
was relatively large (β=-0.41 95% CI -0.57, -0.24), such that white women who 
experienced CSA had lower SRP, attributable to CSA. Furthermore, the magnitude of 
effect was greater among white women compared to both Indigenous and Black African 
women (Appendix 7). Thus, the effect of CPSA on SRP was more broadly similar to the 
effect of CSA, and the CSA analysis revealed some further variability across ethnoracial 
groups. 
HIV stigma 
For the total sample, women who experienced CPSA had HIV stigma scores 1.37 (95% 
CI 0.35, 2.40) points higher than they would have had, had CPSA not occurred. On the 
HIV stigma scale, which ranged from 0-40, this meant that CPSA+ women had an 
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estimated score of 23.5 (95% CI 23.0, 24.1). While no reference scores for this scale were 
identified, this appears to indicate mid-range HIV stigma. Interestingly, among Black 
African women CPSA had a substantial effect on HIV stigma; Black African women who 
experienced CPSA had HIV stigma scores 3.93 (95% CI 2.16, 5.70) points higher than 
would be expected had CPSA not occurred (Table 13, Figure 6). This effect was 2.52 
(95% CI 0.19, 4.86) points greater than that observed among white women.  
Both CPA and CSA independently had overall effects on HIV stigma in the weighted 
sample (CPA β=1.83 95% CI 0.58, 3.08; CSA β=1.33 95% CI 0.19, 2.48). These 
estimated differences were broadly consistent with the result for CPSA which indicated 
that CPSA+ women experienced slightly elevated HIV stigma because of their CPSA 
experiences. However, in the CPA analysis, the effect among Black African women 
which was observed for CPSA appeared to be attenuated; HIV stigma was only 1.40 
(95% CI 0.44, 5.92) points greater because of CPA (Appendix 7). Furthermore, while 
CSA had an effect among Black African women prior to weighting (β=2.83 95% CI 0.56, 
5.09), the effect could not be attributed to CSA after weighting (β=2.34 95% CI -0.21, 
4.90). It is possible that the construct driving the relationship between CPSA and HIV 
stigma was not the presence of either CPA or CSA alone, but their co-occurrence, which 
would be controlled for in the sensitivity analyses but not in the overall analysis where 
the exposure was child physical or sexual abuse. It is also possible that because CPA and 
CSA independently elevated HIV stigma among white women (CPA β=2.09 95% CI 
0.24, 3.94; CSA β=1.75 95% CI 0.08, 3.41), their effects among Black African women 
were more comparable.   
Social support 
CPSA had no overall effect on perceived social support among women who experienced 
CPSA. In particular, a difference of -0.33 (95% CI -0.92, 0.24) points on the MOS-SSS 
scale was attributed to CPSA, though the confidence interval crossed the null value of 1. 
In the overall sample the estimated mean level of social support for women who 
experienced CPSA+ was 14.0 (95% CI 13.7, 14.4) on a scale from 4-20, a value not 
substantially different from mean level observed in the original 4-item MOS-SSS 
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validation study (x̅ =14.88, standard deviation=3.97). The mean observed from the 
validation study came from a sample of 330 low-income American mothers receiving 
services for children with emotional or behavioural problems.230 When considering 
stratum-specific estimates, among white women only a difference of -1.04 (95% CI -2.06, 
-0.02) points was attributable to CPSA (Table 13, Figure 7). This effect was not 
significantly different when compared to the effects among other ethnoracial groups.  
The results of both sensitivity analyses were broadly similar to those from the main 
analysis. Neither CPA nor CSA had an independent effect on perceived social support 
among their exposed populations (CPA β=-0.43 95% CI -1.09, 0.21; CSA β=-0.31 95% 
CI -1.01, 0.40). Within ethnoracial strata, CSA had no effect on perceived social support, 
while CPA was linked to reduced social support among Black African women (β=-1.35 
95% CI -2.58, -0.11) and women from the other ethnoracial group (β=-2.72 95% CI -
4.88, -0.56) (Appendix 7). When the CPA effects were compared across strata, “other” 
women experienced -2.81 (95% CI -5.18, -0.44) fewer points attributable to CPA relative 
to white women. However, given the within-group heterogeneity of this stratum, the 
interpretability of this potential difference was compromised. Thus, overall the observed 
CPA and CSA effects did not diverge excessively from those observed in the main 
analysis.  
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Table 13: Effect of CPSA on barriers to HIV disclosure among women who experienced 
CPSA 
  Stratum-specific estimates  
Outcome Ethnoracial group Unweighted Weighted Effect modification 
A
d
u
lt
 
p
h
y
si
ca
l 
a
b
u
se
 ¶
 
White 1.72 (1.47, 2.03) 1.56 (1.31, 1.85) REF 
Indigenous 2.34 (1.73, 3.18) 2.18 (1.56, 3.05) 1.40 (0.96, 2.04) 
Black African 2.10 (1.62, 3.18) 2.11 (1.62, 2.74) 1.35 (0.99, 1.85) 
Black Caribbean 3.12 (1.64, 5.93) 3.53 (1.78, 7.01) 2.27 (1.12, 4.60) 
Other 2.69 (1.47, 4.93) 2.49 (1.27, 4.89) 1.60 (0.80, 3.21) 
A
d
u
lt
  
se
x
u
a
l 
 
a
b
u
se
 ¶
 
White 1.83 (1.46, 2.28) 1.56 (1.23, 1.99) REF 
Indigenous 2.52 (1.62, 3.91) 2.02 (1.27, 3.20) 1.29 (0.77, 2.18) 
Black African 1.77 (1.32, 2.37) 1.75 (1.30, 2.36) 1.12 (0.76, 1.65) 
Black Caribbean 1.98 (0.97, 4.06) 1.69 (0.79, 3.61) 1.08 (0.49, 2.40) 
Other 2.74 (1.31, 5.75) 2.90 (1.32, 6.38) 1.86 (0.81, 4.23) 
S
ex
u
a
l 
in
a
ct
iv
it
y
 ¶
 White 1.00 (0.85, 1.19) 1.05 (0.87, 1.28) REF 
Indigenous 0.99 (0.75, 1.30) 1.05 (0.76, 1.46) 1.00 (0.68, 1.46) 
Black African 1.10 (0.86, 1.41) 1.10 (0.86, 1.42) 1.05 (0.76, 1.44) 
Black Caribbean 0.93 (0.61, 1.44) 0.91 (0.59, 1.40) 0.86 (0.54, 1.38) 
Other 0.68 (0.48, 0.95) 0.69 (0.47, 1.02) 0.66 (0.43, 1.02) 
S
ex
u
a
l 
re
la
ti
o
n
sh
ip
 
p
o
w
er
 ±
 
White -0.19 (-0.35, -0.04) -0.17 (-0.33, -0.01) REF 
Indigenous -0.13 (-0.39, 0.13) -0.06 (-0.32, 0.21) 0.12 (-0.19, 0.42) 
Black African -0.12 (-0.30, 0.06) -0.15 (-0.33, 0.04) 0.02 (-0.22, 0.27) 
Black Caribbean 0.04 (-0.34, 0.42) -0.02 (-0.41, 0.36) 0.15 (-0.27, 0.56) 
Other -0.33 (-0.70, 0.05) -0.32 (-0.66, 0.02) -0.15 (-0.53, 0.23) 
H
IV
  
S
ti
g
m
a
 ±
 
White 1.90 (0.50, 3.30) 1.41 (-0.12, 2.93) REF 
Indigenous 0.07 (-2.25, 2.39) -0.80 (-3.39, 1.78) -2.21 (-5.21, 0.79) 
Black African 3.76 (2.05, 5.48) 3.93 (2.16, 5.70) 2.52 (0.19, 4.86) 
Black Caribbean -0.54 (-3.93, 2.86) -0.27 (-3.56, 3.02) -1.68 (-5.31, 1.95) 
Other -0.25 (-3.31, 2.81) 0.53 (-2.39, 3.45) -0.88 (-4.17, 2.42) 
S
o
ci
a
l 
su
p
p
o
rt
 ±
 White -1.36 (-2.11, -0.61) -1.04 (-2.06, -0.02) REF 
Indigenous -0.36 (-1.43, 0.70) 0.39 (-0.91, 1.69) 1.43 (-0.22, 3.08) 
Black African -0.36 (-1.35, 0.62) -0.31 (-1.32, 0.70) 0.72 (-0.71, 2.16) 
Black Caribbean 0.90 (-1.21, 3.01) 0.82 (-1.19, 2.83) 1.86 (-0.39, 4.11) 
Other -2.33 (-4.32, -0.35) -2.83 (-4.70, -0.96) -1.79 (-3.92, 0.34) 
 
¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95% 
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null 
value of 1. 
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e. 
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals. 
Shaded cells represent those where the confidence interval does not cross the null value of 0.  
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Points represent estimated prevalence ratios for the effect of CPSA, the vertical axis at x=1 represents the 
null value, and stems represent robust 95% confidence intervals. 
 
 
Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems 
represent robust 95% confidence intervals.  
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Figure 5: Effect of CPSA on sexual relationship power by ethnoracial group 
 
Figure 4: (a) Effect of CPSA on physical abuse and (b) sexual abuse by 
ethnoracial group 
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Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems 
represent robust 95% confidence intervals.  
 
Figure 7: Effect of CPSA on social support by ethnoracial group 
Bars represent estimated mean outcome level by exposure status for the AEE weighted sample, while stems 
represent robust 95% confidence intervals.  
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Figure 6: Effect of CPSA on HIV stigma by ethnoracial group 
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Chapter 5  
5 Discussion and Implications 
This chapter will reiterate the main descriptive and analytic findings, discussing them in 
the context of the literature and evaluating them in light of the study’s strengths and 
limitations. Extensions for future research will be identified, and implications for policy 
and practice will be described.  
5.1 Main Findings 
5.1.1 Summary 
This thesis adapted a novel theoretical model based on eco-social theory and 
intersectionality which contextualizes the causes and consequences of CPSA among 
women with HIV in Canada. The framework relayed the importance of unpacking culture 
as related to child abuse, described how intersecting systems of oppression operate at the 
four eco-social levels to produce societies, communities, families, and individuals 
vulnerable to child abuse, and introduced colonialism as an axis of oppression affecting 
Indigenous women with HIV in Canada. In accordance with this model, it was of interest 
to determine whether child maltreatment affected barriers to HIV status disclosure among 
women with HIV after controlling for eco-social risk, and to determine whether these 
relationships differed across intersectional ethnoracial groups. Results showed that CPSA 
appeared to generate barriers to HIV disclosure, specifically increasing prevalence of 
both physical and sexual abuse, and increasing levels of HIV stigma. Furthermore, 
subgroup analysis showed that the effect of CPSA on some outcomes did vary across the 
intersectional ethnoracial groups; CPSA significantly decreased sexual relationship 
power among white women only, while increasing HIV stigma among only Black 
African women. A sensitivity analysis found that CPA may account for effects of CPSA 
on physical abuse in adulthood, while CSA may account for effects on sexual abuse in 
adulthood, and sexual relationship power. In summary, women with HIV who 
experienced CPSA did appear to face greater barriers to partner disclosure than those 
without such experiences, and this relationship may be of a causal nature. The 
relationship between CPSA and some barriers may not be homogeneous across 
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ethnoracial groups, and thus intersectional perspectives should be of great importance for 
research, intervention planning, and policy making in the future.  
5.1.2 Descriptive Findings 
Burden of Risk for CPSA 
CPSA has been theorized to have causes at the level of the individual child, their family, 
their community, and their society. As research has further disentangled the causes of 
CPSA, Belsky’s original eco-social model has been adapted and refined, resulting in 
several theoretical principles and broad risk factors for CPSA at each level.136,142 These 
principles were applied in the current analysis when selecting propensity score covariates. 
As expected, the prevalence of all CPSA risk factors was elevated among those who 
reported experiencing CPSA, though not all differences reached statistical significance. 
For example, the prevalence of sexual minority and gender minority women among those 
who experienced CPSA was significantly greater than that among women who did not 
experience CPSA (16.8% vs. 6.78% sexual minorities, 5.62% vs. 2.46% gender 
minorities). These, and other observed disparities across exposure groups (e.g. with 
respect to stress-related immigration in childhood and family residential school 
attendance) illustrate the life circumstances of these women that may have preceded both 
child maltreatment and HIV diagnosis. While the CHIWOS sample is not population-
based and exposure-stratified prevalence estimates for CPSA risk factors cannot be 
interpreted as causal, the fact that the retrospective burden of risk for CPSA was 
consistently greater among women who experienced CPSA lends support to the proposed 
theoretical model and to the analysis as a whole.  
5.1.3 Analytic Findings 
Revictimization  
Arguably the most important finding from this analysis was the rate of revictimization 
from childhood to adulthood, in terms of both adult physical abuse and sexual abuse. 
Women who experienced CPSA were consistently at higher risk for experiencing further 
violence in adulthood. This relationship was expected, and contributes to the body of 
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evidence reporting not only the descriptive rate of revictimization, but controlled risk 
estimates. The relationship between CPSA (and CPA/CSA independently) and further 
abuse in adulthood among the general population has been documented extensively in 
longitudinal6,231 and meta-analytic studies.7 However, revictimization has more 
frequently been studied as a risk factor for HIV (eg. 232,233) than a construct generating 
further risk among people with HIV. Thus, the present study contributes new evidence 
suggesting that the relationship between CPSA and violence in adulthood persists among 
women with HIV in ways that may further complicate their lives and health.  
Comparing the magnitude of the relationship between childhood violence and later 
revictimization for women with HIV and the general population presents methodological 
difficulties. Population-based studies of women with HIV are scant and likely under-
represent marginalized women, and thus convenience and quota samples become the 
most optimal method for studying risk within the population of women with HIV. 
However, the lack of a population-based sampling frame complicates comparisons to the 
larger population of women in Canada. On the basis of measurement and study design 
(though not geography or ethnoracial composition), the sample most comparable to 
CHIWOS may be that of Simoni and Ng who produced descriptive estimates of 
revictimization among a community-recruited sample of 230 women with HIV in New 
York City.128 As with CHIWOS, prevalence estimates for CPSA (50%), adult physical 
abuse (63%), and adult sexual abuse (46%) were alarmingly high. Furthermore, the study 
found a zero-order correlation of 0.50 (p<0.01) between CPSA and physical or sexual 
abuse in adulthood, demonstrating a substantial amount of recurring abuse. Community 
samples like CHIWOS and Simoni and Ng demonstrate the high burden of abuse and 
revictimization among women with HIV. When considered alongside studies implicating 
revictimization as a risk factor for HIV in the first place,232,233 one can conclude that 
revictimization, regardless of the magnitude of risk compared to the general population, 
is an issue among women with HIV. While risk comparisons to the general population or 
men with HIV may be interesting, they are not necessary in order to justify interventions 
to reduce risk for violence against women with HIV, based on the high levels of violence 
alone and the unique socio-legal implications that violence generates for this population.  
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The present analysis also demonstrated the effect of CPSA on adult physical and sexual 
abuse largely persisting within each ethnoracial group. The single exception to this 
statement was the effect of CPSA on adult sexual abuse among Black Caribbean women, 
where the effect was in the positive direction but the robust 95% confidence interval 
crossed 1. Black Caribbean women constituted the smallest ethnoracial group under 
consideration (n=64), and consequently estimates for this group were relatively imprecise 
across all outcomes. The lack of observed relationship between CPSA and adult sexual 
abuse for this group should not be interpreted as a lack of grounds for intervention among 
this group, but rather as a potential type II error which warrants further investigation. 
This point is bolstered by the observed relationships between CPSA and abuse in 
adulthood across all other ethnoracial groups.  
Another important result reflected in the main CPSA analysis as well as the CPA 
sensitivity analysis was that the magnitude of effect for childhood maltreatment on adult 
physical abuse was greater for Black women when compared to white women. This 
phenomenon was especially prominent among Black Caribbean women who experienced 
CPA; for this group, CPA multiplied risk of adult physical abuse by 3.61 (95% CI 1.58, 
8.24) relative to white women. Published rates of physical and/or sexual revictimization 
disaggregated by ethnoracial groups for comparison were difficult to locate. Two recent 
studies have found that children and adolescents who identified as members of 
ethnoracial minority groups were more likely to report sexual revictimization than their 
white peers,234,235 however, further research is needed to examine revictimization at the 
intersection of race, gender, and class. There is some evidence to suggest that that women 
of colour are disproportionately affected by violence.236 However, when interpreting 
ethnoracial inequities and especially when planning interventions, it is important to be 
cognisant of the social and structural factors that may impact vulnerability to and 
reporting of violence against women of colour. The results of the present study provide 
further justification for developing anti-violence interventions that are appropriate and 
accessible for women of colour with HIV.  
Sexual Relationship Power and Sexual Inactivity 
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This analysis found that, overall, women who experienced CPSA had lower sexual 
relationship power than they would have had CPSA not occurred. When broken down by 
ethnoracial group, it was revealed that this overall effect was primarily attributable to the 
strong effect among white women. Furthermore, the adjusted mean level of sexual 
relationship power possessed by women who experienced CPSA was still within the 
range of high sexual relationship power, as dictated by the scale’s unvalidated tertile cut-
points. It was expected that this effect would be larger in magnitude and would persist 
across ethnoracial groups, however, given the inherent limitations due to survey design 
and measurement, this result was not entirely surprising. Sample sizes for the SRPS items 
within ethnoracial groups were reduced compared those of other outcomes, lowering the 
probability of observing the effect of CPSA if it was truly present.  
During Wave 2 of the survey, the SRPS was only asked of women who reported 
engaging in consensual sexual activity within the past 6 months. While the scale was 
developed and validated among women with male sexual partners, it is possible that 
sexual relationship power as a construct (or a related construct) may exist outside the 
confines of a recent sexual encounter. For instance, the knowledge that one has the 
tendency to become involved in controlling relationships, sexual or otherwise, may 
prompt the conscious decision to avoid sexual relationships. This may be especially true 
for women with HIV; a manipulative sexual partner can use one’s HIV status as a point 
of power. Furthermore, CPSA may affect this potential sexual relationship power and 
decision making just as it may affect enacted sexual relationship power. However, 
because it is unknown whether the SRPS could measure potential sexual relationship 
power, and thus sexual relationship power was only measured among sexually active 
women, the relationship between CPSA and sexual agency cannot fully be described in 
the present analysis. 
In an effort to rule out or rule in the posited relationship between CPSA and consensual 
sex, we measured the effect of CPSA on sexual inactivity over the past 6 months, and 
found no statistically significant effects. This provided some indication that CPSA may 
affect women who are sexually inactive in the same way as it does women who are 
sexually active, though we cannot know this for sure. Furthermore, because the sub-
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sample who were sexually active and completed the SRPS consisted of only 486 of 
n=1307 women, effect estimates for the SRPS (especially within under-represented 
ethnoracial groups) were relatively imprecise. The fact that the only confidence interval 
that does not cross zero was among white women, the largest ethnoracial group in the 
sample, lends further support to the theory that CPSA driven differences in SRP (or lack 
thereof) could be attributable to a lack of precision. Some imprecision relative to other 
outcomes was expected, however, the SRPS outcome remained a part of the analysis plan 
on the basis of its importance as a risk factor for HIV non-disclosure and as an effort to 
encourage other researchers to incorporate SRP as not just a risk factor for HIV, but as a 
potential cause of further vulnerability among people with HIV. To our knowledge, no 
other studies have used specific measures of sexual agency or sexual relationship power 
in relation to CPSA or HIV disclosure, rather opting to measure characteristics of 
relationships with power imbalances. Because sexual relationship power is a construct 
that aggregates across multiple controlling characteristics and is already in use within the 
HIV literature, it is our hope that this concept can be further refined and applied more 
widely in the future.  
HIV Stigma 
An unexpected finding from this analysis was the effect of CPSA on HIV stigma being 
limited to Black African women. The relationship between CPSA and HIV stigma was 
examined on the basis of HIV stigma’s ability to impact HIV disclosure, and the ability 
of CPSA to engender perceived and internalized stigma related to the abuse. Furthermore, 
in the context of HIV, stigmas are often co-occurring and not necessarily independent 
(for example, stigmatizing attitudes about AIDS and people who inject drugs tend to co-
occur,237 and internalized HIV stigma can be related to internalized blame about 
experiencing abuse).238 Furthermore, dimensions of multiple stigmas can vary across 
ethnoracial groups, for example, in one study negative attitudes towards people who 
inject drugs predicted AIDS stigma among Black participants while negative attitudes 
towards gay people predicted AIDS stigma among white participants.237 On the basis of 
the present analysis, future research should explore what drives the relationship between 
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CPSA and HIV stigma, whether it be cultural differences in measurement, attitudes, or 
unmeasured confounders.  
Wright’s abbreviated HIV stigma scale measured stigma across four dimensions: 
personalized stigma, disclosure, negative self-image, and public attitudes – all of which 
have been associated with HIV disclosure in previous research using various measures. In 
investigating the unique relationship between CPSA and HIV stigma among Black 
African women, we should consider whether the effect is driven by HIV stigma in the 
broadest sense as captured in the given measure, or by certain dimensions within the 
given measure. The full HIV stigma scale was chosen based on existing evidence linking 
multiple dimensions of HIV stigma to partner disclosure, and the desire to examine 
multiple barriers to disclosure rather than the dimensionality of a single barrier. The latter 
option would have necessitated three additional study outcomes, which could potentially 
overwhelm results pertinent to other important barriers to HIV disclosure. However, in 
validation studies, both the full and abbreviated HIV stigma scales have demonstrated 
differential relationships between the subscales and construct validity outcomes such as 
perceived social support.113,229 Because HIV stigma as measured is truly a 
multidimensional construct, further research should explore the relationship between 
CPSA and multidimensional HIV stigma across ethnoracial groups.  
Intersectionality theory helps us to understand that interlocking matrices of domination 
affect the experiences of people as they sit at the intersections of multiple social 
positions. A qualitative study of women with HIV in Ontario has explored the unique 
experiences of Black women with HIV produced by the intersection of sexism, racism, 
and HIV stigma.238 One Black African woman highlighted the enacted stigma she had 
experienced while receiving HIV services, stating “I need you to listen me and to help 
me. But you’re thinking ‘you come from Africa you don’t understand’”. This intersection 
of HIV stigma, sexism, and racial discrimination against Black African (and Caribbean) 
women and its effect on lived experiences has been explored in qualitative and 
quantitative research in North America.238–241 However, it is less clear how experiences 
of CPSA may fit into this picture.  
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While no studies specific to experiences of CPSA and HIV stigma among Black African 
women in North America were identified, the narratives of Black African women who 
experienced CPSA may provide a starting point for further inquiry among women with 
HIV. One qualitative study of African American women who were survivors of CSA 
highlighted how children often blame themselves for their own abuse.242 Through “truth-
telling”, or reaching out to others who believed and validated their experiences, some 
women were able to find greater self-acceptance. This pattern is common among 
survivors of child abuse more generally.243 Among women with HIV, it is possible that 
internalized blame about CPSA could be a component of internalized HIV stigma, 
especially if the women perceive the two to be related. An aspect of this cycle of 
internalization and truth-telling that may be unique to the intersection of anti-Black 
racism and sexism is the pressure on Black CSA survivors to avoid disclosing their 
abuse. In the same qualitative CSA study, one participant described hearing other women 
express the idea that Black women who experienced abuse at the hands of Black men 
should remain silent so as not to contribute to a legal system which is already pitted 
against Black men.242 In addition to suppressing CSA disclosure, this pressure may close 
women off from community support and self-acceptance. Thus, it is possible that barriers 
to CPSA disclosure may mediate the relationship between CPSA and internalized stigma 
related to abuse and HIV. However, this hypothesis results from piecing together CPSA 
research on the intersections of gender and ethnoracial group with HIV research that is 
not specific to CPSA. Further research should explore lived experiences at this particular 
intersection. 
Social Support 
The effect of CPSA on perceived social support appeared to be negligible in the present 
study. The weighted mean level of social support reported by women who experienced 
CPSA was comparable to both the estimated mean level had those same women not 
experienced CPSA, as well as to the average social support observed in the abbreviated 
MOS-SSS validation study.230 Similar to the measure of HIV stigma, the abbreviated 
MOS-SSS captures four dimensions of perceived social support: emotional-informational 
support, tangible support, affectionate support, and positive social interaction.119,230 The 
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literature review provided some indication that perceived or anticipated social support 
was most salient to partner disclosure, such that women who felt that their partners would 
support them regardless of their HIV status were empowered to disclose, while women 
who were doubtful or unsure of how their partner would react were less likely to disclose. 
While this was not the exact construct measured by the MOS-SSS, the two share some 
overlapping dimensions such as love and acceptance. The most significant difference 
between the two was that social support from sexual partners was most relevant to partner 
disclosure, while the MOS-SSS measured global social support from no target in 
particular. This limitation should be noted when considering the implications of these 
results.  
The lack of observed relationship between CPSA and perceived social support may have 
been attributable to construct multidimensionality, or the two may simply not be related. 
While the link between anticipated social support and HIV non-disclosure has been well 
developed in the literature, that between CPSA and later perceived social support has 
been under-researched among the general population and, to our knowledge, not 
explicitly studied among people with HIV. The outcome was included based on its 
relationship with HIV non-disclosure along with the rationalization that reduced social 
support may be one of the many downstream consequences of CPSA. Additional 
qualitative research should investigate whether and how CPSA may play into anticipated 
social support just as such research has shed light on the relationship between social 
support and disclosure. Furthermore, as qualitative research has identified anticipated 
HIV-related social support as a construct of interest in the study of HIV disclosure, a 
corresponding quantitative measure of the construct should be developed in order to 
further investigate its relationships with both CPSA and partner disclosure.   
5.1.4 Sensitivity Analysis 
The planned sensitivity analyses revealed some heterogeneity in the observed effects of 
CPA as compared to CSA. In particular, the relationships between CPSA and adult 
physical abuse bore more similarity to the effects of CPA than CSA, while those between 
CPSA and adult sexual abuse, as well as sexual relationship power appeared to be driven 
by CSA. Furthermore, comparing the main analysis to the sensitivity analyses for the 
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HIV stigma outcome raised the question of whether the co-occurrence of CPA and CSA 
may have driven the observed effects. The observed heterogeneity according to the type 
of abuse suggested that the sensitivity analyses were valuable additions to the study, and 
that they may offer direction for future research. The segregation of effect such that 
physical abuse more consistently predicted physical revictimization and sexual abuse 
more consistently predicted adverse sexual experiences in adulthood was unexpected, but 
not unreasonable. Furthermore, the propensity score model which allowed for the 
collapsing of multiple confounders may have been an optimal way to control for the 
effect of a covariate that is highly collinear to the exposure (i.e. controlling CSA when 
studying CPA). However, it is acknowledged that the outcome analysis was unable to 
definitively account for variability in the original propensity score model, and thus the 
potential for misestimation exists as with traditional regression models. Future studies 
should further explore the ability of propensity score models to collapse multiple 
covariates in order to avoid multicollinearity issues; given the high frequency of co-
occurring abuse, accurately estimated propensity score models may be ideally suited to 
this problem.  
Also related to abuse co-occurrence, the findings related to HIV stigma and the potential 
interactivity of multiple types of abuse presented thought provoking ideas novel to the 
current study. A growing body of literature has addressed the consequences of co-
occurring types of abuse, termed “poly-victimization”.244 When studied as an antecedent 
to mental health conditions and trauma symptomology in childhood, poly-victimization 
has been found to almost completely eclipse single-type victimizations as a 
predictor.245,246 Recent findings from poly-victimization research along with the results of 
the sensitivity analyses suggest that future research should pay attention to the potential 
for divergent effects by type of child abuse, as well as the potential synergistic effects of 
multiple types of adverse childhood experiences. 
5.1.5 Eco-Social Intersectionality 
In fulfillment of Objective 1, this thesis produced a novel theoretical model to 
contextualize the relationship between CPSA and HIV disclosure among women with 
HIV in Canada. This model paired intersectionality with eco-social theory to understand 
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vulnerability to CPSA at multiple levels, and at the intersection of gender, HIV status, 
and ethnoracial group. The model illustrated how systemic oppression drives inequalities, 
acknowledged culture as context rather than a cause of CPSA, described the effects of 
colonialism and intergenerational trauma on Indigenous women, and integrated all of 
these factors in the design of a quantitative analysis. While eco-social theory and 
intersectionality have been considered jointly in the past,168 this model extended the 
theories to incorporate novel concepts vital to the population at hand. Specifically, the 
determinants of CPSA for Indigenous women are known to be qualitatively different 
from populations that have not experienced colonial disruption of culture and family. For 
this reason, it was important to not only be conscious of potential effect modification 
across ethnoracial groups, but to include culturally specific determinants of CPSA in the 
causal model. Unfortunately, this practice is less common in the wider literature, with 
some publications reporting Indigenous data without giving consideration to Indigenous 
determinants of health and wellbeing. Notably, in the present analysis, when survival and 
family attendance at residential school were controlled for, there was no significant 
difference in the effect of CPSA on disclosure barriers among Indigenous women 
compared to white women. The value of approaches which model or control for the 
effects of inequitable processes such as residential school attendance is their ability to 
demonstrate that population inequities do not represent intractable differences. 
Furthermore, some inequitable processes are amenable to intervention and thus reduction 
of population inequities. Future research should take this eco-social and intersectional 
approach into consideration, adapting the relevant determinants and axes of oppression to 
the context at hand.  
In addition to marking novel theoretical territory, this model appeared to demonstrate 
some empirical validity in its use of eco-social risk factors for CPSA. Of the risk factors 
considered, all those which different significantly across the CPSA+ and CPSA- 
exposure groups did so in the expected direction. Specifically, the CPSA+ group was 
composed of significantly more sexual minority women, trans or intersex women, women 
with a family member who attended residential school, women and who declined to 
answer items on self-attendance and family attendance at residential school. One area 
where the theoretical underpinnings of this model could have been better incorporated 
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into analysis is the inclusion of protective factors for CPSA, as well as additional higher-
level factors such as quality of the child protection system and societal attitudes towards 
corporal punishment. However, these represented limitations to the data rather than the 
theoretical model itself. 
5.2 Limitations 
Quota sampling 
The use of quota sampling as opposed to population based sampling in CHIWOS 
presented both a limitation and an advantage. Prevalence estimates reported in the 
descriptive statistics section of this analysis are not necessarily generalizable to the larger 
population of women with HIV in Canada. However, it is arguable that a population 
based study of women with HIV (i.e. using household or clinical sampling frames) would 
be inefficient and/or only representative of women with HIV accessing clinical care.247 It 
is unlikely that a clinical sample would represent marginalized women with HIV, making 
this strategy incongruent with the CHIWOS objective to apply an intersectional approach 
in understanding the positionality and determinants of health for women with HIV. Thus, 
the quota sampling method which allowed for relatively precise effect estimates within 
key populations of women with HIV was likely an optimal approach. Furthermore, 
CHIWOS coverage of the base population is numerically strong; the study is estimated to 
capture 10% of women with HIV in Canada.14 Sociodemographic coverage of CHIWOS 
is more difficult to evaluate, given the known under-coverage of women with HIV in 
both surveillance and clinical data. Manipulation of the data to represent either of these 
populations would therefore be inappropriate, as it would not meet the study objectives or 
justifiably improve representativeness. Thus, the ability to draw causal inference from the 
CHIWOS dataset fell on the assumption that exposure groups were comparable with 
respect to potential confounders; the accuracy of this assumption is evaluated below. 
Limited capability for adjustment 
One potential limitation of the given study was the small effect size for propensity score 
covariates on the exposure variable, leading to fewer than expected observable 
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differences between the weighted and unweighted results. While all propensity score 
covariates were selected in an a priori protocol developed using epidemiological theory 
and were within the confines of an established theoretical model, the data presented 
limitations that could not have been foreseen. The small covariate effect sizes and limited 
effect of weighting may be indicative of issues with covariate selection, measurement, 
temporality, or unmeasured confounding, as discussed below. However, given that CPSA 
is an unfortunately common experience characterized more so by a network of risk 
factors than strong causal factors, it is possible that the effect sizes for predictors on 
CPSA are truly as small as estimated here. The consequence of these secondary data 
limitations was that AEE estimates, which were intended to be causal, should be 
interpreted with caution. As the first known study to suggest a link between CPSA and 
barriers to HIV disclosure to sexual partners among women, the resulting exploratory 
effect estimates are still valuable. Furthermore, where significant effects were observed 
they were consistently in the hypothesized direction, providing support for the underlying 
theory, and justification for further inquiry into the magnitude of any potentially causal 
effects.  
Temporality 
The inability to definitively establish temporality presents an issue with most cross-
sectional research, including the present study. This issue is particularly common in child 
maltreatment research, where most measures of CPSA are retrospective regardless of 
study design. The cut-off age (<16) for the exposure variable in conjunction with the 
CHIWOS inclusion criteria (age ≥16) allowed us to establish a temporal sequence such 
that CPSA and propensity score covariates preceded measurement of outcomes. 
Unfortunately, it was not possible to establish whether propensity score covariates 
preceded the exposure. In an effort to mitigate this, propensity score covariates where 
chosen from a pool of variables which were identifiable as having the potential to take 
effect prior to age 16. Within this pool of variables, those which theoretically were more 
likely to mediate relationships between CPSA and outcomes (i.e. experience with foster 
care or adoption) than to cause CPSA were eliminated. However, it is possible that some 
time-dependent propensity score covariates occurred after CPSA, meaning that 
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propensity score models may control the effect of mediators along the causal pathway. 
The consequence of this limitation may be that some of the true exposure effect was 
adjusted away.248 However, this limitation was considered to be less significant in light of 
the more considerable limitation presented by the small effect sizes for propensity score 
covariates on CPSA. 
Unmeasured confounders 
Because CHIWOS is a study of adults focusing primarily on variables measured at 
present, the ability to include variables from the eco-social intersectional model of child 
maltreatment was limited. Some notable variables that were unmeasured included: 
childhood health issues, caregiver (un)employment, family socioeconomic status, family 
isolation and household composition, and instability outside of the context of 
immigration. It is expected that the inclusion of a wider range of childhood variables 
would block additional non-causal pathways and result in a more accurately specified 
propensity score model. The implications of being unable to balance a more robust set of 
variables are that the weighting did not render the CPSA+ and CPSA- groups sufficiently 
balanced, and thus that the observed effects may have been attributable to unmeasured 
factors. This possibility was mitigated to the best of our abilities by controlling for factors 
not only identifiable as occurring during childhood (such as immigration prior to age 16), 
but for factors which are measured in adulthood but retrospectively known to affect 
childhood maltreatment (such as sexual and gender minority identities). Some results 
from the present analysis such as the impact of CPSA on further abuse in adulthood have 
been heavily documented in the literature (though not necessarily among women with 
HIV) and thus are not expected to change dramatically (i.e. in significance or direction) 
with additional adjustment. However, other results such as the effect of CPSA on HIV 
stigma represent novel additions to the quantitative literature, and should be both 
interpreted with caution and subjected to further scrutiny. 
Collider-stratification bias 
The CHIWOS sample, like most samples of people with HIV is a “selected population”, 
defined by the condition that every woman in the study has been diagnosed with HIV. 
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From a causal modelling perspective, a selected population may be problematic when the 
exposure of interest (CPSA) precedes the selection/stratification factor (here, HIV) along 
a causal pathway.249 In the present example, CPSA is a known risk factor for HIV, while 
the causal pathway of interest is that between CPSA and barriers to HIV disclosure. The 
issue of collider-stratification bias presents itself here when a common cause exists for 
both HIV and an outcome, making HIV a collider along the causal CPSA to outcome 
pathway. In this situation, effects observed between CPSA and the outcome among the 
selected population would be biased unless the common causes could be controlled. 
However, if no common causes of HIV and an outcome could be identified, then the 
selected population variable would not be a collider, and collider-stratification bias would 
not be an issue. Thus, for the present study, it is important to consider potential common 
causes of HIV and outcomes in order to evaluate the risk and potential consequences of 
collider-stratification bias. Because HIV risk has been studied extensively while some 
outcomes such as sexual relationship power represent emergent concepts, a logical 
strategy is to evaluate whether any of the causes of HIV may also cause the given 
outcomes. A review of broad risk factors for HIV revealed three categories of potential 
confounders as they relate to the present analysis: (1) those that were controlled by 
propensity score weighting, (2) those what were not controlled, and (3) those that 
represent mediators along the CPSA to outcome pathway.  
Within the first category, sexual orientation and gender identity have been associated 
with differential HIV risk profiles, especially among MSM. Risk differences also exist 
among women, though these have been addressed less frequently in the literature. In 
particular, self-identified lesbian and bisexual women may differ from heterosexual 
women in terms of HIV testing250,251 and HIV risk behaviors251,252. While differences 
between sexual minority and heterosexual women were addressed by propensity score 
weighting, differences between lesbian and bisexual women may have been obscured by 
collapsing these groups into a single category. Transgender women also likely differ from 
cisgender women in terms of HIV risk behaviours and testing, though formal 
comparisons between these populations are complicated by the frequent lack of explicit 
inclusion of gender diverse people in population-based health studies. These differences 
were addressed in the current study by propensity score weighting. Thus, it is unlikely 
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that the effects of sexual orientation and gender identity on HIV risk and study outcomes 
contributed to collider-stratification bias. However, knowledge about HIV is one factor 
which affects HIV risk253 as well as HIV stigma,254 and thus may have biased measures 
of effect for this outcome. Thus, it is possible that the observed positive relationship 
between CPSA and HIV stigma may have been partially attributable to HIV related 
knowledge. No explicit evaluation of HIV-related knowledge was available in the 
CHIWOS dataset, but future researchers should be cognizant of this potential bias.  
The third category of confounders which could potentially induce collider-stratification 
bias are those which both affect HIV and outcomes, but may also be mediators along the 
causal pathway from CPSA to outcomes. These include factors influenced by CPSA, 
such as: alcohol use,255 injection drug use,256,257 and sex work.258 The existence of such 
factors introduces a methodological limitation: controlling for these variables would 
block causal pathways between the exposure and the outcome, while failing to control for 
them leaves the analysis vulnerable to collider-stratification bias and spurious 
associations. The consequence of this limitation in the present analysis is that the 
observed effects may have been attributable to the effect of CPSA on stratifier-outcome 
confounders. A review of methods to address such exposure-induced collider-
stratification bias revealed no clear solution to this issue, as well as a lack of attention to 
collider-stratification bias more generally. Given the high prevalence of “selected 
populations” in clinical research, and the threat to validity posed by collider-stratification 
bias, this is an issue that should be addressed with further methodological work.  
Measures 
All measures in CHIWOS were reliant on self-report, which meant that results were 
vulnerable to potential response biases such as social desirability bias and recall bias. 
Given the emotionally burdensome content of the survey, social desirability bias may 
present the largest threat to measurement validity. For many reasons including 
embarrassment or mistrust of researchers, participants may have felt uncomfortable 
disclosing information on items related to experiences of abuse throughout the life 
course, as well as sexual relationship power and residential school experiences. Notably, 
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123 Indigenous women declined to answer the block of questions on residential school; 
given the Canada’s history of exploitative research against Indigenous peoples, this level 
of refusal was not unsurprising.259 While this was the largest identifiable example of item 
non-response in the survey and other item refusals were much smaller in magnitude, there 
was also the possibility for unidentifiable response bias. Most concerning given the 
subject matter was the possibility for under-reporting of adverse experiences such as 
physical or sexual abuse. Self-reporting of abuse is recognized as able to capture more 
cases of violence as compared to abuse reported to police or child protective 
services,260,261 however self-report measures are still vulnerable to response bias as well 
as recall bias. Multiple strategies were used by the CHIWOS team to mitigate such 
response bias, including: having interviews conducted by community-involved women 
with HIV in order to establish rapport, assuring participants of data confidentiality, 
allowing for self-completion of sensitive survey items, and using behavioural rather than 
definitional measures of self-reported violence.262  
No disclosure measure 
Readers may wonder why no effort was made in the present thesis to establish links 
between not only CPSA and barriers to disclosure, but between barriers to disclosure and 
a measure of HIV disclosure to sexual partners. Given that much of the existing research 
on disclosure to sexual partners is qualitative in nature, such an extension would bolster 
the study’s relevance and make a valuable addition to the literature. However, it is worth 
noting that the Canadian legal context which justified the current study on barriers to HIV 
disclosure also made it unethical to measure HIV disclosure to sexual partners. The 
Canadian Criminal Code allows courts to subpoena information from those who may 
have information related to criminal cases. This information can include communications 
between people with HIV and clinicians, counsellors and researchers, depending on 
whether or not it was gained under certain circumstances which qualify the information 
as “privileged” (i.e. inadmissible in court).263 Even in situations where privacy and/or 
anonymity has been guaranteed by the researcher or service provider, information can 
sometimes be subpoenaed. Not only do these conditions this make research on non-
disclosure ethically unacceptable, but they bar people with HIV from seeking 
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professional counsel related to HIV disclosure. Thus, the CHIWOS team made a 
conscious decision not to ask directly about HIV disclosure to sexual partners in order to 
protect their participants and PRAs from legal vulnerability. Instead, the team surveyed 
general knowledge and opinions on Canadian criminalization of non-disclosure, as well 
as barriers to HIV disclosure as operationalized in the current study.  
5.3 Strengths 
One of the main strengths of the given analysis was its innovative approach to the study 
of HIV disclosure via barriers and facilitators. Members of the CHIWOS team, legal 
practitioners specializing in HIV non-disclosure, and women with HIV in Canada have 
made it clear that the present study is well-justified and innovative, and that the results 
will be valuable in informing policy and practice. Actionability was a main goal of this 
thesis from the identification of research questions through design of the statistical 
methods and interpretation of the results. In line with this goal, the present study (1) 
adapted a theoretical framework which renders results (and future research on this topic) 
interpretable in ways that are non-stigmatizing and true to community experience; (2) 
centred effect estimates on CPSA+ women rather than the population as a whole in order 
to estimate the impact of targeted intervention; and (3) leveraged data that was rendered 
limited by the surrounding policy environment (i.e. no disclosure measure) in a way that 
sheds light on the inadequacy of that same policy. While this thesis endeavoured to 
produce causal effect estimates in order to accurately evaluate the level of socio-legal 
vulnerability directly attributable to adverse childhood experiences, the resulting adjusted 
risk estimates are still valuable. Both the descriptive and analytic results, while not 
necessarily representative of all women with HIV, indicated an incredibly high burden of 
recurring violence among marginalized women with HIV. Regardless of the causal root 
of these experiences, the majority of women in CHIWOS had experienced physical or 
sexual assault in adulthood, which translates easily into socio-legal vulnerability. While 
estimates of the level of disclosure barriers attributable to HIV may have been vulnerable 
to misspecification, this thesis succeeded in showing the heavy burden of violence in 
adulthood and consequent need for interventions to temper the impact of such violence, 
especially in the context of HIV criminalization.   
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This project also successfully responded to calls for research that conceptualizes violence 
as not only a cause of HIV, but as a cause of further vulnerability among women with 
HIV.89 Research on the causes and consequences of violence against women is plentiful, 
and the concepts relayed in this body of work are easily extendable to women with HIV. 
Furthermore, studying established concepts such as stigma and revictimization among 
women with HIV provides the opportunity to investigate not only whether such concepts 
hold across populations, but also how HIV may nuance these concepts. In 2018, when 
medical advances have significantly bridged the life expectancy gap between people with 
HIV and people without HIV, we must turn our focus on how people with HIV move 
through the world, which is often skewed against them. The extension of existing 
research paradigms to this population is one way to accomplish this. Here, the application 
of a suite of barriers to HIV disclosure and their attribution to distal factors outside of 
one’s own control represented a novel approach in the quantitative HIV literature. It is 
our hope that, on the basis of these promising initial results, further research will build on 
this conceptualization in an effort to necessarily complicate the legal system’s 
understanding of HIV disclosure and its antecedents.  
5.4 Directions for Future Research 
Directions for future research have been identified intermittently throughout this 
discussion, but will be briefly summarized in this section. In direct response to the 
potential shortcomings of the present study, it is of interest to estimate the effects of 
CPSA on barriers to disclosure while controlling for a more robust suite of potential 
confounders in order to block all identifiable non-causal pathways. This could be 
accomplished with access to a dataset that has a heavier focus on childhood experiences. 
Alternatively, shifting the approach to confounding control from blocking non-causal 
pathways proximal to the exposure to an approach controlling true confounders or parents 
of the outcome may present viable methods for estimating causal effects with datasets not 
focused on childhood variables. Furthermore, studies of HIV disclosure barriers should 
pay attention to measurement limitations in the present study, with an eye towards 
potentially developing new measures. The literature review identified several relevant 
constructs for which no measure existed (e.g. potential sexual relationship power), as 
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well as constructs for which the CHIWOS measure did not map neatly onto the construct 
of interest (e.g. perceived social support versus anticipated partner support), and 
multidimensional constructs that warranted further exploration (e.g. HIV stigma). If 
ethically permissible, it would also be ideal to formally study the relationship between the 
barriers to HIV disclosure and partner disclosure. Hopefully this will be possible in the 
future given changes to the legal circumstances surrounding HIV disclosure or research 
confidentiality.   
The sensitivity analyses of the independent effects of CPA and CSA on barriers to HIV 
disclosure revealed the potential for interactive effects (i.e. poly-victimization) when 
compared to the main analysis of the effects of childhood physical or sexual abuse. 
Moving forward, researchers should think critically about whether a unitary approach to 
victimization is sufficient to address a given research question, and whether data will 
allow for the estimation of interaction effects between multiple types of adverse 
childhood experiences. These are not limited to childhood physical and sexual abuse, but 
may also include emotional abuse (when appropriately measured), exposure to intimate 
partner violence in childhood, and neglect. The relatively recent body of work on poly-
victimization is compelling, and should be taken into consideration by researchers across 
disciplines where childhood adversities are relevant predictors.246  
The present analysis also provided a hypothesized causal framework well-suited to 
mediation analysis. A wide range of factors may mediate the observed effects, and even 
the relationships where no significant effect was detected.264 For some outcomes where 
causal mechanisms have been well-established among the general population (e.g. known 
mediators between CSA and revictimization include dissociation, targetability, and risk-
recognition),265 concept validation and extension among women with HIV should prove 
fairly straightforward. For others, such as the relationship between CPSA and HIV stigma 
among Black African women, mediation analysis represents uncharted territory. While 
navigating this territory, researchers should consider potential mediators that have proven 
to be salient determinants of other CPSA sequelae in the literature. These include coping 
strategies,266 exposure to interventions,267 self-blame,268 and family support.266 Mediation 
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analysis will prove extremely valuable in identifying modifiable factors to target for 
intervention.  
5.5 Implications for Practice and Policy 
Practice 
The results of the present study in conjunction with prior research present several 
potential points for intervention, including enhancing protection for children, intervening 
on mediating pathways between CPSA and revictimization and/or HIV, and interventions 
for adults who have experienced CPSA with the goal of maintaining personal safety and 
understanding disclosure. In line with this study’s theoretical framework, any 
intervention should be accessible and acceptable to women and girls across all 
intersections of gender and ethnoracial group. In some cases, this will necessitate the 
development of intersection specific resources. Authors Etherington and Baker provide a 
useful guide for applying intersectionality theory in practice related to children exposed 
to intimate partner violence, which could be easily adapted to interventions related to 
CPSA.269 Institutions and individuals that are positioned to provide interventions and 
resources along this pathway include: child protection services, schools, women’s 
shelters, AIDS service organizations, physicians, psychologists, and other 
health/wellbeing practitioners. Some potential interventions focused on recognizing and 
reducing CPSA may include: educating children on personal autonomy and consent, 
providing access to parenting classes, educating parents and teachers on the signs of child 
abuse, recalibrating the child protection system to allow for lower caseloads, and 
providing intersectional anti-oppression training to those who work closely with children. 
Other interventions may focus on providing remedial support to children who have been 
victims of CPSA, including services such as professional counselling for children and 
their caregivers.  
The results of this analysis also have implications specific to individuals and institutions 
that work with HIV positive women. However, service providers must be aware of how 
they as counsellors may open their HIV positive clients to legal vulnerability, and should 
receive education on the intricacies of disclosure related counselling before engaging in 
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any discussions on disclosure. The Canadian HIV/AIDS Legal Network in partnership 
with other organizations has developed an online resource intended to educate those who 
regularly work with people with HIV regarding client confidentiality, recommended 
record keeping practices, and counselling people with HIV on matters related to 
disclosure.263 This information is well disseminated among AIDS service organizations, 
but should be increasingly targeted towards general practitioners and other health care 
providers, who tend to engage less frequently in discussions of HIV criminalization with 
their HIV positive patients even though they may also be vulnerable to disclosure related 
legal action.270 On top of existing educational resources about HIV disclosure, the current 
project presents new information that may be informative for individuals who engage in 
disclosure counselling. Providers should understand that women with a history of CPSA 
may be at greater risk for further abuse at present, and thus may be legally vulnerable. At 
the individual level, this information may provide HIV positive women who have 
experienced CPSA with some peace of mind in knowing that their experiences 
negotiating partner disclosure are valid and at least partially rooted in factors outside of 
their own control. At present, steps are already being taken to incorporate this 
information into the harmonized volunteer training materials for AIDS service 
organizations across Toronto, and consultations are underway with legal practitioners at 
HIV & AIDS Legal Clinic Ontario (HALCO) to develop additional knowledge 
translation strategies.  
The information collated in this thesis on the burden of violence and abuse among 
women with HIV merits further attention beyond knowledge translation strategies. Where 
they are not already doing to, AIDS service organizations and health care providers 
should offer programming teaching women with HIV who are at risk for violence about 
how the law has typically handled cases of HIV non-disclosure, and how they can best 
negotiate their bodily safety and legal vulnerability. A search for potential resources 
yielded several components of what would make for a larger and more comprehensive 
strategy. In 2015, HALCO developed a text-based resource for women with HIV who are 
experiencing or at risk of experiencing violence.271 This resource was intended to provide 
education on navigating the legal system as related to violence and HIV, including non-
disclosure. The legal information contained in this resource is highly valuable and could 
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provide the basis for a more accessible (i.e. face-to-face) intervention related to violence 
against women with HIV. Additionally, a 2015 systematic review of interventions to 
facilitate HIV disclosure in the context of violence identified two randomized trials from 
Africa which both appeared to increase rates of partner disclosure, though the effect 
could not conclusively be attributed to the disclosure counselling components as they 
were both part of larger multifaceted interventions.272 The interventions included 
screening all new HIV diagnoses among women for histories of violence, followed by an 
evaluation of safety and best options for disclosure or non-disclosure if that was deemed 
the best option.273,274 Concurrent screening for HIV and intimate partner violence is 
already in practice in some Canadian clinics,275 though it is unclear the extent to which 
this approach has been adopted nationally. Furthermore, screening for violence represents 
only the first step in a comprehensive strategy to protect women with HIV from 
additional vulnerability. An ideal intervention would incorporate the already established 
strategies above, along with acknowledgement of intersectionality and social power in the 
educational material and in the delivery of the intervention to women from multiply 
marginalized populations.  
Policy  
The findings of this analysis indicated that women with HIV, like other women, are 
vulnerable to physical and sexual violence in adulthood, and that experiences of CPSA 
increase risk for such violence. This evidence, coupled with research establishing a 
relationship between CPSA and HIV risk among women reiterates that recurring violence 
is an issue within this community. Furthermore, in the context of criminalization of HIV 
non-disclosure, violence against women with HIV has socio-legal implications beyond 
the already devastating implications of violence against women in general. Experiences 
of physical, sexual, and emotional violence undermine the power of women and girls, 
including women’s power to disclose their HIV status to their sexual partners, whether or 
not the current relationship is abusive. Within an abusive relationship, the decision to 
disclose one’s HIV status is often a negotiation where acceptance, reputation, shelter, 
financial security, bodily safety, and even one’s own life are on the line. In most of 
Canada where HIV non-disclosure is a crime, women with HIV must also consider the 
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potential for criminal charges and incarceration when negotiating disclosure. Sadly, even 
if women do disclose their HIV status to their sexual partners, they are not protected from 
false legal accusations by abusive partners attempting to exact control or revenge.  
What the current analysis provides is an additional piece within the larger body of 
evidence which tells us that children cannot cause their own abuse, girls who experience 
abuse are at risk for HIV as well as revictimization, and the co-occurrence of HIV and 
abuse makes HIV disclosure dangerous. When legal bodies ignore scientific evidence on 
HIV transmission and fail to recognize disclosure-related risks for people with HIV they 
are not only complacent to this cycle of abuse and vulnerability, but they enable it. As a 
consequence, these systems may be disproportionately punitive to those who are 
especially vulnerable based on early-life violence.   
Steps are being take to remedy this as newer scientific evidence becomes incorporated 
into the legal system. Most recently, in December 2017 the Ontario Attorney General and 
Ontario Minister of Health and Long Term Care announced that in light of scientific 
developments, Ontario’s crown prosecutors would no longer pursue HIV non-disclosure 
cases where an individual has had a suppressed viral load for six months.58 This decision 
represents an important step towards achieving justice for people with HIV in Canada, 
however, the policy’s reach is limited to Ontario and does not yet address the legal 
precedent for other situations where HIV transmission risk is known to be negligible, 
including: oral sex, anal or vaginal sex with a condom, and anal or vaginal sex without a 
condom while having low viral load.58 A community consensus statement signed by over 
150 Canadian organizations in 2017 further advocated for the application of non-
disclosure law only as a last resort in the case of intentional HIV transmission, which is 
very rare.276 Their call to action included the following demands:  
1. Federal and provincial Attorneys-General should develop sound prosecutorial 
guidelines to preclude unjust HIV prosecutions.  
2. The federal government should reform the Criminal Code to limit the unjust 
use of the criminal law against people living with HIV.  
3. All three levels of government should support the development of resources 
and training to address misinformation, fear and stigma related to HIV.276  
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This position was echoed by the Department of Justice’s 2017 commissioned report on 
the criminal justice system’s response to non-disclosure of HIV.277 These advances are 
highly promising, and represent exciting potential for advancement of human rights in 
Canada.  
5.6 Conclusion  
In summary, the findings of this thesis confirmed that women with HIV in Canada 
experience a high burden of violence which may be at least partially attributable to earlier 
experiences of violence in childhood. Such experiences may also be associated with 
adverse outcomes in adulthood, such as low sexual relationship power or high HIV 
stigma, that disenable women from disclosing their HIV status to their sexual partners. 
These barriers and facilitators to HIV disclosure are especially relevant in Canada where, 
as of August 2018, people with HIV continue to be charged and convicted for HIV non-
disclosure despite heavily documented scientific and ethical objections to this practice. 
While the current analysis was not able to ascertain causality, adjusted risk estimates 
provided some indication that women with HIV who experienced child abuse may be 
more vulnerable than women without such experiences to non-disclosure, and thus legal 
actions or threats. These results introduce the possibility that HIV non-disclosure law 
over-criminalizes women with HIV who experienced child abuse, punishing them for 
making what is deemed to be the wrong decision when their personal safety and 
autonomy is at risk. On the basis of this reasoning, interventions which restore autonomy 
to women with HIV by way of education, empowerment, and national policy change are 
recommended. This includes explicit decriminalization of HIV non-disclosure at the 
national level. 
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Appendices 
Appendix 1: Hierarchy of HIV exposure categories 
Source: Public Health Agency of Canada19 
1. MSM: Men who have sex with men. This category includes men who report 
either homosexual or bisexual sexual contact.  
2. MSM/IDU: Men who have sex with men and use injection drugs.  
3. IDU: Injection drug use.  
4. Blood/blood products  
a. Recipient of blood/clotting factor: Before 1998, it was not possible to 
separate this exposure category. However, where possible, it has been 
separated into subcategories b and c.  
b. Recipient of blood: Received transfusion of whole blood or blood 
components, such as packed red cells, plasma, platelets, or cryoprecipitate.  
c. Recipient of clotting factor: Received pooled concentrates of clotting 
factor VIII or IX for treatment of hemophilia/coagulation disorder.  
5. Heterosexual contact  
a. Origin from an HIV-endemic country (Het-Endemic): People who were 
born in a country where HIV is endemic. An HIV-endemic country is 
defined as having an adult (ages 15–49) prevalence of HIV that is 1.0% or 
greater and one of the following: • 50% or more of HIV cases attributed to 
heterosexual transmission • a male to female ratio of 2:1 or less • HIV 
prevalence greater than or equal to 2% among women receiving prenatal 
care Before 1998, it was not always possible to separate Origin from an 
HIV-endemic country and sexual contact with a person at risk. However, 
where possible, it has been separated into subcategories a and b.  
b. Sexual contact with a person at risk (Het-Risk): People who report 
heterosexual contact with someone who is either HIV-infected or who is at 
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increased risk of HIV infection (e.g. a person who injects drugs, a bisexual 
male, or a person from an HIV-endemic country).  
c. No Identified Risk-Heterosexual (NIR-Het): If heterosexual contact is the 
only risk factor reported and nothing is known about the HIV-related 
factors associated with the partner, the case is classified as NIR–Het.  
6. Occupational exposure: Exposure to HIV-contaminated blood or body fluids, 
or concentrated virus in an occupational setting. This applies only to reported 
AIDS cases and not to HIV-cases where the occupational exposure category is 
captured under “other”. The Canada Communicable Disease Report (CCDR) 
contains more information about occupational exposure.  
7. Perinatal transmission: The transmission of HIV from a woman infected with 
HIV to her infant, either in utero, during childbirth, or through breastfeeding.  
8. Other: Used to classify cases where the mode of HIV transmission is known 
but cannot be classified into any of the major exposure categories listed here; 
for example, a recipient of semen from an HIV-positive donor.  
9. No identified risk (NIR): Used when the history of exposure to HIV through 
any of the other modes listed is unknown, or there is no reported history (e.g. 
because of death, or loss to follow-up).  
10. Not reported: In certain provinces and territories, exposure categories are not 
reported to the Public Health Agency of Canada and are classified as Not 
Reported.  
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Appendix 2: SAS Code 
File 1: Data cleaning, generating propensity scores, evaluating balance diagnostics 
*Import macros; 
%include 'U:\SAS\Macros\twang_mac.sas'; 
/*-IMPORT AND SORT W1/W2 DATA BY PART_ID*/ 
LIBNAME USB 'E:\Data'; 
DATA CHIWOSW1; 
 SET USB.CHIWOSW1; 
PROC SORT DATA=CHIWOSW1; 
 BY PART_ID; 
DATA CHIWOSW2; 
 SET USB.CHIWOSW2; 
PROC SORT DATA=CHIWOSW2; 
 BY PART_ID; 
 
/*CREATE TEMP DATASET WITH COMBINED W1+W2 by variable PART_ID (match-
merging)*/ 
DATA CHIWOSW1_2; 
 MERGE CHIWOSW1 CHIWOSW2; 
 BY PART_ID; 
 
/*DEFINE ALL ARRAYS. AAA=SRPS W1&2; BBB=Y,N,DK,PA; CCC=MOS-SSS; DDD=HIV 
Stigma W1&2; EEE=HAT-QoL-Disclosure; FFF=HIV Stigma w1&w2; GGG=HAT QoL 
Disclosure W1&W2;*/ 
ARRAY AAA S8Q24j_1-S8Q24j_15 W2S9Q15_0-W2S9Q15_14; 
ARRAY BBB S7Q2a W2S8Q02 S7Q5a W2S8Q14 S7Q6a S7Q8a S1Q5a S1Q24 S1Q26 
S1Q27 S1Q8O_1-S1Q8O_7; 
ARRAY CCC S9Q4_1-S9Q4_4; 
ARRAY DDD S5Q1_1-S5Q1_10 W2S6Q01_0-W2S6Q01_9; 
ARRAY EEE S5Q5_1-S5Q5_6 W2S6Q02_0-W2S6Q02_5; 
ARRAY FFF S5Q1_1-S5Q1_10 W2S6Q01_0-W2S6Q01_9; 
ARRAY GGG S5Q5_1-S5Q5_5 W2S6Q02_0-W2S6Q02_4; 
 
/*-------------- REMOVE MISSINGS -------------------*/ 
DO OVER AAA; 
 IF AAA=5 then AAA=.; 
 END; 
DO OVER BBB; 
 IF BBB= 3 then BBB=.; 
 IF BBB= 4 then BBB=.; 
 END; 
DO OVER CCC; 
 IF CCC= 6 then CCC=.; 
 IF CCC= 7 then CCC=.; 
 END; 
DO OVER DDD; 
 IF DDD= 6 then DDD=.; 
 END; 
DO OVER EEE; 
 IF EEE= 6 then EEE=.; 
 END;  
 
/*-------------- OUTCOMES  ------------------*/ 
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*(a) Sexual Relationship Power Scale (SRPS) Relationship Control 
Subscale Waves 1 and 2; 
*1. Summing total of 15 items [CHECKED]; 
sum_SRPSw1 = sum(of S8Q24j_1-S8Q24j_15); 
sum_SRPSw2 = sum(of W2S9Q15_0-W2S9Q15_14); 
*2. Determining number of items answered; 
total_SRPSw1 = n(of S8Q24j_1-S8Q24j_15); 
total_SRPSw2 = n(of W2S9Q15_0-W2S9Q15_14); 
*3 Calculating scale value as SUM of items/#nonmissing items (average 
of answered items). 
*When instructions they say missing items *automatically* assigned mean 
score for completed items, this is what they mean; 
SRPSw1 = sum_SRPSw1/total_SRPSw1;  *Score is average across 
completed items; 
SRPSw2 = sum_SRPSw2/total_SRPSw2; 
*Those missing 3 or more (15-3=12) items are dropped; 
if total_SRPSw1 le 12 then SRPSw1=.; *Missing SRPSw1=; 
if total_SRPSw2 le 12 then SRPSw2=.; *Missing SRPSw2=; 
 
/*(b) Adult physical abuse, ever (W1 ever, W2 since last CHIWOS 
interview) W1: S7Q2a, W2: W2S8Q02 
If w1 missing and w2 is no --> missing. If w1 is missing and w2 is yes 
--> yes. If w2 is missing always default to w1 answer*/ 
APABUSE=.; 
if S7Q2a=2 and W2S8Q02=2 then APABUSE=0; *no adult physical abuse ever; 
if S7Q2a=. and W2S8Q02=2 then APABUSE=.; *n=65 if w1 missing and w2 
(since) is no --> missing since this is not "ever"; 
if S7Q2a=2 and W2S8Q02=. then APABUSE=0; *no adult physical abuse ever 
as reported to CHIWOS; 
if S7Q2a=1 or W2S8Q02=1 then APABUSE=1; *yes adult physical abuse ever 
(including if w1 missing and w2(since) is yes --> if happened since, 
this is part of "ever"; 
if S7Q2a=. and W2S8Q02=. then APABUSE=.; *if both waves missing, var is 
missing; 
*Checking source of missingness; 
if s7q1=1 then w1section7=1; 
if s7q1=2 then w1section7=2; 
if s7q1=3 then w1section7=.; 
if w2s8q01=1 then w2section8=1; 
if w2s8q01=2 then w2section8=2; 
if w2s8q01=3 then w2section8=.; 
 
/*(c) Adult sexual abuse (W1 ever, W2 since last CHIWOS interview)W1: 
S7Q5a, W2: W2S8Q14 [CHECKED] 
If w1 missing and w2 is no --> missing. If w1 is missing and w2 is yes 
--> yes. If w2 is missing always default to w1 answer*/ 
ASABUSE=.; 
if S7Q5a=2 and W2S8Q14=2 then ASABUSE=0; *no adult sexual abuse ever; 
if S7Q5a=. and W2S8Q14=2 then ASABUSE=.; *if w1 missing and w2 (since) 
is no --> missing since this is not "ever"; 
if S7Q5a=2 and W2S8Q14=. then ASABUSE=0; *no adult sexual abuse ever as 
reported to CHIWOS; 
if S7Q5a=1 or W2S8Q14=1 then ASABUSE=1; *yes adult sexual abuse ever 
(including if w1 missing and w2(since) is yes --> if happened since, 
this is part of "ever"; 
if S7Q5a=. and W2S8Q14=. then ASABUSE=.; *if both waves missing, var is 
missing; 
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/*(d) Social Support [Medical Outcomes Study – Social Support Scale 4 
item]. W1: S9Q4_1 to S9Q4_4, DV: MOS_SSS_Score (W1).*/  
*1. Reverse code all items (not officially RC, response options just 
asked in opposite order in CHIWOS) (see 
http://www.theanalysisfactor.com/easy-reverse-code/); 
S9Q4_RC_1=6-S9Q4_1; 
S9Q4_RC_2=6-S9Q4_2; 
S9Q4_RC_3=6-S9Q4_3; 
S9Q4_RC_4=6-S9Q4_4; 
*2. Summing all 4 items; 
MOSSw1 = sum(of S9Q4_RC_1-S9Q4_RC_4); 
*3. Determining number of items answered; 
total_MOSSw1 = n(of S9Q4_RC_1-S9Q4_RC_4); 
*4. If any item is missing, drop from analysis; 
if total_MOSSw1 lt 4 then MOSSw1=.; *Results in n=55 missing; 
 
/*(e) HIV Stigma Scale W1: S5Q1_1 to S5Q1_10; W2: W2S6Q01_0 to 
W2S6Q01_9; DV: None*/ 
*1. Recode response options [CHECKED]; 
DO OVER FFF; 
 FFF=5-FFF; 
 END;  
*2. Sum all 10 items for each wave [CHECKED: scales range from 0-40]; 
STIGMAw1 = sum(of S5Q1_1-S5Q1_10); 
STIGMAw2 = sum(of W2S6Q01_0-W2S6Q01_9); 
*3. If missing 2 or more items on scale of 10, drop from analysis; 
total_STIGMAw1 = n(of S5Q1_1-S5Q1_10); 
total_STIGMAw2 = n(of W2S6Q01_0-W2S6Q01_9); 
if total_STIGMAw1 le 8 then STIGMAw1=.; 
if total_STIGMAw2 le 8 then STIGMAw2=.; 
 
*(g)Sexual Inactivity (6 months) W2: S902 (Have you had consensual sex 
in the past 6 months 1 yes 2 no 3 DKPN); 
if W2S9Q02=1 then inactivityw2=0; *Yes to consensual sex --> not 
inactive; 
if W2S9Q02=2 then inactivityw2=1; *No to consensual sex --> not active; 
if W2S9Q02=. then inactivityw2=.; 
 
/*-------------- EXPLANATORY VARIABLES  ------------------*/ 
 
/*1a. CPSA  W1: S7Q6a [physical] W1: S7Q8a [sexual]*/ 
CPSA=.; 
if S7Q6a=2 and S7Q8a=2 then CPSA=0; *no physical or sexual abuse; 
if S7Q6a=1 or S7Q8a=1 then CPSA=1; *yes physical and/or sexual abuse; 
if S7Q6a=. and S7Q8a=. then CPSA=.; *if both are missing, var is 
missing; 
 
/*1b. Child physical abuse S7Q6a*/ 
if S7Q6a=2 then CPA=0; *no physical abuse; 
if S7Q6a=1 then CPA=1; *yes physical abuse; 
if S7Q6a=. then CPA=.; 
 
/*1c. Child sexual abuse S7Q8a*/ 
if S7Q8a=2 then CSA=0; *no sexual abuse; 
if S7Q8a=1 then CSA=1; *yes sexual abuse; 
if S7Q8a=. then CSA=.; 
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/*2. Race/ethnicity W1: S1Q7_1 to S1Q7_18 and S1Q7_18_sp (other,spec). 
Black african=S1Q7_3, Black Caribbean=S1Q7_4, Black Other=S1Q7_5, DV: 
S1Q7_dv. */ 
RACE=.; 
if S1Q7_dv=1 then RACE=1; *Aboriginal; 
if S1Q7_dv=2 and S1Q7_3=3 then RACE=2; *Black African; 
if S1Q7_dv=2 and S1Q7_4=4 then RACE=3; *Black Caribbean; 
if S1Q7_dv=2 and S1Q7_5=5 and S1Q7_3=. and S1Q7_4=. then RACE=5; *Black 
other with no other black ID=other [5/11 "Black other" fall into this 
category]; 
if S1Q7_dv=3 then RACE=4; *Caucasian; 
if S1Q7_dv=4 then RACE=5; *Other; 
if S1Q7_dv=. then RACE=.; 
 
/*-------------- PS VARIABLES  ------------------*/ 
 
/*1. Gender Identity. W1/DV: S1Q2a_dv. Combine transwomen and other 
[checked]*/ 
GENDERID=.; 
if S1Q2a_dv=1 then GENDERID=0; *cis women; 
if S1Q2a_dv=2 or S1Q2a_dv=3 then GENDERID=1; *trans women and other; 
if S1Q2a_dv=. then GENDERID=.; 
 
/*2. Leaving home country at or before age 16. W1: S1Q5a (Were you 
born in Canada); W1: S1Q5c_1 (in what year did you come to Canada to 
live);W1: S0QDOB_Y (Year of birth) [CHECKED]*/ 
*A. Create var for age of immigration (year of imm to canada subtract 
birth year); 
IMMAGE=sum(S1Q5c_1-S0QDOB_Y); 
*B. Dichotomize IMMAGE into le 16, gt 16; 
if IMMAGE le 16 then IMLE16=1; *immigrated at or before 16; 
if IMMAGE gt 16 or S1Q5a=1 then IMLE16=0; *immigrated after 16 or not 
an immigrant; 
if S1Q5a=. or S0QDOB_Y=. then IMLE16=.; 
if PART_ID in(REDACTED FOR DATA SECURITY) then IMLE16=.; *immigrants 
without year of immigration; 
if PART_ID in REDACTED FOR DATA SECURITY) then IMLE16=0; *Non-
immigrants without year of birth; 
if PART_ID in (REDACTED FOR DATA SECURITY) then IMLE16=.; *immigrants 
without year of birth; 
 
/*3. Stress-related reason for immigration during childhood. W2: 
W2S1Q14_1 to W2S1Q14_16 and W2S1Q14_14_SP (Reason for moving to Canada 
- check all)*/ 
*if IMLE16=1;  
*A. Create non age-restricted stress related immigration var; 
if S1Q5a=1 then IMSTRESS=0; *not an immigrant; 
if S1Q5a ne 1 and W2S1Q14_3 ne 3 and W2S1Q14_7 ne 7 and W2S1Q14_8 ne 8 
and W2S1Q14_9 ne 9 and W2S1Q14_10 ne 10 and W2S1Q14_11 ne 11 then 
IMSTRESS=0; *immigrant w/no stress related reason; 
if W2S1Q14_3=3 or W2S1Q14_7=7 or W2S1Q14_8=8 or W2S1Q14_9=9 or 
W2S1Q14_10=10 or W2S1Q14_11=11 then IMSTRESS=1; *yes any stress related 
reason; 
if S1Q5a=. then IMSTRESS=.; *if born in Canada is missing, item is 
missing; 
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if S1Q5a=2 and W2S1Q14_1=. and W2S1Q14_2=. and W2S1Q14_3=. and 
W2S1Q14_4=. and W2S1Q14_5=. and W2S1Q14_6=. and W2S1Q14_7=. and 
W2S1Q14_8=. and W2S1Q14_9=. and W2S1Q14_10=. and W2S1Q14_11=. and 
W2S1Q14_12=. and W2S1Q14_13=. and W2S1Q14_14=. and W2S1Q14_15=. and 
W2S1Q14_16=. then IMSTRESS=.; *immigrant w/no answers for reason of 
immigration; 
if PART_ID in(REDACTED FOR DATA SECURITY) then IMSTRESS=1; *other 
specify indicating stress where not captured in quant vars; 
*B. Create IMSTRESS <=16; 
if IMLE16=0 or IMSTRESS=0 then IMSTRESS16=0; *didn't immigrate 
at/before 16 or didn't experience immigration stress; 
if IMLE16=1 and IMSTRESS=1 then IMSTRESS16=1; *immigrated at/before 16 
AND experienced immigration stress; 
if IMLE16=. OR IMSTRESS=. then IMSTRESS16=.; 
 
/*4. Attendance at residential school W1: RACE (aboriginal=1), S1Q8k 
(skip section?), S1Q8L (did you attend)*/ 
if RACE ne 1 then SELFATTEND=0; *not aboriginal in Canada; 
if RACE=1 and S1Q8k=2 then SELFATTEND=.; *Aboriginal but skip 
residential school section; 
if RACE=1 and S1Q8k=1 and S1Q8L=2 then SELFATTEND=0; *aboriginal, 
answered, didn't attend; 
if RACE=1 and S1Q8k=1 and S1Q8L=1 then SELFATTEND=1; *aboriginal, 
answered, attended; 
if RACE=1 and S1Q8k=1 and (S1Q8L=4 or S1Q8L=.) then SELFATTEND=.; 
*aboriginal, answered, missing self attendance; 
 
/*5. Any family attended residential school*/ 
if S1Q8O_dv=0 then FAMATTEND=0; *not aboriginal in Canada; 
if S1Q8O_dv=1 then FAMATTEND=1; *at least 1 fam said yes; 
if S1Q8O_dv=2 then FAMATTEND=0; *all family members said no; 
if S1Q8O_dv=5 then FAMATTEND=0; *does not id as first nation; 
if S1Q8O_dv=8 then FAMATTEND=.; *skipped rschool questions; 
if S1Q8O_dv=9 then FAMATTEND=.; *DK/PA; 
 
/*6. Sexual orientation - S1Q3_dv (prev sex minority = 12.66%)*/ 
if S1Q3_dv=1 then sexid=0; *heterosexual; 
if S1Q3_dv=2 then sexid=1; *not heterosexual; 
if S1Q3_dv=9 then sexid=.; *missing; 
 
/*7. Age. var=age*/ 
 
/*Remove obs with no outcome data (n=115) and unused vars*/ 
 
DATA mainanalysis; 
 SET CHIWOSW1_2(KEEP=CPSA CSA CPA GENDERID IMLE16 IMSTRESS16 
SELFATTEND FAMATTEND PART_ID RACE SRPSw1 SRPSw2 APABUSE ASABUSE MOSSw1 
STIGMAW1 STIGMAW2 inactivityw2 sexid age); 
 IF CPSA ne .; 
 
/*-------------  END OF DATA STEP  ------------*/ 
 
 
/*-----------------Analysis with TWANG Macros  -----------------*/ 
*ESTIMATE PSs USING GBM, EVALUATE QUALITY USING COVARIATE BALANCE; 
 %ps(treatvar=CPSA, 
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          vars=GENDERID IMLE16 IMSTRESS16 SELFATTEND FAMATTEND sexid 
age, 
          class=GENDERID IMLE16 IMSTRESS16 SELFATTEND FAMATTEND sexid, 
          dataset=mainanalysis, 
          ntrees=5000, 
          intdepth=3, 
          shrinkage=0.01, 
          permtestiters=500, 
          stopmethod=ks.mean es.mean, 
          sampw=, 
          estimand=ATT, 
          output_dataset=USB.mainanalysis, 
   Rcmd=C:\Program Files\R\R-3.4.3\bin\x64\R.exe, 
          plotname=Weight_QualityCPSA.pdf, 
          objpath=U:\SAS\TWANG); 
 
RUN; 
 
 
/*----------------- END OF PS CODE -----------------*/ 
 
File 2: Outcome analysis 
*IMPORT AND SORT W1/W2 DATA BY PART_ID; 
LIBNAME USB 'E:\Data'; 
DATA chiwosw1_2_attwgtsv7; 
 SET USB.chiwosw1_2_attwgtsv7; 
 
*Indicator variables for missingness of PS vars; 
ARRAY AAA age sexid genderid imle16 imstress16 selfattend famattend; 
ARRAY BBB ageNA sexidNA genderidNA imle16NA imstress16NA selfattendNA 
famattendNA; 
do over AAA; 
 if AAA=. then BBB=1; 
 if AAA=1 then BBB=0; 
 if AAA=0 then BBB=0; 
end; 
 
*recode race with white reference group; 
if race=4 then raceref=0; *white; 
if race=1 then raceref=4; *Indigenous; 
if race=2 then raceref=3; *Black African; 
if race=3 then raceref=2; *Black Caribbean; 
if race=5 then raceref=1; *Other; 
if race=. then raceref=.; 
 
LABEL raceref="Race (((4=Indig, 3=BA, 2=BC, 1=Other, 0=White)))"; 
 
 
/*-----------------  END OF DATA STEP  -----------------------*/ 
 
PROC SORT DATA=chiwosw1_2_attwgtsv7; 
 BY descending raceref descending CPSA; 
 
/*--------------------  APABUSE (BINARY)  ------------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
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CLASS PART_ID raceref CPSA; 
MODEL APABUSE=CPSA|raceref /dist=poisson link=log; 
REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "APABUSE: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID raceref CPSA; 
MODEL APABUSE=CPSA|raceref /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "APABUSE: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID; 
MODEL APABUSE=CPSA /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'Beta' CPSA 1 / exp; 
TITLE "APABUSE: Weighted, OVERALL"; 
 
/*--------------------  ASABUSE (BINARY)  ------------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID raceref CPSA; 
MODEL ASABUSE=CPSA|raceref /dist=poisson link=log; 
REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "ASABUSE: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID raceref CPSA; 
MODEL ASABUSE=CPSA|raceref /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "ASABUSE: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID; 
MODEL ASABUSE=CPSA /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'Beta' CPSA 1 / exp; 
TITLE "ASABUSE: Weighted, OVERALL"; 
 
/*--------------------  INACTIVITYW2 (BINARY) -----------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID raceref CPSA; 
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MODEL INACTIVITYW2=CPSA|raceref /dist=poisson link=log; 
REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "INACTIVITYW2: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID raceref CPSA; 
MODEL INACTIVITYW2=CPSA|raceref /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref exp diff cl plots=none; *stratum 
specific effects; 
TITLE "INACTIVITYW2: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data desc; 
CLASS PART_ID; 
MODEL INACTIVITYW2=CPSA /dist=poisson link=log; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'Beta' CPSA 1 / exp; 
TITLE "INACTIVITYW2: Weighted, OVERALL"; 
 
/*--------------------  SRPSW2 (CONTINUOUS)  ------------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL SRPSw2=CPSA|raceref /dist=normal link=id; 
REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
TITLE "SRPSw2: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL SRPSw2=CPSA|raceref /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
TITLE "SRPSw2: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID; 
MODEL SRPSw2=CPSA /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'lincomb' intercept 1 CPSA 1; 
TITLE "SRPSw2: Weighted, OVERALL"; 
 
/*--------------------  MOSSW1 (CONTINUOUS)  ------------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL MOSSw1=CPSA|raceref /dist=normal link=id; 
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REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
TITLE "MOSSw1: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL MOSSw1=CPSA|raceref /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
TITLE "MOSSw1: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID; 
MODEL MOSSw1=CPSA /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'lincomb' intercept 1 CPSA 1; 
TITLE "MOSSw1: Weighted, OVERALL"; 
 
/*--------------------  STIGMAW1 (CONTINUOUS)  ----------------------*/ 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL STIGMAW1=CPSA|raceref /dist=normal link=id; 
REPEATED sub=PART_ID / type=ind; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
TITLE "STIGMAW1: Unw, Slice"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID raceref CPSA; 
MODEL STIGMAW1=CPSA|raceref /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; *gives risk estimates relative to 
white women; 
SLICE CPSA*raceref /sliceby=raceref diff cl plots=none; *stratum 
specific effects; 
*SLICE CPSA*raceref /sliceby=CPSA exp diff cl plots=none; *pairwise if 
necessary; 
TITLE "STIGMAW1: Weighted, slice, relative"; 
 
PROC GENMOD DATA=chiwosw1_2_attwgtsv7 order=data; 
CLASS PART_ID; 
MODEL STIGMAW1=CPSA /dist=normal link=id; 
WEIGHT ks_mean_att; 
REPEATED sub=PART_ID / type=ind; 
ESTIMATE 'lincomb' intercept 1 CPSA 1; 
TITLE "STIGMAW1: Weighted, OVERALL"; 
 
*MISSINGNESS OF PS COVARIATES; 
 
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7; 
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tables ageNA sexid sexidNA genderid genderidNA imle16 imle16NA 
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA 
/row; 
title "Missingness of PS Covariates"; 
 
*BALANCE DIAGNOSTICS; 
PROC SORT DATA=chiwosw1_2_attwgtsv7; 
 BY CPSA; 
 
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7; 
tables CPSA*(sexid sexidNA genderid genderidNA imle16 imle16NA 
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA) 
/row wchisq; 
weight ks_mean_att; 
title "Weighted balance diagnostics for binary PS vars"; 
 
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7; 
tables CPSA*(ageNA sexid sexidNA genderid genderidNA imle16 imle16NA 
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA) 
/row wchisq; 
title "Unweighted balance diagnostics for binary PS vars"; 
 
PROC TTEST; 
class cpsa; 
var age; 
weight ks_mean_att; 
title "Weighted balance diagnostic for age"; 
 
PROC TTEST; 
class cpsa; 
var age; 
title "Unweighted balance diagnostic for age"; 
 
*BALANCE DIAGNOSTICS BY ETHNORACIAL (i.e. testing for differences 
across CPSA within ethnoracial groups); 
 
PROC SORT DATA=chiwosw1_2_attwgtsv7; 
 BY race; 
 
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7; 
tables CPSA*(sexid sexidNA genderid genderidNA imle16 imle16NA 
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA) 
/row wchisq; 
weight ks_mean_att; 
by race; 
title "Weighted balance diagnostics for binary PS vars"; 
 
PROC SURVEYFREQ DATA=chiwosw1_2_attwgtsv7; 
tables CPSA*(ageNA sexid sexidNA genderid genderidNA imle16 imle16NA 
imstress16 imstress16NA selfattend selfattendNA famattend famattendNA) 
/row wchisq; 
by race; 
title "Unweighted balance diagnostics for binary PS vars"; 
 
PROC TTEST; 
by race; 
class cpsa; 
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var age; 
weight ks_mean_att; 
title "Weighted balance diagnostic for age by ethnoracial"; 
 
PROC TTEST; 
by race; 
class cpsa; 
var age; 
title "Unweighted balance diagnostic for age by ethnoracial"; 
 
RUN; 
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“Balance measure” represents the absolute standardized mean difference (ES mean) and the mean 
Kolmogorov Smirnov test statistic (KS mean), respectively. Figures created using RAND corporation’s 
TWANG macro.209  
Appendix 3: GBM optimization for main CPSA analysis, ES mean and KS 
mean stopping points 
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“Treatment” indicates CPSA status with 2 representing the CPSA+ group and 1 
representing the CPSA- group. Figures created using RAND corporation’s TWANG 
macro.209 
 
Boxplot 1: Propensity score overlap for main CPSA analysis, ES mean and KS mean 
stopping points 
 
 
  
Appendix 4: Boxplots of propensity scores by exposure group 
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Boxplot 2: Propensity score overlap for CPA sensitivity analysis, KS mean stopping 
point 
 
Boxplot 3: Propensity score overlap for CSA sensitivity analysis, KS mean stopping 
point 
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ES mean refers to the absolute standardized effect size difference, while KS mean refers to the mean 
Kolmogorov Smirnov test statistic. Blue lines represent decreases in absolute standardized difference for 
covariates across exposure groups post-weighting, while red lines represent increases post-weighting. An 
absolute standard difference ≤0.20 is considered balanced. Figures created using RAND corporation’s 
TWANG macro.209 
  
Appendix 5: Absolute standardized effect size differences pre and post 
AEE weighting 
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Appendix 6: Stratum-specific balance diagnostics 
Table 1: Unweighted stratum-specific balance diagnostics for effect of CPSA 
SE denotes standard error. 
P-values for continuous variables were derived from unweighted t-tests (PROC SURVEYMEANS) while 
P-values for binary variables were derived from unweighted Wald Chi Square tests (PROC 
SURVEYFREQ).  
  
 
Indigenous Black African Black 
Caribbean 
White Other 
PS Covariate N=288 N=302 N=64 N=554 N=103 
Age  - years (SE) 
CPSA- 37.9 (1.46) 43.1 (0.77) 45.4 (2.13) 44.0 (0.89) 43.4 (1.87) 
CPSA+ 40.9 (0.62) 39.8 (0.79) 45.1 (1.79) 44.7 (0.55) 43.6 (1.16) 
P-value 0.0598 0.0032 0.9196 0.4957 0.9492 
Sexual Minority - % (SE) 
CPSA- 17.9 (4.69) 1.32 (0.93) 2.94 (2.92) 7.28 (1.81) 10.3 (5.68) 
CPSA+ 21.8 (2.79) 6.71 (2.05) 10.0 (5.52) 19.3 (2.14) 13.51 (3.99) 
P-value 0.4753 0.0175 0.2627 <.0001 0.6495 
Gender Minority - % (SE) 
CPSA- 5.97 (2.90) 0.66 (0.66) 0 2.90 (1.17) 3.44 (3.40) 
CPSA+ 6.76 (1.69) 0 10.0 (5.52) 4.68 (1.14) 16.2 (4.31) 
P-value 0.8148 N/A N/A 0.2765 0.0253 
Immigrated at or before age 16 - % (SE) 
CPSA- - 2.67 (1.32) 9.09 (5.04) 4.37 (1.43) 10.3 (5.68) 
CPSA+ - 4.76 (1.76) 33.3 (8.68) 3.81 (1.04) 24.7 (5.07) 
P-value - 0.3413 0.0187 0.7524 0.0672 
Immigration-related stress at or before age 16 - % (SE) 
CPSA- - 0.74 (0.74) 0 0.49 (0.49) 7.69 (5.25) 
CPSA+ - 3.05 (1.51) 11.5 (6.32) 0.30 (0.30) 10.4 (3.76) 
P-value - 0.1692 N/A 0.7341 0.6710 
Survivor of residential school - % (SE) 
CPSA- 8.70 (5.90) - - - - 
CPSA+ 7.92 (2.70) - - - - 
P-value 0.9051 - - - - 
Family member(s) attended residential school - % (SE) 
CPSA- 51.7 (9.31) - - - - 
CPSA+ 67.5 (4.29) - - - - 
P-value 0.1331 - - - - 
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Table 2: AEE Weighted stratum-specific balance diagnostics for effect of CPSA 
SE denotes standard error. 
P-values for continuous variables were derived from weighted t-tests (PROC SURVEYMEANS) while P-
values for binary variables were derived from weighted Wald Chi Square tests (PROC SURVEYFREQ).  
  
 Indigenous Black African Black 
Caribbean 
White Other 
PS Covariate N=288 N=302 N=64 N=554 N=103 
Age  - years (SE) 
CPSA- 39.2 (1.20) 43.4 (0.71) 45.8 (1.99) 44.0 (0.79) 42.8 (1.67) 
CPSA+ 40.9 (0.62) 39.8 (0.79) 45.1 (1.79) 44.7 (0.55) 43.6 (1.16) 
P-value 0.2156 0.0008 0.7883 0.4385 0.7020 
Sexual Minority - % (SE) 
CPSA- 23.6 (6.62) 2.81 (2.26) 8.93 (8.33) 16.4  (4.12) 21.0 (10.7) 
CPSA+ 21.8 (2.79) 6.71 (2.05) 10.0 (5.52) 19.3 (2.14) 13.5 (3.99) 
P-value 0.8006 0.1996 0.9151 0.5574 0.5222 
Gender Minority - % (SE) 
CPSA- 9.78 (5.08) 1.28 (1.27) 0 7.00 (3.78) 4.44 (4.37) 
CPSA+ 6.76 (1.69) 0 10.0 (5.52) 4.68 (1.14) 16.2 (4.31) 
P-value 0.5752 N/A N/A 0.5597 0.0621 
Immigrated at or before age 16 - % (SE) 
CPSA- - 3.37 (1.77) 11.7 (6.50) 7.24 (2.41) 23.1 (11.5) 
CPSA+ - 4.76 (1.76) 33.3 (8.68) 3.81 (1.04) 24.7 (5.07) 
P-value - 0.5772 0.0504 0.1947 0.9022 
Immigration-related stress at or before age 16 - % (SE) 
CPSA- - 0.65 (0.65) 0 1.25 (1.24) 21.3 (12.4) 
CPSA+ - 3.05 (1.51) 11.5 (6.32) 0.30 (0.30) 10.4 (3.76) 
P-value - 0.1448 N/A 0.4552 0.4300 
Survivor of residential school - % (SE) 
CPSA- 8.17 (5.74) - - - - 
CPSA+ 7.92 (2.70) - - - - 
P-value 0.9687 - - - - 
Family member(s) attended residential school - % (SE) 
CPSA- 70.1 (8.49) - - - - 
CPSA+ 67.5 (4.29) - - - - 
P-value 0.7901 - - - - 
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Appendix 7: Sensitivity analyses 
Table 1: Effect of CPA on barriers to HIV disclosure, weighted to control for the effect of 
child sexual abuse and other potential confounders 
  Stratum-specific estimates  
Outcome Ethnoracial 
group 
Unweighted AEE Weighted Effect modification 
A
d
u
lt
 
p
h
y
si
ca
l 
a
b
u
se
 ¶
 
White 1.58 (1.38, 1.81) 1.23 (1.04, 1.44) REF 
Indigenous 1.87 (1.49, 2.34) 1.20 (1.02, 1.42) 0.98 (0.78, 1.23) 
Black African 2.10 (1.64, 2.68) 2.03 (1.41, 2.92) 1.65 (1.11, 2.46) 
Black Caribbean 3.32 (1.75, 6.31) 4.43 (1.97, 9.96) 3.61 (1.58, 8.24) 
Other 1.58 (1.07, 2.33) 0.92 (0.72, 1.17) 0.75 (0.56, 1.00) 
A
d
u
lt
  
se
x
u
a
l 
 
a
b
u
se
 ¶
 
White 1.63 (1.34, 1.98) 1.27 (0.98, 1.63) REF 
Indigenous 1.78 (1.28, 2.45) 0.98 (0.72, 1.32) 0.77 (0.52, 1.14) 
Black African 1.68 (1.27, 2.23) 1.40 (0.95, 2.05) 1.10 (0.70, 1.74) 
Black Caribbean 2.11 (1.03, 4.32) 2.20 (0.92, 5.27) 1.73 (0.70, 4.31) 
Other 1.97 (1.14, 3.38) 1.21 (0.68, 2.14) 0.95 (0.51, 1.78) 
S
ex
u
a
l 
in
a
ct
iv
it
y
 ¶
 White 1.03 (0.88, 1.21) 1.17 (0.91, 1.51) REF 
Indigenous 1.02 (0.78, 1.32) 0.97 (0.65, 1.45) 0.83 (0.52, 1.33) 
Black African 1.11 (0.87, 1.41) 1.10 (0.79, 1.53) 0.94 (0.62, 1.42) 
Black Caribbean 1.00 (0.65, 1.54) 1.31 (0.67, 2.54) 1.12 (0.55, 2.28) 
Other 0.78 (0.54, 1.12) 0.88 (0.54, 1.45) 0.75 (0.43, 1.32) 
S
ex
u
a
l 
re
la
ti
o
n
sh
ip
 
p
o
w
er
 ±
 
White -0.18 (-0.33, -0.04) -0.13 (-0.30, 0.03) REF 
Indigenous -0.11 (-0.35, 0.13) -0.03 (-0.24, 0.18) 0.10 (-0.16, 0.37) 
Black African -0.08 (-0.27, 0.10) 0.05 (-0.22, 0.31) 0.18 (-0.13, 0.49) 
Black Caribbean 0.01 (-0.37, 0.39) -0.10 (-0.42, 0.22) 0.04 (-0.32, 0.39) 
Other 0.24 (-0.21, 0.70) 0.59 (0.17, 1.02) 0.73 (0.27, 1.19) 
H
IV
  
S
ti
g
m
a
 ±
 
White 2.17  (0.84, 3.51) 2.09 (0.24, 3.94) REF 
Indigenous 0.89 (-1.26, 3.04) 1.73 (-0.91, 4.37) -0.36 (-3.59, 2.86) 
Black African 3.72 (2.01, 5.43) 1.40 (0.44, 5.92) 1.09 (-2.22, 4.40) 
Black Caribbean -0.37 (-3.75, 3.01) 0.50 (-2.54, 3.54) -1.59 (-5.15, 1.97) 
Other -1.22 (-4.12, 1.69) -2.83 (-6.49, 0.83) -4.92 (-9.02, -0.82) 
S
o
ci
a
l 
su
p
p
o
rt
 ±
 White -0.83 (-1.56, -0.10) 0.09 (-0.89, 1.07) REF 
Indigenous -0.54 (-1.53, 0.45) -0.25 (-1.78, 1.27) -0.34 (-2.15, 1.47) 
Black African -0.67 (-1.66, 0.31) -1.35 (-2.58, -0.11) -1.43 (-3.01, 0.14) 
Black Caribbean 0.98 (-1.13, 3.09) 1.09 (-0.81, 3.00) 1.01 (-1.14, 3.15) 
Other -2.45 (-4.31, -0.59) -2.72 (-4.88, -0.56) -2.81 (-5.18, -0.44) 
 
¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95% 
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null 
value of 1. 
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e. 
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals. 
Shaded cells represent those where the confidence interval does not cross the null value of 0.  
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Table 2: Effect of CSA on barriers to HIV disclosure, weighted to control for the effect of 
child physical abuse and other potential confounders 
  Stratum-specific estimates  
Outcome Ethnoracial 
group 
Unweighted Weighted Effect modification 
A
d
u
lt
 
p
h
y
si
ca
l 
a
b
u
se
 ¶
 
White 1.56 (1.38, 1.76) 1.26 (1.09, 1.47) REF 
Indigenous 1.64 (1.38, 1.94) 1.18 (0.99, 1.41) 0.93 (0.74, 1.18) 
Black African 1.48 (1.18, 1.86) 1.12 (0.88, 1.43) 0.89 (0.67, 1.18) 
Black Caribbean 1.56 (0.90, 2.70) 0.99 (0.59, 1.68) 0.78 (0.45, 1.36) 
Other 1.68 (1.21, 2.31) 1.19 (0.88, 1.62) 0.94 (0.67, 1.32) 
A
d
u
lt
  
se
x
u
a
l 
 
a
b
u
se
 ¶
 
White 1.91 (1.60, 2.29) 1.49 (1.18, 1.88) REF 
Indigenous 2.45 (1.77, 3.41) 1.97 (1.21, 3.21) 1.32 (0.77, 2.27) 
Black African 1.61 (1.22, 2.13) 1.32 (0.96, 1.81) 0.89 (0.60, 1.31) 
Black Caribbean 1.31 (0.58, 2.96) 1.06 (0.45, 2.53) 0.71 (0.29, 1.76) 
Other 2.93 (1.80, 4.77) 2.92 (1.53, 5.55) 1.96 (0.99, 3.89) 
S
ex
u
a
l 
in
a
ct
iv
it
y
 ¶
 White 0.95 (0.80, 1.12) 0.96 (0.77, 1.20) REF 
Indigenous 0.91 (0.72, 1.17) 1.01 (0.68, 1.51) 1.06 (0.67, 1.67) 
Black African 0.92 (0.65, 1.29) 0.81 (0.56, 1.16) 0.84 (0.55, 1.29) 
Black Caribbean 0.37 (0.11, 1.25) 0.35 (0.10, 1.21) 0.37 (0.10, 1.28) 
Other 0.89 (0.61, 1.31) 1.07 (0.64, 1.78) 1.11 (0.64, 1.94) 
S
ex
u
a
l 
re
la
ti
o
n
sh
ip
 
p
o
w
er
 ±
  
White -0.35 (-0.49, -0.21) -0.41 (-0.57, -0.24) REF 
Indigenous -0.13 (-0.37, 0.11) 0.32 (-0.12, 0.76) 0.73 (0.26, 1.20) 
Black African -0.08 (-0.32, 0.16) -0.05 (-0.31, 0.21) 0.36 (0.05, 0.67) 
Black Caribbean -0.05 (-0.44, 0.33) -0.16 (-0.65, 0.33) 0.25 (-0.27, 0.76) 
Other -0.23 (-0.62, 0.16) -0.08 (-0.52, 0.36) 0.33 (-0.15, 0.80) 
H
IV
  
S
ti
g
m
a
 ±
 
White 1.68 (0.33, 3.03) 1.75 (0.08, 3.41) REF 
Indigenous 0.14 (-1.80, 2.09) 0.55 (-2.07, 3.17) -1.20 (-4.31, 1.91) 
Black African 2.83 (0.56, 5.09) 2.34 (-0.21, 4.90) 0.59 (-2.46, 3.64) 
Black Caribbean 2.31 (-2.19, 6.81) 2.65 (-1.83, 7.13) 0.90 (-3.88, 5.69) 
Other 1.30 (-1.59, 4.18) 1.84 (-1.33, 5.02) 0.10 (-3.48, 3.68) 
S
o
ci
a
l 
su
p
p
o
rt
 ±
 White -1.35 (-2.09, -0.61) -0.94 (-1.91, 0.01) REF 
Indigenous -1.00 (-1.96, -0.04) -0.40 (-2.11, 1.31) 0.54 (-1.42, 2.50) 
Black African 0.03 (-1.23, 1.29) 0.19 (-1.27, 1.64) 1.13 (-0.61, 2.87) 
Black Caribbean 0.87 (-2.13, 3.87) 0.57 (-2.63, 3.77) 1.51 (-1.83, 4.86) 
Other -2.21 (-4.16, -0.26) -1.82 (-4.29, 0.65) -0.88 (-3.53, 1.77) 
 
¶ Indicates binary outcome variables. Effect estimates are prevalence ratios and their robust 95% 
confidence intervals. Shaded cells represent those where the confidence interval does not cross the null 
value of 1. 
± Indicates continuous outcome variables. Effect estimates are coefficients from linear regression (i.e. 
estimated difference in mean outcome for CPSA+ compared to CPSA-) and their 95% confidence intervals. 
Shaded cells represent those where the confidence interval does not cross the null value of 0.  
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RESEARCH EXPERIENCE 
 
MSc Thesis, Department of Epidemiology and Biostatistics, UWO 2016-2018 
Advisor: Dr. Greta Bauer, PhD MPH 
 Completed quantitative analysis of barriers to HIV status disclosure using advanced 
causal epidemiological methods (propensity score weighting, machine learning) 
 Adapted theoretical framework using eco-social theory and intersectionality to 
contextualize experiences of women living with HIV in Canada 
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Improving Quantitative Health Research Methods: Multidimensionality and 
Intersectionality, CIHR 
 Contributed to design of parent and youth surveys as well as clinical case report forms for 
a national study of transgender youth in clinical care. This included selecting, adapting, 
and developing survey measures valid for transgender youth and their families. Grant: 
Trans Youth CAN!, CIHR 
 Contributed to grant writing and study design for proposed national epidemiological 
study of transgender people in Canada. Grant: CIHR Spring 2018 Project Grant 
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methodological capacity for analytic intersectionality research in Canada. Grant: CIHR 
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Contract Researcher, International Centre for Science in Drug Policy 2017-2018 
Supervisor: Dr. Ayden Scheim, PhD 
 Completed title/abstract/full-text screening, and data extraction for a systematic review 
on effects of drug decriminalization/regulation, to be published in 2018 
 
Contract Researcher, LGBT Purge Class Action Lawsuit 2017 
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Supervisors: Crystal Palleschi, MSc and Dr. Sudit Ranade, MD MPH 
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